TWI322144B - Tetrahydroquinoline derivatives - Google Patents

Tetrahydroquinoline derivatives Download PDF

Info

Publication number
TWI322144B
TWI322144B TW91111887A TW91111887A TWI322144B TW I322144 B TWI322144 B TW I322144B TW 91111887 A TW91111887 A TW 91111887A TW 91111887 A TW91111887 A TW 91111887A TW I322144 B TWI322144 B TW I322144B
Authority
TW
Taiwan
Prior art keywords
alkyl
group
aryl
phenyl
heteroaryl
Prior art date
Application number
TW91111887A
Other languages
Chinese (zh)
Inventor
Straten Nicole Corine Renee Van
Someren Rudolf Gijsbertus Van
Jurgen Schulz
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Priority to TW91111887A priority Critical patent/TWI322144B/en
Application granted granted Critical
Publication of TWI322144B publication Critical patent/TWI322144B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

1322144 A7 _______B7 五、發明説明(1 ) 發明領城,: 本發明係關於一種具有F S Η調制活性之化合物,特 別地爲一種四氫鸣啉衍生物,含有該等化合物之藥學衍生 物,以及該等化合物用於醫學治療之用途。 發明背暑: 促性腺激素在人體有多種不同重要的功能,包括代謝 、溫度調節及生殖作用。促性腺激素作用在特殊類型的性 腺細胞上以造成卵巢及睪九分化及類固醇產生《例如腦下 垂體之促性腺激素F S Η (濾泡刺激素)對於刺激濾泡的 發展及成熟方面扮演著重要的角色;而L Η (黃體素)則 可導致排卵(Sharp,R.M.Clin Endocrinol.33:787-807 ,1990 ;Dorrington and Armstrong,Recent Prog. Horm.Res. 35 :301 -3 42,19 79) »近年來,F S H已被應用在臨床上,其係與L Η組合使用以刺激卵巢,例如在人工受精(IVF )時對卵巢 高度刺激以及在非自願性之不孕婦女誘發排卵( Insler,V_,Int.J.Fertility 33: 85-97,1988,Navot and Rosenwaks ,J.Vitro Fert.Embryo Transfer 5:3- 1 3,1 98 8 ),以及用來治療 男性性腺機能不足及男性不孕。 促性腺激素F S Η係在青春期早期受到促性腺激素一 釋放激素及雌激素的影響及懷孕期間從胎盤被釋放出來。 在雌性體內,F SH作用在卵巢上時會促進濾泡的發展且 爲調節雌激素分泌最重要的激素。在雄性體內,F SH則 負責輸精管的統整且作用在Sertoli細胞上以支援配子(精 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先閲讀背面之注意事項再填寫本頁) •項再填ΐ 經濟部智慧財產局員工消費合作社印製 -4- 1322144 A7 £7_ 五、發明説明(2) 子)形成。純化的F SH在臨床上係用來治療女性不孕及 男性某些無法生成精子的不孕類型。治療用的促性腺激素 可從人類脲液中分離出來但是純度很低(Morse et al, Amer. J. Reproduet. Immunol. And Microbiology 17:143,1988 )。另一選擇地,它們可用重組促性腺激素來製備。重組 人類F S Η爲市售可購得的且被用來幫助生育(Olijve et al. Mol.Hum.Reprod.2:37 1,1996;Devroey et al.Lancet 339:1 170, 1992)。 F S H激素的作用係由特殊的血漿膜受器所調制,其 爲G -蛋白質偶合型受器之大家庭的一名成員。此等受器 係由單獨一條多肽與七個經膜區域(transmenbrane domains )所組成,且可與G蛋白質交互反應,造成腺苷酸環化酶 的活化。 F S Η受器在卵巢濾泡的生長過程中爲一種具高度特 異性的標的且在卵巢內被排它性地表現。阻斷此受器或者 将F S Η -調制之受器活化經常誘發的訊號抑制掉時將會 干擾到濾泡的發展,因而影響到排卵及受孕。所以低分子 量的F S Η掊抗劑便構成了新穎避孕法的基礎。此等 F S Η拮抗劑可以減低濾泡的發展(不排卵)但是仍可維 持有足夠雌激素生成以避免不良的副作用如骨質流失。 發明目的及槪沭= 本發明係在說明低分子量激素類似物的製備,該類似 物對於F S Η受器有選擇性地調制活性。本發明化合物可 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) ,項再填 經濟部智慧財產局員工消費合作社印製 1322144 A7 B7 五、發明説明(3) 爲FSH-受器的(部份)激動劑或(部份)洁抗劑。 所以,本發明現在發現到如下式1之四氫1 _啉化合物 或藥學可接受鹽類具有F S Η -調制活性:1322144 A7 _______B7 V. INSTRUCTION DESCRIPTION OF THE INVENTION (1) The invention relates to a compound having FS Η modulation activity, in particular a tetrahydromorphine derivative, a pharmaceutical derivative containing the same, and The use of such compounds for medical treatment. Inventive heat: Gonadotropin has many important functions in the human body, including metabolism, temperature regulation and reproduction. Gonadotropin acts on specific types of gonadal cells to cause ovarian and sputum differentiation and steroid production. For example, the gonadotropin FS Η (follicle stimulating hormone) of the pituitary gland plays an important role in stimulating the development and maturation of follicles. Role; L Η (luteal voxel) can cause ovulation (Sharp, RMClin Endocrinol. 33: 787-807, 1990; Dorrington and Armstrong, Recent Prog. Horm. Res. 35:301 -3 42,19 79) »In recent years, FSH has been used clinically, in combination with L Η to stimulate the ovaries, such as high ovarian stimulation during artificial insemination (IVF) and ovulation in involuntary infertile women (Insler, V_ , Int. J. Fertility 33: 85-97, 1988, Navot and Rosenwaks, J. Vitro Fert. Embryo Transfer 5: 3- 1 3, 1 98 8 ), and used to treat male hypogonadism and male infertility. The gonadotropin F S steroid is affected by gonadotropin-releasing hormone and estrogen during early adolescence and is released from the placenta during pregnancy. In females, F SH acts on the ovary to promote follicular development and is the most important hormone regulating estrogen secretion. In males, F SH is responsible for the integration of the vas deferens and acts on Sertoli cells to support gametes (the standard paper size applies to the Chinese National Standard (CNS) Α4 specification (210Χ297 mm) (please read the notes on the back first) Fill in this page) • Re-filling ΐ Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print -4- 1322144 A7 £7_ V. Invention Description (2) Sub) Formation. Purified F SH is clinically used to treat female infertility and certain types of infertility in men who are unable to produce sperm. Therapeutic gonadotropins can be isolated from human urea fluids but are of low purity (Morse et al, Amer. J. Reproduet. Immunol. And Microbiology 17: 143, 1988). Alternatively, they can be prepared using recombinant gonadotropins. Recombinant human F S Η is commercially available and used to aid fertility (Olijve et al. Mol. Hum. Reprod. 2: 37 1, 1996; Devroey et al. Lancet 339: 1 170, 1992). The action of the F S H hormone is modulated by a special plasma membrane receptor, a member of the family of G-protein coupled receptors. These receptors consist of a single polypeptide and seven transmenbrane domains and interact with the G protein to cause activation of adenylate cyclase. The F S receptor is a highly specific target during the growth of ovarian follicles and is exclusively expressed in the ovary. Blocking this receptor or suppressing the signal often induced by F S Η -modulated receptor activation will interfere with the development of follicles, thus affecting ovulation and conception. Therefore, low molecular weight F S antagonists form the basis of novel contraceptive methods. These F S Η antagonists can reduce the development of follicles (no ovulation) but still maintain sufficient estrogen production to avoid undesirable side effects such as bone loss. OBJECTS AND 槪沭 = The present invention is directed to the preparation of low molecular weight hormone analogs which selectively modulate activity for F S receptors. The compound of the present invention can be applied to the Chinese National Standard (CNS) Α4 specification (210X297 mm) on the paper scale (please read the note on the back and then fill in the page), and then fill in the Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 1322144 A7 B7 V. INSTRUCTIONS (3) A (partial) agonist or (partial) antagonist of the FSH-receiver. Therefore, the present inventors have now found that a tetrahydro-1 porphyrin compound of the following formula 1 or a pharmaceutically acceptable salt has F S Η -modulating activity:

(請先閲讀背面之注意事· 經濟部智慧財產局員工消費合作社印製 其中 R1爲甲醯基、(1—6C)烷羰基或(1 — 6C)烷磺醯 基; R2及R3爲Η或(1 — 4C)烷基; R4爲苯基,其可任意地爲一或多個取代基所取代,該等取 代基係選自羥基、胺基、鹵素、硝基、三氟甲基、氰基、 (1 — 4C)烷基、(2 — 4C)烯基、(2 — 4C)炔 基(1 — 4C)烷氧基、(1-4C)(二)烷胺基。較 佳的取代位置係在對位。 R5爲(1— 4C)烷基; Υ — Χ爲 C (0) - ◦,S (◦) 2-〇, NHC (0) - 〇,NHC (S)-0,0C (0)-〇 ,鍵結—0,C (Ο) -NH,S (0)2 — NH, NHC (0) - NH - NHC (S) - NH > OC(〇)一NH,鍵結一NH,NH-C(0), 〇 — C ( 0 ) ’ NH— S (0) 2,或 0— S (0) 2,或 X — Y表示鍵結; 項再填· 裝-- 寫本頁) -5 4 本纸張尺度適用中國國家標準(CNS > A4規格(210X297公釐) -6- ^144(Please read the notes on the back first. · Printed by the Intellectual Property Office of the Ministry of Economic Affairs, where R1 is methyl ketone, (1-6C) alkylcarbonyl or (1-6C) alkanesulfonyl; R2 and R3 are Η or (1-4C)alkyl; R4 is phenyl which may be optionally substituted by one or more substituents selected from the group consisting of hydroxyl, amine, halogen, nitro, trifluoromethyl, cyano Base, (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl(1-4C)alkoxy, (1-4C)(di)alkylamino. Preferred substitution The position is in the para position. R5 is (1-4C) alkyl; Υ - Χ is C (0) - ◦, S (◦) 2-〇, NHC (0) - 〇, NHC (S)-0, 0C (0)-〇, bonding—0,C (Ο) -NH,S (0)2 — NH, NHC (0) - NH - NHC (S) - NH > OC(〇)-NH, bonding An NH, NH-C(0), 〇-C(0) 'NH-S(0) 2, or 0-S(0) 2, or X-Y represents a bond; item refilling-loading--writing This page) -5 4 This paper scale applies to Chinese national standards (CNS > A4 specification (210X297 mm) -6- ^144

發明説明(4) A7 B7 R6爲氫,三氟甲基,(1 — 6C)烷基,1—或2 燒基(1 一 4C)烷基,(2 - 6)烯基,(2〜 块基,(6_l〇c)芳基’ (3〜9C)雜芳基 〜6c)環烷基’ (2 — 6C)雜環烷基, 燒硫(1 — 4C)烷基,(6 — l〇c)芳基(1 1燒基’ (3 — 9C)雜芳基(1—4C)烷基, 6 6C)環烷基(1 — 4C)烷基’ (2 — 6C)雜 (1〜4C)燒基,rb,R9 —胺羰基(i_4C ,R8,R9 一胺基(1 — 4C)烷基,r8 —氧羧 4C)垸基,R8_氧基(1 —4C)院基,DESCRIPTION OF THE INVENTION (4) A7 B7 R6 is hydrogen, trifluoromethyl, (1 - 6C) alkyl, 1- or 2-alkyl (1 - 4C) alkyl, (2 - 6) alkenyl, (2~ Base, (6_l〇c) aryl '(3~9C)heteroaryl~6c)cycloalkyl' (2-6C)heterocycloalkyl, sulfur-burning (1-4C)alkyl, (6-l〇 c) aryl (1 1 alkyl '(3 - 9C)heteroaryl(1-4C)alkyl, 6 6C)cycloalkyl(1-4C)alkyl' (2-6C) hetero (1~4C) ), rb, R9 - amine carbonyl (i_4C, R8, R9-amino (1 - 4C) alkyl, r8 - oxycarboxy 4C) fluorenyl, R8_oxy (1-4C),

R 環 基 金岡!| C ) (3 C ) 4 C 3 - 烷基 烷基 (1 羰基 〜4 C )烷基;R ring base Jingang!| C ) (3 C ) 4 C 3 - alkylalkyl (1 carbonyl ~ 4 C ) alkyl;

若R 若R 6爲氫,應注意χ — γ不可爲 6爲苯基,該苯基除了如定義 鍵結。 所提到地可具有(6 -0 C )芳基的取代基以外,其取代基還可以任意地爲( 經濟部智慧財產局8工消費合作社印製 6 - C ) 3 -烷氧 ,( -4 氧基 基, 基, (二If R is R 6 , it should be noted that χ - γ cannot be 6 as a phenyl group, except for the definition of a bond. In addition to the substituents which may have a (6-0C) aryl group, the substituents may also be optionally (6-C printed by the Ministry of Economic Affairs, 8th C.). 4 oxy group, group, (two

10C)芳基,(6 — 10C)芳氧基,(6 — 1〇 芳基(1— 4C)烷氧基, 9C)雜芳氧基,(3_9 基,(1 — 4C)烷羰胺基 3—6C)環烷羰氧基,( C)院簾氧基,(1一4C (6—10C)芳羰氧基 (3 — 9C)雜芳基,( C )雜芳基(1 一 4 C ) (1 — 4 C ) 1 — 4 C )院氧 )烷氧(1 - 4 (1—4C)烷磺醯氧基, (1 - 4 C )(二)烷基胺甲醯基,(6-)芳基胺甲醯基,(2—6C)雜環烷基胺 烷羰氧基 羰基(1 C )氧羰 雜芳羰氧 芳磺醯氧 1 0 c ) 甲醯基, ,. n 裝 ^ 訂 (請先閱讀背面之注意事項再填寫本頁) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1322144 Α7 Β7 五、發明説明(5) (6 — 10C)(二)芳胺基,(3 — 6C)環烷基,( 3 — 6C)環烷基(1 — 4C)烷基,(2 - 6C)雜環 烷基,(2 — 6 C )雜環烷基(1 — 4 C )烷基。 R7爲氫,(1 — 4C)烷基,(1 — 4C)烷氧基,鹵 素,三氟甲基,氰基,硝基,羥基; R8及/或R9爲氫,(1—4C)烷基,(2-4C)燃 基,(2 — 4C)炔基,(6 — 10C)芳基,(3 — 9 c)雜芳基,(6 — 10C)芳基(1— 4C)烷基’( 3 — 9C)雜芳基(1 — 4C)烷基,(3-6C)環烷 基(1 — 4C)烷基,(2 - 6C)雜環烷基(1 — 4C )烷基,(1 — 4C)(二)烷胺基(1— 4C)烷基, (1 — 4C)烷氧基(1 一 4C)烷基,(1— 4C)烷 硫基(1— 4C)烷基,(1-4C)烷羰胺基(1一4 C)烷基,(1-4C)烷氧羰基(1— 4C)烷基,( 1 — 4C)烷氧羰胺基(1 — 4C)烷基,(3 — 6C) 環烷基,(2 — 6C)雜環烷基或R8及R9可聯合成一個 (2 — 6 C )雜環烷基之環。 本發明之化合物具有調制F S Η受器之功能,如果它 們的作用有如激動劑般,那麼便可以用在與天然F S Η作 用相同的臨床目的上,此外還具有經改變之安定性且可以 經不同途徑來投藥的優點。如果該等化合物會阻斷F S Η 受器,那麼它們便可以用在例如避孕的目的上。 所以,本發明之F S Η -受器調制劑可以用來治療不 孕,避孕及治療與激素有關的異常如乳癌' 前列腺癌及子 本纸張尺度適用中國國家標準(CNS)A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 項再填☆ 經濟部智慧財產局員工消費合作社印製 -8- 1322144 Α7 Β7 經濟部智慧財產局員工消費合作社印製 五、發明説明(6) 宮內膜炎。較佳地,本發明化合物係用來使F SH -受器 失活化。 在定義中使用術語(1 - 4 C )烷基時係意指具有1 一 4個碳原子的分支或不分支烷基,如甲基、乙基、丙基 、異丙基、丁基、第二丁基及第三丁基。 在定義中使用術語(1 - 6 C )烷基時係意指具有1 -6個碳原子的分支或不分支烷基,如甲基、乙基、丙基 、異丙基、丁基 '第二丁基、第三丁基及己基等。以(1 一 5 C)烷基者較佳,以(1 — 4C)烷基者最佳。 術3吾1 —或2 -金剛院(1 一 4 C )院基意指一個金 剛烷基被依附在含有1 - 4個碳原子之烷基的第1或第2 位置上,其中該烷基具有前文定義的相同意義。 術語(2 - 4 C )嫌基意指具有2 - 4個碳原子之分 支或不分支烯基如乙烯基及2 - 丁烯基。 術語(2 - 6 C )烯基意指具有2 - 6個碳原子之分 支或不分支烯基如乙烯基、2 -丁烯基及正戊烯基。 術語(2 — 4C)炔基意指具有2- 4個碳原子之分 支或不分支烯基如乙炔基及丙炔基。 術語(2 — 6 C)炔基意指具有2 -6個碳原子之分 支或不分支烯基如乙炔基'丙炔基及正戊炔基。 術語(3 - 6 C )環烷基意指具有3 — 6個碳原子之 環烷基,其可爲環丙基' 環丁基、環戊基及環己基。 術s吾(2 — 6 C )雜環院基意指具有2 - 6個碳原子 之雜環烷基,其較佳地具有3 - 5個碳原子,且至少包括 (請先閱讀背面之注意事 I# •項再填· 裝— ,寫本買) 訂 Φ. 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -9 - 1322144 A7 _B7 五、發明説明(7 ) (請先閲讀背面之注意事項再填寫本頁) 一個選自N、◦及/或S之雜原子,若適當其可透過一·雜 原子或碳原子來被依附。較佳的雜原子爲氮或氧。最佳的 例子爲哌啶、嗎啉及吡咯啶。 術語(1 一 4 C)烷氧基意指具有1 一 4個碳原子的 烷氧基,其中該烷基部份具有如前文定義之相同意義。以 (1_2C)烷氧基爲佳》 術語(6_10C)芳基意指具有6—10個碳原子 之芳香族烴,如苯基、萘基、四氫萘基或節基,其可任意 地爲一或多個取代基取代,該等取代基係選自羥基、胺基 、鹵素、硝基、三氟甲基、氰基、(1— 4C)烷基、( 2 — 4C)烯基、(2 — 4C)炔基、(1 — 4C)烷氧 基'(1-4C)(二)烷胺基,該烷基部份具有如前文 所定義之相同意義。較佳的芳香族烴基爲苯基。 術語(3 — 9 C )雜芳基意指具有3 — 9個碳原子之 芳香族基,其可有取代或無取代且至少包括一個選自氮氧 及/或硫之雜原子,例如咪唑基、噻二唑基、吡啶基、( 苯并)噻吩基、(苯并)呋喃基、喹啉基、四氫喳啉基、 經濟部智慧財產局員工消費合作社印製 0奎噁啉基或吲哚基。雜芳基上的取代基可以選自列爲芳基 取代基之群組中。若適當該雜芳基可透過碳原子或雜原子 來被依附。較佳的雜芳基爲噻吩基、呋喃基及吡啶基》 術語(6 — 1 0C)芳氧基意指一個前文定義之6 — 10個碳原子之芳基依附在一氧原子上。(3-9C)雜 芳氧基爲(3 — 1 0碳)芳氧基之類似物,其含有至少一 個選自氮、氧及硫之雜原子。 本纸張尺度適用中國國家標準(CNS ) A4規格(21〇Χ297公釐) -10- 1322144 A7 B7 五、發明説明(8) 術語(1 一 4 C )烷氧羰基(1 — 4 C )烷基意指一 種烷氧羰基烷基,其中含有1 - 4個碳原子之烷氧基部份 具有前文定義之相同意義且含有1 - 4個碳原子之烷基貝IJ 具有前文定義之相同意義。 術語(1 一 4C)烷氧基(1 一 4C)烷基意指一種 烷氧基烷基,其中含有1 - 4個碳原子之烷氧基部份具有 前文定義之相同意義且含有1 - 4個碳原子之烷基則具有 前文定義之相同意義。 術語(3 - 6 C)環垸基(1 — 4 C)院基意指有3 _ 6個碳原子之環院基依附在任一種1 - 4個碳原子之院 基上,其中該環烷基爲前文定義之(3 - 6 C )環烷基且 該烷基爲前文定義之(1 — 4C)烷基。 術語(2 — 6C)雜環烷基(1 一 4 C)烷基意指有 2 - 6個碳原子之雜環烷基依附在任一種1 - 4個碳原子 之烷基上,其中該雜環烷基爲前文定義之(2 - 6 C )雜 環烷基且該烷基爲前文定義之(1 - 4C)烷基。 術語(1 一 4 C )(二)烷胺基意指一種(二)烷胺 基,其烷基含有1 - 4個碳原子且具有前文定義之相同意 義。 術語(6-10C)(二)芳胺基意指一種(二)芳 胺基,其芳基含有6 - 1 0個碳原子且據有前文定義之相 同意義。 術語(1 — 4C)(二)烷胺基(1-4C)烷基意 指一種(二)烷胺烷基,其烷基含有1 - 4個碳原子且具 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 項再填{! 經濟部智慧財產局員工消費合作社印契 -11 - 1322144 經濟部智慧財產局員工消費合作社印製 Α7 Β7 五、發明説明(9) 有前文定義之相同意義。 術語(1 - 4 C )烷硫基(1 — 4 C )烷基意指一種 烷硫烷基,其烷基含有1 - 4個碳原子且具有前文定義之 相同意義。 在R8,R9 —胺羯基(1 — 4 C )院基之定義中的術 語胺羰基(1 -4 C)烷基意指一種胺羰烷基,其烷基含 有1 -4個碳原子且具有前文定義之相同意義。以胺羰基 甲基爲較佳的胺羰基烷基。 在R 8,R9 —胺基(1 — 4 C)烷基之定義中的術語 胺基(1 _4 C )烷基意指一種胺烷基,其烷基含有1 一 4個碳原子且具有前文定義之相同意義。 在R8-氧羰基(1-4C)烷基之定義中的術語氧羰 基(1 一 4 C )烷基意指一種氧羰烷基,其烷基含有1 一 4個碳原子且具有前文定義之相同意義。以氧羰甲基爲較 佳的氧羰烷基。 在R8 —氧(1 -4 C)烷基之定義中的術語氧(1 一 4 C )烷基意指一種氧烷基,其烷基含有1 - 4個碳原子 且具有前文定義之相同意義。 在R8 —羰基(1 _ 4 C)烷基之定義中的術語簾基( 1 一 4C)烷基意指一種羰烷基,其烷基含有1 — 4個碳 原子且具有前文定義之相同意義。 術語(6_ 1 0C)芳基(1 — 4C)烷基意指—種 具有7 - 1 4個碳原子之芳烷基,其中同前文定®般院基 爲(1 — 4C)烷基且芳基爲(6 — 1 0C)芳基。以苯 本紙張尺度適用中國國家榇準(CNS ) Α4規格(2丨Ο X 297公釐) I I I*— I I —裝— I I —I I 訂— I I I I (請先閲讀背面之注意事項再填寫本頁) -12 - 1322144 A7 B7 五、發明説明(0 (請先閱讀背面之注意事項再填寫本頁) (1 — 4C)烷基爲較佳的芳烷基,如苯甲基。(3 - 9 c)雜芳基(1 — 4C)烷基爲(6 — 10C)芳基(1 一4C)烷基之類似物,其含有至少一個選自氮、氧及/ 或硫之雜原子,若適合該雜芳基可經由碳原子或雜原子來 被依附。 在NR8R9的定義中術語”結合成(2 — 6C)雜環 烷基之環”,其中R8及R9共同與其所依附的氮原形成一 個環,其意指一個含氮環且其最多另含有2 - 6個碳原子 ’該環還可以額外含有一或多個選自氮、氧及/或硫之雜 原子。此等環之實例有吖丁啶、吡咯定、哌啶、哌嗪及( 噻)嗎啉。 術語鹵素意指氟、氯、溴或碘。 · 術語(1 一 6 C )烷羰基意指一種烷羰基,其烷基含 有1 - 6個碳原子且具起前文定義之相同意義。以(1 — 4 C )烷羰基較佳。 經濟部智慧財產局員工消費合作社印製 術語(1 一 4 C )烷羰胺基(1 一 4 C )烷基意指一 種烷羰胺烷基,其烷基含有1 - 4個碳原子且具有前文定 義之相同意義。 術語(6 - 1 0C)芳基(1 — 4C)烷氧基意指一 種同前文定義之6 - 1 0個碳原子之芳基依附到一個同前 文定義之(1— 4C)烷氧基上。(3 - 9C)雜芳基( 1 — 4C)院氧基爲(6 - 1 0C)芳基(1 — 4C)院 氧基之類似物,其含有至少一個選自氮、氧及/或硫之雜 原子,若適合該雜芳基可經由碳原子或雜原子來被依附。 本纸張尺度適用中國國家標準(CNS)A4規格(210x297公楚) 1322144 A7 B7 五、發明説明(11) (請先閲讀背面之注意事項再填寫本頁) 術語(1 — 4C)烷氧羰基(1_4C)烷羰氧基意 指一個(1 一 4 C )烷氧羰基依附到一個烷基部份含有1 - 4個碳原子之院裁氧基上,其院氧基具前文定義之相同 意義。 術語(1 — 4 C )院氧基(1 — 4 C院羰氧基意指一 個1 - 4個碳原子之烷氧基依附到1 一 4個碳原子之烷羰 氧基上,該烷氧基及烷基具有前文定義之相同意義。 術語(1 一 4 C )烷羰胺基意指烷基含有1 — 4個碳 原子之烷羰胺基。 術語(1-4C)烷氧羰胺基(1 一 4C)烷基意指 一個同前文定義之1 - 4個碳原子之烷氧羰基依附到一個 胺烷基上,該烷基含有1 - 4個碳原子且具有前文定義之 相同意義。 經濟部智慧財產局員工消費合作社印製 術語(6_1 0C)芳羰氧基意指一種具有6-1 0 個碳原子之芳基。較佳的芳羰氧基爲苯羰氧基。(3-9 C )雜芳羰氧基爲(6 - 1 0 C )芳羰氧基之類似物,其 含有至少一個選自氮、氧及/或硫之雜原子,且若適合可 經由碳原子或雜原子來被依附。 術語(1 _4 C)烷磺醯基意指一種烷磺醯基,其烷 基含有1 - 6個碳原子且具有前文定義之相同意義。以( 1 — 3C)烷磺醯基爲佳。 術語(1 一 4 C)烷磺醯氧基意指一種烷磺醯氧基’ 其烷基含有1 - 4個碳原子且具有前文定義之相同意義° 以(1 — 3 C)烷磺醯氧基爲佳。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -14- 1322144 A7 B7 五、發明説明(1匀 術語(6 — 1 0 C )芳磺醯氧基意指一種芳磺醯氧基 ,其芳基具有6 - 1 0個碳原子且具有前文定義之相同意 義。以苯磺醯氧基爲佳。(3 — 9C)雜芳磺醯氧基爲( 6 - 1 0 C )芳磺醯氧基之類似物,其含有至少一個選自 氮、氧及/或硫之雜原子,且若適合可經由碳原子或雜原 子來被依附。 術語(1 一 4C)(二)烷基胺甲醯基意指一種(二 )烷基胺甲醯基,其烷基含有1 - 4個碳原子且具有前文 定義之相同意義。 術語(6 — 1 0 C )(二)芳基胺甲醯基意指一種( 二)芳基胺甲醯基,其芳基物份含有6 - 1 0個碳原子且 具有前文定義之相同意義。 術語(2 - 6 C )雜環烷基胺甲醯基意指一種雜環院 基胺甲醯基,其雜環烷基含有2 - 6個碳原子且具有前文 定義之相同意義。 本發明較佳化合物爲式I化合物,其中Y - X爲 C (0) - NH,0C (〇) — NH 或 C (〇.) — 〇。最 佳的化合物爲其中Y — X無c (0) - NH者。 更佳之化合物爲其中R1爲(1 _4 C)烷羰基,較佳 地爲乙醯基及/或R2及/或R3及R5各自爲(1 — 4C )烷基,較佳爲甲基。 R 較佳地爲一主體基(bulky group)。較佳的化合物 爲其中R6爲(6 — 10C)芳基,(3 — 9C)雜芳基, (6 — 1 〇C)芳基(1—4C)烷基或(3 — 9C)雜 本纸張尺度適用中國國家標隼(CNS > Α4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) •項再填ΐ 經濟部智慧財產局員工消費合作社印製 -15- 1322144 經濟部智慧財產局員工消費合作社印製 A7 _____B7_五、發明説明(1玲 芳基(1 一 4 C)烷基者。最佳的化合物爲其中R6爲(6 -10C)芳基’最好爲苯基。較佳的R7基爲氫,(1一 4 C)烷基或(1 — 4C)烷氧基。最佳者爲氫或(1 - 4 C )烷基,最好爲氫或甲基。最好的化合物爲r7爲η者 0 根據本發明,最佳的化合物中R 1爲(1 _ 4 C )烷羰 基,R2,R3 ’ R5各自爲(1—4C)烷基,R4爲苯基 且Υ — Χ爲C (〇) — ΝΗ且R7爲Η。最好的化合物爲其 中R1爲乙醯基,R2,R3,R5各自爲甲基,R4爲苯基 且Υ—Χ爲C (〇)—ΝΗ且R7爲Η。正如同在基團的定 義中所說明地,是容許對上述較佳化合物進行取代的。在 R 6中的苯基可以如R 6定義所述般進一步地被取代。··- • 1 丨.· 於本發明中排除的化合物有1 -乙醯基-6 -苯甲醯 胺基—4— (4-甲苯基)一1 ,2,3,4_四氫一 2 ’ 2,4一三甲基喹啉,1 一乙醯基一 4 —苯基一 1 ,2 ,3 ,4_四氫一2,2 ,4 ,6—四甲基喹啉,1 一乙 酿基—4 苯基一 1 ,2,3,4 —四氮—2,2,4,6 ,8_五甲基α奎啉,1—乙醯基—6 —甲氧基—4 —苯基 -1 ,2 ’ 3 ,4 —四氫一2,2,4 —三甲基奎啉,1 一乙醯基—6 —三氟乙醯胺基一4— (4 —甲苯基)一1 ,2 ,3 ’ 4 —四氫一 2 ,2 ,4 —三甲基π奎啉,1 一乙 醯基—6 —三氟乙醯胺基—4 —苯基—1 ,2,3,4一 四氫—2 ’ 2,4 —三甲基d奎啉,1—乙醯基一 4 一(4 一氯苯基)—1 ,2,3,4 一四氫—2,2,4,6_ 本纸張尺度適用中國國家標率(CNS )八姑^ ( 210Χ297公釐) (請先閲讀背面之注意事項再填寫本頁) ΙΦ 項再填」 裝· 訂 -16- 1322144 A7 B7 五、發明説明( 四甲基d奎啉及1—乙醯基_4 一(4 —溴苯基) ,3,4 一四氫一2,2,4,6-四甲基喹啉。 1 ,2 此等排除係關於 Ref.Zh.,Khim,Abstr.No.lZh311, 1 972;Khim.Geterosikl.Soedin.7:795,1 97 l;Ambinter.Screening Collection.order nrs 28020-A0839/0039328(CAS 3 10456-97-4) 及-A0705/0032919(CAS 327981-38-4);ChemDiv Inc . order nr 8005-9747(CAS360760-14-l);ChemStar.Product.list,nr. CHS 006 5 4 1 3 (C A S 2994 1 8 - 67 - 0); Asi nex Compound Collection, order nr BAS0068990(CAS 299970-20-0 )之揭示。 在此大略地顯示製備本發明化合物之適當方法: R710C) aryl, (6-10C) aryloxy, (6 - 1 aryl (1-4C) alkoxy, 9C) heteroaryloxy, (3-9, (1-4C) alkylcarbonyl) 3-6C) cycloalkylcarbonyloxy, (C) alcoxy, (1 - 4C (6-10C) arylcarbonyloxy (3-9C) heteroaryl, (C) heteroaryl (1 - 4) C) (1 - 4 C ) 1 - 4 C ) alkoxy)alkoxy (1 - 4 (1-4C) alkanesulfonyloxy, (1 - 4 C )(di)alkylaminecarbamyl, ( 6-) arylamine-carbamyl, (2-6C)heterocycloalkylamine alkylcarbonyloxycarbonyl (1 C)oxycarbonyl aryl aryloxy sulfonyloxy 1 0 c ) formazan, ,. Install and order (please read the note on the back and fill in this page) This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) 1322144 Α7 Β7 V. Invention description (5) (6-10C) 2) an arylamino group, (3-6C)cycloalkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl, (2-6C)heterocycloalkane Base (1 - 4 C ) alkyl. R7 is hydrogen, (1-4C)alkyl, (1-4C)alkoxy, halogen, trifluoromethyl, cyano, nitro, hydroxy; R8 and/or R9 are hydrogen, (1-4C) Base, (2-4C) ruthenium, (2 - 4C) alkynyl, (6 - 10C) aryl, (3 - 9 c) heteroaryl, (6 - 10C) aryl (1-4C) alkyl '( 3 - 9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (1 - 4C) (di)alkylamino (1-4C)alkyl, (1-4C)alkoxy(1-4C)alkyl, (1-4C)alkylthio(1-4C)alkyl (1-4C)alkylcarbonylamino (1-4 C)alkyl, (1-4C) alkoxycarbonyl (1-4C)alkyl, (1-4C) alkoxycarbonylamino (1-4C) Alkyl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl or R8 and R9 may be combined to form a ring of (2-6C)heterocycloalkyl. The compounds of the present invention have the function of modulating FS receptors, and if they function as agonists, they can be used for the same clinical purpose as natural FS ,, in addition to having altered stability and can be different The advantages of the route to the drug. If these compounds block the F S receptor, they can be used, for example, for contraception purposes. Therefore, the FS Η-receiver modulator of the present invention can be used for treating infertility, contraception and treatment of hormone-related abnormalities such as breast cancer 'prostate cancer and sub-paper scale applicable to China National Standard (CNS) A4 specification (210X297 public)厘) (Please read the notes on the back and fill out this page) Refill ☆ Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed -8- 1322144 Α7 Β7 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed V. Invention Description ( 6) Endometritis. Preferably, the compounds of the invention are used to deactivate the FSH-receptor. The term (1 - 4 C )alkyl is used in the definition to mean a branched or unbranched alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, Dibutyl and tert-butyl. When the term (1 - 6 C )alkyl is used in the definition, it means a branched or unbranched alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl' Dibutyl, tert-butyl and hexyl, and the like. Preferably, it is preferably a (1 - 5 C) alkyl group and a (1-4C) alkyl group. 3, 1 or 2 - King Kong (1 - 4 C ), means that an adamantyl group is attached to the first or second position of an alkyl group having 1 to 4 carbon atoms, wherein the alkyl group Has the same meaning as defined above. The term (2 - 4 C ) is intended to mean a branched or unbranched alkenyl group having 2 to 4 carbon atoms such as a vinyl group and a 2-butenyl group. The term (2 - 6 C )alkenyl means a branched or unbranched alkenyl group having 2 to 6 carbon atoms such as a vinyl group, a 2-butenyl group and a n-pentenyl group. The term (2 - 4C) alkynyl means a branched or unbranched alkenyl group having 2 to 4 carbon atoms such as an ethynyl group and a propynyl group. The term (2-6 C)alkynyl means a branched or unbranched alkenyl group having 2 to 6 carbon atoms such as ethynyl 'propynyl and n-pentynyl. The term (3 - 6 C )cycloalkyl means a cycloalkyl group having 3 to 6 carbon atoms which may be a cyclopropyl 'cyclobutyl group, a cyclopentyl group and a cyclohexyl group. The heterocyclic alkyl group having 2 to 6 carbon atoms, which preferably has 3 to 5 carbon atoms, and at least includes (please read the back of the note first) I# • Refilling · Loading — , writing to buy) Φ. This paper scale applies to China National Standard (CNS) Α 4 specification (210X297 mm) -9 - 1322144 A7 _B7 V. Invention description (7 ) (Please Read the precautions on the back and fill out this page. A hetero atom selected from N, ◦ and/or S, if appropriate, can be attached via a hetero atom or carbon atom. Preferred heteroatoms are nitrogen or oxygen. The most preferred examples are piperidine, morpholine and pyrrolidine. The term (1-4C)alkoxy means an alkoxy group having 1 to 4 carbon atoms, wherein the alkyl moiety has the same meaning as defined above. The (1_2C) alkoxy group is preferred. The term (6-10C) aryl means an aromatic hydrocarbon having 6 to 10 carbon atoms, such as a phenyl group, a naphthyl group, a tetrahydronaphthyl group or a benzyl group, which may be optionally Substituted by one or more substituents selected from the group consisting of hydroxyl, amine, halogen, nitro, trifluoromethyl, cyano, (1-4C)alkyl, (2-4C)alkenyl, 2 - 4C) alkynyl, (1-4C)alkoxy '(1-4C)(di)alkylamino group having the same meaning as defined above. A preferred aromatic hydrocarbon group is a phenyl group. The term (3-9C)heteroaryl means an aromatic radical having 3 to 9 carbon atoms which may be substituted or unsubstituted and which includes at least one hetero atom selected from nitrogen oxides and/or sulfur, such as imidazolyl. , thiadiazolyl, pyridyl, (benzo)thienyl, (benzo)furanyl, quinolyl, tetrahydroporphyrinyl, Ministry of Economic Affairs, Intellectual Property Office, employee consumption cooperative, printing 0 quinoline or hydrazine哚基. The substituent on the heteroaryl group may be selected from the group listed as an aryl substituent. If appropriate, the heteroaryl group can be attached via a carbon atom or a hetero atom. Preferred heteroaryl groups are thienyl, furyl and pyridyl. The term (6-10C) aryloxy means that an aryl group of 6 to 10 carbon atoms as defined above is attached to an oxygen atom. (3-9C) Heteroaryloxy is an analog of a (3 - 10 carbon) aryloxy group containing at least one hetero atom selected from the group consisting of nitrogen, oxygen and sulfur. This paper scale applies to China National Standard (CNS) A4 specification (21〇Χ297 mm) -10- 1322144 A7 B7 V. Description of invention (8) Term (1 - 4 C ) alkoxycarbonyl (1 - 4 C ) alkane The base means an alkoxycarbonylalkyl group in which an alkoxy moiety having 1 to 4 carbon atoms has the same meaning as defined above and an alkylene group IJ having 1 to 4 carbon atoms has the same meaning as defined above. The term (1-4C)alkoxy(1-4C)alkyl means an alkoxyalkyl group in which the alkoxy moiety having 1 to 4 carbon atoms has the same meaning as defined above and contains 1 - 4 The alkyl group of one carbon atom has the same meaning as defined above. The term (3 - 6 C)cyclodecyl (1 - 4 C), means that a ring of 3 to 6 carbon atoms is attached to any of the groups of 1 to 4 carbon atoms, wherein the cycloalkyl group (3-6C)cycloalkyl as defined above and the alkyl group is a (1-4C)alkyl group as defined above. The term (2-6C)heterocycloalkyl(1 -4 C)alkyl means that a heterocycloalkyl group having 2 to 6 carbon atoms is attached to an alkyl group of any of 1 to 4 carbon atoms, wherein the heterocyclic ring The alkyl group is a (2 - 6 C)heterocycloalkyl group as defined above and the alkyl group is a (1-4C)alkyl group as defined above. The term (1 - 4 C ) (di)alkylamino means a (di)alkylamino group having an alkyl group having 1 to 4 carbon atoms and having the same meaning as defined above. The term (6-10C)(di)arylamino group means a (di)arylamine group having an aryl group having 6 to 10 carbon atoms and having the same meaning as defined above. The term (1-4C)(di)alkylamino(1-4C)alkyl means a (di)alkylaminoalkyl group having an alkyl group of 1 to 4 carbon atoms and having a paper scale applicable to Chinese national standards ( CNS ) A4 specification (210X297 mm) (Please read the notes on the back and fill out this page) Re-filling the item {! Ministry of Economic Affairs Intellectual Property Office Staff Cooperatives Printing Seal -11 - 1322144 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative System 7 Β 7 V. Invention Description (9) has the same meaning as defined above. The term (1-4C)alkylthio(1-4C)alkyl means an alkylsulfanyl group having an alkyl group having from 1 to 4 carbon atoms and having the same meaning as previously defined. The term amine carbonyl (1 -4 C)alkyl as defined in the definition of R8, R9-aminoindenyl (1-4C) means an amine carbonylalkyl group having an alkyl group containing from 1 to 4 carbon atoms and Has the same meaning as defined above. The amine carbonylmethyl group is preferably an amine carbonylalkyl group. The term amine (1 _4 C )alkyl in the definition of R 8, R 9 —amino(1 - 4 C)alkyl means an amine alkyl group having an alkyl group having 1 to 4 carbon atoms and having the former The same meaning of the definition. The term oxycarbonyl(1 -4 C )alkyl in the definition of R8-oxycarbonyl(1-4C)alkyl means an oxycarbonylalkyl group having an alkyl group having 1 to 4 carbon atoms and having the above definition The same meaning. The oxycarbonylmethyl group is preferred as the oxycarbonylalkyl group. The term oxygen (1 -4 C )alkyl in the definition of R 8 -oxy(1 -4 C)alkyl means an oxyalkyl group having an alkyl group of 1 to 4 carbon atoms and having the same meaning as defined above. . The term (1 - 4C)alkyl in the definition of R8 -carbonyl(1 _ 4 C)alkyl means a carbonylalkyl group having an alkyl group of 1 to 4 carbon atoms and having the same meaning as defined above. . The term (6-10C)aryl(1-4C)alkyl means an aralkyl group having 7 to 14 carbon atoms, wherein the same as the above-mentioned formula is (1 - 4C) alkyl and aromatic The base is a (6 - 1 0C) aryl group. For Benzene paper scale, apply to China National Standard (CNS) Α4 (2丨Ο X 297 mm) III*—II — Installation — II — II — IIII (please read the notes on the back and fill out this page) -12 - 1322144 A7 B7 V. INSTRUCTIONS (0 (Please read the note on the back and fill out this page) (1 - 4C) Alkyl is the preferred aralkyl group, such as benzyl. (3 - 9 c a heteroaryl (1-4C)alkyl group is an analog of a (6-10C) aryl(1-4C)alkyl group containing at least one hetero atom selected from nitrogen, oxygen and/or sulfur, if appropriate A heteroaryl group can be attached via a carbon atom or a hetero atom. In the definition of NR8R9 the term "bonds to a ring of (2-6C)heterocycloalkyl", wherein R8 and R9 together form a ring with the nitrogen to which they are attached , which means a nitrogen-containing ring and which additionally contains up to 2 to 6 carbon atoms. The ring may additionally contain one or more heteroatoms selected from nitrogen, oxygen and/or sulfur. Examples of such rings are Butyridine, pyrrolidine, piperidine, piperazine and (thia)morpholine. The term halogen means fluorine, chlorine, bromine or iodine. · The term (1-6C) alkane It means an alkylcarbonyl group having an alkyl group having 1 to 6 carbon atoms and having the same meaning as defined above. Preferably, the (1 - 4 C ) alkylcarbonyl group is printed by the Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative (1) A 4 C )alkylcarbonylamino (1 - 4 C )alkyl group means an alkylcarbonylamine alkyl group having an alkyl group having 1 to 4 carbon atoms and having the same meaning as defined above. Term (6 - 1 0C) Aryl (1-4C) alkoxy means that an aryl group of 6 to 10 carbon atoms as defined above is attached to a (1-4C) alkoxy group as defined above. (3 - 9C) The aryl (1-4C) alkoxy is a (6-10C) aryl (1-4C) oxo analog containing at least one hetero atom selected from nitrogen, oxygen and/or sulfur, if appropriate The heteroaryl group can be attached via a carbon atom or a hetero atom. This paper scale applies to the Chinese National Standard (CNS) A4 specification (210x297 public Chu) 1322144 A7 B7 V. Invention Description (11) (Please read the back of the note first) Matters re-fill in this page) The term (1 - 4C) alkoxycarbonyl (1_4C) alkoxycarbonyl means one (1 - 4 C) alkoxycarbonyl group attached to a The alkyl moiety contains 1 to 4 carbon atoms in the oxy group, and its alkoxy has the same meaning as defined above. The term (1 - 4 C ) alkoxy (1 - 4 C hospital carbonyloxy means An alkoxy group of 1 to 4 carbon atoms is attached to an alkylcarbonyloxy group of 1 to 4 carbon atoms, and the alkoxy group and the alkyl group have the same meanings as defined above. The term (1 - 4 C ) alkylcarbonylamine The base means an alkylcarbonylamino group having an alkyl group having 1 to 4 carbon atoms. The term (1-4C) alkoxycarbonylamino (1-4C)alkyl means that an alkoxycarbonyl group having from 1 to 4 carbon atoms as defined above is attached to an amine alkyl group having from 1 to 4 One carbon atom and has the same meaning as defined above. Printed by the Intellectual Property Office of the Ministry of Economic Affairs, the Consumer Cooperatives. The term (6_1 0C) arylcarbonyloxy means an aryl group having 6 to 10 carbon atoms. A preferred arylcarbonyloxy group is a phenylcarbonyloxy group. (3-9 C ) Heteroarylcarbonyloxy is an analog of (6 - 1 0 C )arylcarbonyloxy which contains at least one hetero atom selected from nitrogen, oxygen and/or sulfur and, if appropriate, via carbon An atom or a hetero atom is attached. The term (1 - 4 C) alkanesulfonyl means an alkanesulfonyl group having an alkyl group having 1 to 6 carbon atoms and having the same meaning as defined above. It is preferred to use (1-3C) alkanesulfonyl. The term (1 - 4 C) alkanesulfonyloxy means an alkanesulfonyloxy group whose alkyl group has 1 to 4 carbon atoms and has the same meaning as defined above. (1 - 3 C) alkanesulfonyloxy The base is good. This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -14- 1322144 A7 B7 V. Description of invention (1 uniform term (6 - 1 0 C) Aromatic sulfonyloxy means an aryl sulfonate An oxy group having an aryl group of 6 to 10 carbon atoms and having the same meaning as defined above. Preferably, a benzenesulfonyloxy group is used. (3-9C) a heteroarylsulfonyloxy group is (6 - 10 C) An analogue of an arylsulfonyloxy group containing at least one hetero atom selected from nitrogen, oxygen and/or sulfur, and if appropriate, may be attached via a carbon atom or a hetero atom. The term (1 - 4C) (di) alkane The carbazide group means a (di)alkylaminecarbamyl group having an alkyl group having 1 to 4 carbon atoms and having the same meaning as defined above. The term (6 - 1 0 C ) (di)arylamine A fluorenyl group means a (di)arylaminecarbamyl group having an aryl moiety having 6 to 10 carbon atoms and having the same meaning as defined above. The term (2-6C)heterocycloalkylamine A The fluorenyl group means a heterocyclic compound amidomethyl group having a heterocycloalkyl group having 2 to 6 carbon atoms and having the same meaning as defined above. Is a compound of formula I, wherein Y - X is C(0) - NH, 0C (〇) - NH or C (〇.) - 〇. The most preferred compound is one in which Y - X has no c(0) - NH. More preferably, R1 is (1 _4 C)alkylcarbonyl, preferably ethyl hydrazide and/or R2 and/or R3 and R5 are each (1-4C)alkyl, preferably methyl. Preferably, it is a bulky group. Preferred compounds are those wherein R6 is (6-10C) aryl, (3-9C)heteroaryl, (6-1 〇C) aryl (1-4C) The alkyl or (3-9C) heterogeneous paper scale applies to the Chinese national standard (CNS > Α4 specification (210X297 mm) (please read the notes on the back and fill out this page) • Refill the Ministry of Economics Property Bureau employee consumption cooperative printing -15- 1322144 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing A7 _____B7_ five, invention description (1 Ling aryl (1 4 C) alkyl. The best compound is R6 The (6 - 10C) aryl group is preferably a phenyl group. Preferred R7 groups are hydrogen, (1 - 4 C) alkyl or (1-4C) alkoxy. The most preferred is hydrogen or (1 - 4 C ) alkyl, preferably hydrogen or methyl The most preferred compound is r7 which is η. According to the invention, in the most preferred compound, R 1 is (1 _ 4 C )alkylcarbonyl, R 2 , R 3 ' R 5 are each (1-4C)alkyl, and R 4 is phenyl. And Υ - Χ is C (〇) - ΝΗ and R7 is Η. The best compound is where R1 is ethyl acetyl, R2, R3, R5 are each methyl, R4 is phenyl and Υ-Χ is C (〇 ) - ΝΗ and R7 is Η. As explained in the definition of the group, substitution of the above preferred compounds is permitted. The phenyl group in R 6 may be further substituted as described for the definition of R 6 . ··· • 1 丨.· The compound excluded in the present invention is 1-ethenyl-6-benzamideamino-4-(4-methylphenyl)-1,2,3,4-tetrahydrogen 2 '2,4-trimethylquinoline, 1 -ethylindolyl-4-phenyl- 1,2,3,4-tetrahydro-2,2,4,6-tetramethylquinoline, 1 Ethyl 4-phenyl-1,2,3,4-tetranitro-2,2,4,6,8-pentamethyl-α-quinoline, 1-ethenyl-6-methoxy-4 Phenyl-1,2'3,4-tetrahydro-2,2,4-trimethylquinoline, 1-ethenyl-6-trifluoroacetamido- 4-(4-tolyl) 1 , 2 , 3 ' 4 —tetrahydro-2,2,4-trimethyl π-quinoline, 1 -ethylindolyl-6-trifluoroacetamido-4-phenyl- 1, 2, 3, 4-tetrahydro-2' 2,4-trimethyl d-quinoline, 1-ethenyl- 4-(4-chlorophenyl)-1,2,3,4-tetrahydro-2,2,4 , 6_ This paper scale applies to China National Standard Rate (CNS) Ba Gu ^ (210Χ297 mm) (please read the notes on the back and fill out this page) Ι Φ Refills 装·订-16- 1322144 A7 B7 5 Invention (Tetramethyl d-quinoline and 1-ethenyl_4-(4-bromophenyl), 3,4-tetrahydro-2,2,4,6-tetramethylquinoline. 1 ,2 These Exclusions regarding Ref.Zh., Khim, Abstr. No.lZh311, 1 972; Khim.Geterosikl.Soedin.7:795,1 97 l; Ambinter.Screening Collection.order nrs 28020-A0839/0039328 (CAS 3 10456- 97-4) and -A0705/0032919 (CAS 327981-38-4); ChemDiv Inc. order nr 8005-9747 (CAS360760-14-l); ChemStar.Product.list, nr. CHS 006 5 4 1 3 (CAS 2994 1 8 - 67 - 0); Asi nex Compound Collection, order nr BAS0068990 (CAS 299970-20-0). Appropriate methods for preparing the compounds of the invention are generally shown herein: R7

(請先閱讀背面之注意事 項再填. :寫本頁} 經濟部智慧財產局員工消費合作社印製 II-a: A = 0Alkyl II-b:A = NH(保護基) II-c:A = C(0)〇 Alkyl II-d:A = S(0)2〇Alkyl n-e:A = (具取代)烷基,芳基 III-a: A = 0Alkyl III-b:A = NH(保護基) III-c:A = C(0)0Alkyl III-d:A = S(0)2〇Alkyl III-e:A = (具取代)烷基,芳基 本發明之化合物其中R2及R3爲甲基者可從式I I a - e之(具保護)苯胺其中R7定義同前爲起始化合物 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -17 1322144 A7 B7 五、發明説明(1$ 藉著淸楚記載之Skraup反應來製備,其可產生式III- a -e之1,2 —二氫_2,2,4 —三甲基卩奎啉衍生物。 (請先閲讀背面之注意事項再填寫本頁) 相關的Skraup環化作用可見於文獻:A.Knoevenagel ,Chem. Ber. 54:1 726,1 92 1 ;R.L. Atkins and D.E. Bliss, J. Org.Chem .43:1975,1978;J.V.Johnson,B.S.Rauckman,D.P.Baccanari and B .Roth,J.Med.Chem.32:1942,1989 ;W.C.Lin,S.-T.Huang and S.-T.LinJ.Chin.Chem.Soc.43 :497,1996;J.P.Edwards,S.J.West,K.B. Marschke,D.E.Mais,M.M.Gottardis and T.K.Jones,J.Med.Chem. 41:303,1998 。 經濟部智慧財產局員工消費合作社印製 上述反應一般係在較高溫度下在丙酮、氧化来基或乙基乙 醯醋酸酯於存在碘或質子酸如氫氯酸,對甲苯磺酸或碘化 氫水溶液內進行。另外,式III _ a - e之1,2 _二氫-2,2,4 —三甲基喹啉可藉著將對應之式I I_a — e 之苯胺與丙酮於存在硫酸鎂,4-第三丁基兒茶酚及碘在 反應(L.G.Hamann,R.I.Higuchi,L.Zhi,J.P.EdwardsandX.-N. Wand ,J. Med. Chem. ,41:623,199 8 )。起始材料可直接由商 業來源來購得或藉著此技術習知的芳香族環取代反應來製 備,如揭示於 H.Cerfontain,Y,Zou and B.H.Bakker,Recl.Trav. Chim.Pays-Bas, 1 1 3 :403,1994 ; A.Coppock,J.Org.Chem.22:325 ,19 57 ;M. Schlosser, J. H. Choi and S.Takagishi,Tetrahedron,46: 5633 ,1990 。 另外,通式V I _a — e化合物其中R2及R3爲(2 —4C)烷基且R7定義同前,一般可藉著式I V — a — e 之苯胺與適當的式V酮之環化作用來合成。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -18 - 1322144 A7 B7 五、發明説明(堉(Please read the notes on the back and fill in. : Write this page) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print II-a: A = 0Alkyl II-b: A = NH (protection base) II-c: A = C(0)〇Alkyl II-d:A = S(0)2〇Alkyl ne:A = (substituted)alkyl, aryl III-a: A = 0Alkyl III-b:A = NH(protecting group) III-c: A = C(0)0Alkyl III-d: A = S(0)2〇Alkyl III-e: A = (substituted) alkyl, a compound of the basic invention, wherein R2 and R3 are methyl From the formula II a - e (protected) aniline wherein R7 is defined as the starting compound as the starting material. This paper scale applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) -17 1322144 A7 B7 V. Description of the invention (1$ is prepared by the Skraup reaction described in Chu, which produces the 1,2-dihydro-2,2,4-trimethylhydrazine quinone derivative of formula III-a-e. (Read first Note on the back side of this page.) The relevant Skraup cyclization can be found in the literature: A. Knoevenagel, Chem. Ber. 54:1 726,1 92 1 ; RL Atkins and DE Bliss, J. Org.Chem .43: 1975, 1978; JV Johnson, BS Rauckman, DP Baccanari and B. Roth, J. Med. Chem. 32: 1942 , 1989; WCLin, S.-T. Huang and S.-T. LinJ. Chin. Chem. Soc. 43: 497, 1996; JPED Edwards, SJ West, KB Marschke, DE Mais, MMGottardis and TK Jones, J.Med.Chem. 41:303, 1998. The Ministry of Economic Affairs' Intellectual Property Office employee consumption cooperative prints the above reaction generally at elevated temperatures in acetone, oxidized or ethyl acetamidine in the presence of iodine or protonic acid. Such as hydrochloric acid, p-toluenesulfonic acid or hydrogen iodide aqueous solution. In addition, Formula III _ a - e 1,2 - dihydro-2,2,4-trimethylquinoline can be corresponding The aniline of formula I I_a — e is reacted with acetone in the presence of magnesium sulfate, 4-tert-butylcatechol and iodine (LG Hamann, RI Higuchi, L. Zhi, JPED Edwards and X.-N. Wand, J. Med. Chem., 41: 623, 199 8). The starting materials can be purchased directly from commercial sources or by the aromatic ring substitution reaction known in the art, as disclosed in H. Cerfontain, Y, Zou and BHBakker, Recl. Trav. Chim. Pays-Bas , 1 1 3 : 403, 1994; A. Coppock, J. Org. Chem. 22: 325, 19 57; M. Schlosser, JH Choi and S. Takagishi, Tetrahedron, 46: 5633, 1990. Further, a compound of the formula VI _a - e wherein R 2 and R 3 are (2 - 4 C) alkyl and R 7 is as defined above, generally by cyclization of the aniline of the formula IV - a - e with the appropriate ketone of the formula V synthesis. This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -18 - 1322144 A7 B7 V. Description of invention (堉

++

0 R2^^R3 IV-a:A = 〇Alkyl IV-b:A = NH(保護基) IV-c:A = C(0)0Alkyl IV-d:A = S(0)2〇Alkyl IV-e:A = (具取代)烷基,芳基 VI-a:A = 0 Alkyl VI-b:A = NH(保護基) VI-c:A = C(0)0Alkyl VI-d:A = S(0)2〇Alkyl VI-e:A = (具取代)烷基,芳基 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 式 I V — a 2 前述反應一般係於惰性溶劑如甲苯下於較高溫度細使 用質子酸或路易士酸例如但不限於對甲苯磺酸或三氟化硼 下進行以促進環化(11.评31161',11.531^[311(1>1\\^1^161",^17· Chim.Acta.,75:1274,1992;H.Walter,Helv.Chim.Acta,77:608> 1 994;H.Walter and J.Schneider,Heterocycles,41:1251,1995;J.P. Edwards,J.D.Ringgenberg and T.K.Jones,Tetrahedron Lett.39: 5139,1998)。0 R2^^R3 IV-a: A = 〇Alkyl IV-b: A = NH (protecting group) IV-c: A = C(0)0Alkyl IV-d: A = S(0)2〇Alkyl IV- e: A = (substituted) alkyl, aryl VI-a: A = 0 Alkyl VI-b: A = NH (protecting group) VI-c: A = C(0)0Alkyl VI-d: A = S (0) 2 〇 Alkyl VI-e: A = (substituted) alkyl, aryl (please read the back note first and then fill out this page) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed IV - a 2 The reaction is generally carried out in an inert solvent such as toluene at a relatively high temperature using a protic acid or a Lewis acid such as, but not limited to, p-toluenesulfonic acid or boron trifluoride to promote cyclization (11. 31161', 11.531^[ 311(1>1\\^1^161",^17· Chim.Acta., 75:1274, 1992; H. Walter, Helv. Chim. Acta, 77:608> 1 994; H. Walter and J. Schneider, Heterocycles, 41:1251, 1995; JP Edwards, JDRinggenberg and TK Jones, Tetrahedron Lett. 39: 5139, 1998).

必要的構建單位可藉著式VII 之酮類的Wittig反應來製備。在芳香族環上引入取代基A 可利用此技術習知的芳香族環取代作用在苯胺階段或在1 2,2,4 一三甲基喹啉階段如同在式 化合物中所述般地完成 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -19- 1322144 A7 B7 五、發明説明(1乃The necessary building units can be prepared by the Wittig reaction of the ketones of formula VII. The introduction of a substituent A on an aromatic ring can be accomplished by the aromatic ring substitution conventionally known in the art in the aniline stage or in the 1,2,2,4-trimethylquinoline stage as described in the formula compound. The paper scale applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) -19- 1322144 A7 B7 V. Description of invention (1

(請先閲讀背面之注意事項再填寫本頁) VII-a:A = 〇Alkyl VII-b:A = NH(保護基) VII-c:A = C(0)0Alkyl VII-d:A = S(0)2〇Alkyl ▽ 11^:六=(具取代)烷基,芳基 在另一·個策略中,式V I — a - e化合物其中r2 = R3 = H可以從式I I 一 a 一 e之苯胺與1 —甲基苯乙烯及 甲醛於乙腈於室溫或較高溫度下反應來製備。相關的環化 作用係述於文獻:J.M.Mellor and G.D.Merriman, Tetrahedron,51:6115,1995 。 經濟部智慧財產局員工消費合作社印製 後續的式V I化合物(其中R2、R3、R7及A定義 如前)之1 _ N —醯化或1 - N -磺醯化作用可以用熟悉 此技術者習知的標準條件來進行。在一典型的實驗中,式 V I化合物係於一溶劑如二氯甲烷、四氫呋喃、甲苯或吡 啶與一種醯基鹵或酸酐或磺醯氯於存在一種鹼,例如但不 限於N,N -二異丙基乙基胺,三乙胺,哌啶或氫化鈉下 反應以分別生成式VIII- a及VIII- b之N —醯化或N-磺醯化1,2_二氫一 4 一甲基d奎啉衍生物。 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X 297公釐) -20- 1322144 A7 B7 五、發明説明(1玲(Please read the notes on the back and fill out this page) VII-a: A = 〇Alkyl VII-b: A = NH (protecting group) VII-c: A = C(0)0Alkyl VII-d: A = S (0) 2 〇 Alkyl ▽ 11^: hexa = (substituted) alkyl, aryl in another strategy, formula VI - a - e compound wherein r2 = R3 = H can be from formula II a a - e The aniline is prepared by reacting 1-methylstyrene and formaldehyde with acetonitrile at room temperature or higher. The related cyclization is described in the literature: J. M. Mellor and G. D. Merriman, Tetrahedron, 51: 6115, 1995. The Ministry of Economic Affairs Intellectual Property Office employee consumption cooperative printed the subsequent compound of formula VI (where R2, R3, R7 and A are as defined above) 1 _ N - deuteration or 1 - N - sulfonation can be used by those skilled in the art Conventional standard conditions are used. In a typical experiment, the compound of formula VI is in a solvent such as dichloromethane, tetrahydrofuran, toluene or pyridine with a mercapto halide or anhydride or sulfonium chloride in the presence of a base such as, but not limited to, N,N-di Reaction with propylethylamine, triethylamine, piperidine or sodium hydride to form N-deuterated or N-sulfonated 1,2-dihydro-4-methyl groups of formula VIII-a and VIII-b, respectively D-quinoline derivative. This paper scale applies to China National Standard (CNS) A4 specification (21〇X 297 mm) -20- 1322144 A7 B7 V. Invention Description (1 Ling

VI VIII-a: R' = C(0)Alkyl VIII-b: R1 = S(0)2Alkyl 經濟部智慧財產局員工消費合作社印製 二氫喹啉骨架相關的N-醯化作用可見於如下文獻: Zh.V.Shmyreva,Kh.S.Shikhaliev and E · B. S hpa nig,I z v · V y s s h. Uchebn.Zaved.,Khim.Khim.Tekhnol.3 1:45,1988;Zh.V.Shmyreva ,Kh.S.Shikhaliev,L.P.Zalukaec,Y.A.Ivanov,Y.S.Ryabokobylko and I.E.Pokrovskaya,Zh.Obshch.Khim.59:1391,1989 0 1 一 N -甲醯化作用可以藉著將式V I的二氫D奎啉與 甲酸於存在三氟乙酸於較高溫度下反應(參考例如 P.Bouyssou,C.Le Goff and J.Chenault,J.Heterocycl.Chem.29: 895,1992 )或與甲酸乙酯於存在醋酸鈉下反應(如 N.Atanes,s.Perez,E.Guitan.L.Castedo and J.M.Saa,Tetrahedron ,50:1 1 257,1994之文獻)來達成。將適當的苯基引入二氫喳啉骨架的第4位置可以經由 (具取代)苯衍生物與式VIII化合物(其中R1、R2 ' R3、R7及A定義同前)進行Friedel-Crafts烷化來達成。 (請先閱讀背面之注意事項再填寫本頁) 項再填ΐ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -21 1322144 A7 B7VI VIII-a: R' = C(0)Alkyl VIII-b: R1 = S(0)2Alkyl The N-deuteration of the dihydroquinoline skeleton printed by the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs can be found in the following literature. : Zh.V.Shmyreva, Kh.S.Shikhaliev and E · B. S hpa nig, I zv · V yss h. Uchebn.Zaved., Khim.Khim.Tekhnol.3 1:45,1988;Zh.V. Shmyreva, Kh.S.Shikhaliev, LPZalukaec, YAIvanov, YSRyabokobylko and IEPokrovskaya,Zh.Obshch.Khim.59:1391,1989 0 1 A N-methylation can be achieved by the dihydrogen D of the formula VI Quinoline reacts with formic acid in the presence of trifluoroacetic acid at elevated temperatures (see, for example, P. Bouyssou, C. Le Goff and J. Chenault, J. Heterocycl. Chem. 29: 895, 1992) or in the presence of ethyl formate. This is achieved by a reaction under sodium acetate (for example, N. Atanes, s. Perez, E. Guitan. L. Castedo and JMSaa, Tetrahedron, 50:1 1 257, 1994). The introduction of a suitable phenyl group into the 4th position of the dihydroporphyrin skeleton can be carried out by Friedel-Crafts alkylation via a (substituted) benzene derivative with a compound of the formula VIII wherein R1, R2 'R3, R7 and A are as defined above. Achieved. (Please read the notes on the back and fill out this page.) Refill the paper. This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) -21 1322144 A7 B7

VIII IX 後者之反應通常係在較高溫度下於只有(具取代)苯 下或者於適當的溶劑中如庚烷或己烷以苯作爲試劑下,藉 路易士酸(如AlCl3,AlBr3,FeCl3或VIII IX The latter reaction is usually carried out at a higher temperature under only (substituted) benzene or in a suitable solvent such as heptane or hexane with benzene as a reagent, by Lewis acid (such as AlCl3, AlBr3, FeCl3 or

SnC 14)的催化作用來進行。與1,2 —二氫—2,2 ,4 —三甲基α奎啉的 Friedel-Crafts烷化作用係述於 B.A.Lugovik,L.G.Yudin and A.N.Kost,Dokl.Akad.Nauk SSSR, 1 70: 340,1 966; B. A. Lugo vik,L. G. Yudin, S .M. Vinogrado va and A. N.Kost,Khim.Geterosikl.Soedin, 7:795,1971 之文獻中。 本發明之式XII之化合物(其中R5爹Me且R1、 R2、R3、R4、R7及A定義同前)可以從式X的四氫D奎 啉酮開始合成。所以式X之酮與適當的Wittig試劑進行The catalytic action of SnC 14) is carried out. Friedel-Crafts alkylation with 1,2-dihydro-2,2,4-trimethyl alpha-quinoline is described in BA Lugovik, LG Yudin and ANKost, Dokl. Akad. Nauk SSSR, 1 70: 340 , 1 966; BA Lugo vik, LG Yudin, S. M. Vinogrado va and ANKost, Khim. Geterosikl. Soedin, 7: 795, 1971. The compound of the formula XII of the present invention (wherein R5爹Me and R1, R2, R3, R4, R7 and A are as defined above) can be synthesized starting from the tetrahydro D quinolinone of the formula X. Therefore, the ketone of formula X is treated with a suitable Wittig reagent.

Wittig反應可以產生式X I代表的不飽和衍生物,其而後則 可經由前文所述製備式I X化合物相同的步驟來成爲(具 取代)苯的Friedel-Crafts烷化作用之起始材料。 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製The Wittig reaction can produce an unsaturated derivative of the formula X I which can then be used as the starting material for the Friedel-Crafts alkylation of (substituted) benzene via the same procedure as described above for the preparation of the compound of formula IX. (Please read the notes on the back and fill out this page.) Printed by the Consumer Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs.

XX

XIXI

XII 本紙張尺度適用中國國家標準(CNS〉A4規格(210X29*7公釐) -22- 1322144 A 7 B7 五、發明説明(4 如上的Wittig反應爲熟悉此技術者所習知。 適當的式X之酮可以藉著將式I I之苯胺與3 -氯-3 -甲基-1— 丁炔(XIII )於二乙醚/水中於存在銅粉及 三乙胺下反應來製得,其可生成式XIV之炔。氫-鹵素交 換可以藉著將式XIV化合物於惰性溶劑如四氫呋喃與正丁 基鋰於溫度低於_ 5 0°C下加入對位甲苯磺醯氯進行去質 子化以生成式X V之氯化物。最後,酸(如硫酸)催化的 環化作用可以在較高溫度下於溶劑如聚乙二醇下進行以產 生式XVI化合物,其可如前文對式V I衍生物所述般地被 醯化或磺醯化。 (請先閱讀背面之注意事項再填寫本頁) 項再填XII This paper scale applies to Chinese national standards (CNS>A4 specification (210X29*7 mm) -22- 1322144 A 7 B7 V. Description of invention (4 The Wittig reaction above is known to those skilled in the art. Appropriate formula X The ketone can be prepared by reacting aniline of formula II with 3-chloro-3-methyl-1-butyne (XIII) in diethyl ether/water in the presence of copper powder and triethylamine. XIV alkyne. Hydrogen-halogen exchange can be deprotonated by adding a compound of formula XIV to an inert solvent such as tetrahydrofuran and n-butyllithium at a temperature below -50 ° C to form p-toluenesulfonyl chloride to form formula XV. Finally, the cyclization catalyzed by an acid such as sulfuric acid can be carried out at a higher temperature in a solvent such as polyethylene glycol to produce a compound of formula XVI as described above for the derivative of formula VI. Deuterated or sulfonated. (Please read the notes on the back and fill out this page.)

II XIII: B = H XIV: B = H XVI: C = H XV: B = C1 X: C = R' 經濟部智慧財產局員工消費合作社印製 如上反應順序係述於文獻:P.Barmettler and H.J. Hansen,Helv.Chim.Acta,73:1515,1990 (及在此所引用之參考 資料)。 對於式XII之四氫鸣啉第6位置之官能基化作用可以 經由此技術習知的去保護-偶合步驟來完成: 本發明式I — a化合物(其中X = 0且Y = C (0) 本纸韻用中國國家標準(c叫娜⑺0X2崎) 1322144 A7 B7 五、發明説明(21) ,S(0)2>NHC(0) ,nhc(s) ,oc(o) 或鍵結)可以從式x 1 I —a之含6 -甲氧基四氫哇啉來 製得。去甲基化已爲熟悉此技術者習知之事。II XIII: B = H XIV: B = H XVI: C = H XV: B = C1 X: C = R' Printed by the Intellectual Property Office of the Intellectual Property Office of the Ministry of Economic Affairs. The above reaction sequence is described in the literature: P. Barmettler and HJ Hansen, Helv. Chim. Acta, 73: 1515, 1990 (and references cited herein). The functionalization of the sixth position of tetrahydromorphine of formula XII can be accomplished via a deprotection-coupling step as is known in the art: a compound of formula I - a of the invention (where X = 0 and Y = C (0) This paper rhyme uses Chinese national standards (c called Na (7) 0X2 Saki) 1322144 A7 B7 V. Invention description (21), S(0)2>NHC(0), nhc(s), oc(o) or bond) It is prepared from 6-methoxytetrahydromorpholine of the formula x 1 I - a. Demethylation has been known to those skilled in the art.

XII-a: Z = Me XVII: Z = Η R6、XII-a: Z = Me XVII: Z = Η R6,

I-a (請先閲讀背面之注意事項再填寫本頁) XVIII-a-g 經濟部智慧財產局員工消費合作社印製 於一典型的實驗中,去甲基化可藉著式XII- a化合物 與B B r 3在一惰性溶劑例如但不限於二氯甲烷或四氫呋喃 於低溫下反應以生成式XVII之去保護化合物。另一選擇意 ,去甲基化可以藉著式XII— a化合物與B F3· Me 28複 合物在室溫下於前述B B r 3去甲基化所用之惰性溶劑中反 應來進行。 〇 Re^^ci ο Re^^oH R6〆、CI XVIII-a XVIII-b XVIII-c 本纸張尺度適用中國國家標準(CNS ) A4規格(2丨Ο X 297公釐) -24- 1322144 A7 B7 五、發明説明(鸿Ia (please read the notes on the back and fill out this page) XVIII-ag Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed in a typical experiment, demethylation can be done by formula XII-a compound and BB r 3 The reaction is carried out in an inert solvent such as, but not limited to, dichloromethane or tetrahydrofuran at low temperature to give the deprotected compound of formula XVII. Alternatively, demethylation can be carried out by reacting a compound of the formula XII-a with a B F3·Me 28 complex at room temperature in the inert solvent used for the demethylation of the B B r 3 described above. 〇Re^^ci ο Re^^oH R6〆, CI XVIII-a XVIII-b XVIII-c This paper size applies to Chinese National Standard (CNS) A4 specification (2丨Ο X 297 mm) -24-1322144 A7 B7 V. Invention Description (Hong

χνΠΙ-d XVIII-e XVIII-f XVIII-g 經濟部智慧財產局員工消費合作社印製 對式XVII衍生物中游離0 H基的後續官能化作用爲熟 悉此技術者所習知且可使用式XVIII — a - g試劑輕易地達 成。 對於式XVIII之含鹵素試劑而言,前述反應典型地係 在室溫下於適當溶劑如非質子性溶劑如N,N -二甲基甲 醯胺、二氯甲烷或四氫呋喃中,於存在一種鹼例如但不限χνΠΙ-d XVIII-e XVIII-f XVIII-g Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed Subsequent Functionalization of Free OH Groups in Formula XVII Derivatives is well known to those skilled in the art and can be used with Formula XVIII — a - g reagent is easily achieved. For the halogen-containing reagent of formula XVIII, the foregoing reaction is typically carried out at room temperature in a suitable solvent such as an aprotic solvent such as N,N-dimethylformamide, dichloromethane or tetrahydrofuran in the presence of a base. For example but not limited

於N,N -二異丙基乙基胺或氫化鈉中進行。添加物如N ’ N-二甲胺基吡啶或碘化四丁基銨可以促進後者之反應 。再者,利用式XVIII— d及XVIII- e之異氰酸鹽或異硫 氰酸鹽於惰性溶劑於室溫下或較高溫度反應則分別可以生 成式I — a化合物其中Y = NHC (0)或NHC (S) 〇 化合物其中Y = c (0)者亦可以使用另一種方法來 製得,利用式XVIII— b之羧酸,使用偶合劑例如〇 -(苯 并三唑—1—基)—N,N,N, > N ' _四甲基脲鎰四 氟硼酸鹽(TBTU) ,0_ (7 —氮雜苯并三唑—1_ 基)—N’N’N, ,N,—四甲基脲鑰六氟磷酸鹽( HATU)或溴三吡咯啶磷鎗六氟磷酸鹽(p y b r 0P )及一種三級鹼如N,N-二異丙基乙基胺於一種溶劑如 Μ ’ N -二甲基甲醯胺或二氯甲烷於室溫或較高溫度下進 行。 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) I ^ ^ 1 I J —訂 11111 (請先閱讀背面之注意事項再填寫本頁) -25- 1322144 A7 B7 五、發明説明(约 式I —b — C化合物(其中W=R8,R9N或R8〇 )可以分別藉著將式Χγπ化合物與式XIX醯基氯於標準條 件下反應來合成。This is carried out in N,N-diisopropylethylamine or sodium hydride. Additives such as N'N-dimethylaminopyridine or tetrabutylammonium iodide promote the latter reaction. Further, by reacting an isocyanate or an isothiocyanate of the formula XVIII-d and XVIII-e in an inert solvent at room temperature or at a higher temperature, respectively, a compound of the formula I-a can be produced wherein Y = NHC (0 Or an NHC (S) hydrazine compound wherein Y = c (0) can also be obtained by another method using a carboxylic acid of the formula XVIII-b, using a coupling agent such as hydrazine-(benzotriazole-1-yl) )—N,N,N, > N ' _tetramethyluronium tetrafluoroborate (TBTU), 0_(7-azabenzotriazol-1-yl)-N'N'N, ,N, - tetramethylurea hexafluorophosphate (HATU) or bromopyrrolidine phosphate hexafluorophosphate (pybr 0P ) and a tertiary base such as N,N-diisopropylethylamine in a solvent such as hydrazine 'N-Dimethylformamide or dichloromethane is carried out at room temperature or at elevated temperature. This paper size is applicable to China National Standard (CNS) Α4 specification (210X297 mm) I ^ ^ 1 IJ - order 11111 (please read the note on the back and fill out this page) -25- 1322144 A7 B7 V. Description of invention ( Compounds of the formula I-b-C (wherein W=R8, R9N or R8〇) can be synthesized by reacting a compound of the formula Χγπ with a compound of the formula XIX, respectively, under standard conditions.

_ R5 R4_ R5 R4

XIX: n=l-4 I-b: W = R8,R9N I-c: W = R8〇 經濟部智慧財產局員工消費合作社印製 另一選擇地,式I — b - c化合物可以從式XVII衍生 物及式XIX之醯基氯(其中W=〇 e t )開始,繼而以鹼 (如氫氧化鈉)-調制的皂化作用及後續自由羧酸的縮合 作用與式R8,R9NH之胺或式R8〇H之醇於存在偶合 劑如稍早提到的TBTU、HATU或PyB r 0P及三 級鹼如N,N —二異丙基乙基胺下反應來製備》 式I — d_e化合物(其中V = R8,R9N或R80 )可以分別經由鹵素如溴之親核性的取代作用,在存在式 XXI化合物下與式R8,R9NH之胺或R8OH之醇反應來 製得。其次,適當的式XXI之四氫喹啉可以從式XVII化合 物及式XX之溴醯基氯,使用此技術習知的合成步驟來合成 XVII +XIX: n=l-4 Ib: W = R8, R9N Ic: W = R8 〇 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed another option, formula I — b - c compound can be derived from formula XVII and The sulfhydryl group of XIX (wherein W=〇et) starts, followed by saponification with a base (such as sodium hydroxide) and subsequent condensation of the free carboxylic acid with an amine of the formula R8, R9NH or an alcohol of the formula R8〇H The compound of formula I - d_e is prepared by reacting a coupling agent such as TBTU, HATU or PyB r 0P mentioned earlier and a tertiary base such as N,N-diisopropylethylamine (wherein V = R8, R9N) Or R80) can be obtained by a nucleophilic substitution of a halogen such as bromine, respectively, in the presence of a compound of the formula XXI with an amine of the formula R8, R9NH or an alcohol of R8OH. Next, a suitable tetrahydroquinoline of the formula XXI can be synthesized from the compound of the formula XVII and the bromofluorenyl chloride of the formula XX using a synthetic procedure known in the art to synthesize XVII +

I-d: V = R8,R9N I-e: V = R80 ϊ~ J 裝 —Ί I n {請先閱讀背面之注意事項再填寫本頁) XX : n = 1-4 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -26 1322144 A7 B7 五、發明説明(2今 式I 一 f 一 g化合物(其中u=(具取代)雜芳香基 或(具取代)苯基)可分別經由式XXII之(具取代)碘苯 甲醯基衍生物與式XXIII— a- b之硼酸的三菱偶合作用來 製得。Id: V = R8, R9N Ie: V = R80 ϊ~ J Install - Ί I n {Please read the notes on the back and fill out this page) XX : n = 1-4 This paper scale applies to Chinese national standards (CNS A4 size (210X297 mm) -26 1322144 A7 B7 V. Description of the invention (2) This formula I-f-g compound (where u=(substituted) heteroaryl or (substituted)phenyl) can be respectively A (substituted) iodobenzylidene derivative of XXII is used in combination with a Mitsubishi coupling of boric acid of the formula XXIII-a-b.

-Β(ΟΗ),-Β(ΟΗ),

(請先閲讀背面之注意事項再填寫本頁)(Please read the notes on the back and fill out this page)

XXII XXIII-a U =(具取代)雜芳香基 XXIII-b U =(具取代)芳香基 經濟部智慧財產局員工消費合作社印製 於一典型實驗中,式XXII之碘化物係將式XXIII- a -b之硼酸於溶劑混合物如二甲氧基乙烷/乙醇使用氟化 絶及絕催化劑如絕肆三苯基膦或參(二伸苯基丙酮)二記 於較高溫度下於氮氣氛中反應製得。添加三苯基膦可以促 進反應且增進產量。前述反應已詳細述於文獻。可參考例 如:A.Suzuki,Acc.Chem.Res. 15:178,1982;N.Miyaura,T.Ishiyama ,H.Sasaki,M.Ishikawa,M.Satoh and A.Suzuki, J.Am.Chem.Soc. 111:314,1989 。 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) -27- 1322144 A7 __B7 五、發明説明(2导 類似地’式I 一 h化合物(其中χ = ΝΗ且Y如前文 定義)可以透過合成式I 一 a — f化合物(其中χ = 〇) 所述之方法來合成。 R5 R4 R6、XXII XXIII-a U = (Substituted) Heteroaromatic XXIII-b U = (Substituted) Aromatic Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperatives Printed in a typical experiment, the iodide system of formula XXII will be of formula XXIII- The boric acid of a-b is used in a solvent mixture such as dimethoxyethane/ethanol using a fluorination absolute catalyst such as decyltriphenylphosphine or bis(phenylene phenylacetate) at a higher temperature in a nitrogen atmosphere. In the middle of the reaction. The addition of triphenylphosphine promotes the reaction and increases yield. The foregoing reactions have been described in detail in the literature. For example, A. Suzuki, Acc. Chem. Res. 15: 178, 1982; N. Miyaura, T. Ishiyama, H. Sasaki, M. Ishikawa, M. Satoh and A. Suzuki, J. Am. Soc. 111: 314, 1989. This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -27- 1322144 A7 __B7 V. Description of invention (2 leads similarly to formula I-h compound (where χ = ΝΗ and Y is as defined above) It can be synthesized by the method described in the synthesis of a compound of formula I-a (where χ = 〇). R5 R4 R6,

式I—I—j化合物(其中X=C(0)或S(0)2 且Y=NH或0)分別可以透過對應的式XXV之醯基氯 或磺醯基氯與式R6NH2之胺或式R6〇H之醇經由稍早 所述製備式I - a化合物相同的方法反應製得。 (請先閲讀背面之注意事項再填寫本頁) R5 R4Compounds of formula I-I-j (wherein X=C(0) or S(0)2 and Y=NH or 0) may be respectively passed through the corresponding mercapto chloride or sulfonyl chloride of formula XXV with an amine of formula R6NH2 or The alcohol of the formula R6〇H is obtained by the same method as described earlier for the preparation of the compound of the formula I-a. (Please read the notes on the back and fill out this page) R5 R4

XXIV: Q = 0H XXV: Q = C1 R5 R4 R6、XXIV: Q = 0H XXV: Q = C1 R5 R4 R6,

I-i: Y = NI I-j: Y = 0 經濟部智慧財產局員工消費合作社印製 式XXV適當的醯基氯或磺醯氯可以從對應的式χχιν 化合物藉著用P0C 13,PC 15,草醯氯,光氣或 S0C 12處理,於溶劑如甲苯、乙腈或N,N —二甲基甲 醯胺來製得,如文獻中詳細所述。參考例如 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 28- 1322144 Α7 Β7 五、發明説明(2与 M. B on na t, M. Bra die y and J.D.Kilburn,Tetrahedron Lett.37:5409 ,1996;J.G.Montana,G.M.Buckley,N.Copper,H.J.Dyke and L. Gowers,Bioorg.Med.Chem.Lett,8:2635,1998;J.Hayler,P.D.Kane, D.LeGrand,F.Lugrin,K.Menear,R.Price,M.Allen,X.Cockcroft,J. Ambler,K.Butler and K.Durren,Bioorg.Med.Chem.Le11.1 0:1 567 ,2000 。 另一選擇地,式XXIV化合物(其中X = C (〇))可 以直接用來作爲製備式I 一 I _ j衍生物之起始材料,藉 著利用前述的偶合劑來製得該衍生物。 對於式I— k 一 p化合物(其中X = C (◦)或 S(〇)2及Y = NH或0及n = l — 4),可以依照此技 術習知的合成步驟來製得。 (請先閱讀背面之注意事項再填寫本頁)Ii: Y = NI Ij: Y = 0 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed XXV Appropriate hydrazinyl or sulfonium chloride can be used from the corresponding formula χχιν compound by P0C 13, PC 15, grass 醯 chlorine , phosgene or SOC 12 treatment, prepared in a solvent such as toluene, acetonitrile or N,N-dimethylformamide, as described in detail in the literature. For example, the paper scale applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) 28- 1322144 Α7 Β7 V. Invention description (2 and M. B on na t, M. Bra die y and JDKilburn, Tetrahedron Lett. 37:5409, 1996; JG Montana, GMBuckley, N. Copper, HJ Dyke and L. Gowers, Bioorg. Med. Chem. Lett, 8: 2635, 1998; J. Hayler, PDKane, D. LeGrand, F. Lugrin, K. Menear, R. Price, M. Allen, X. Cockcroft, J. Ambler, K. Butler and K. Durren, Bioorg. Med. Chem. Le11.1 0: 1 567, 2000. The compound of the formula XXIV (wherein X = C (〇)) can be directly used as a starting material for the preparation of the derivative of the formula I-I j, by using the aforementioned coupling agent to prepare the derivative. The k-p compound (where X = C (◦) or S(〇) 2 and Y = NH or 0 and n = l - 4) can be prepared according to the synthetic steps known in the art. (Please read the back first) Note on this page)

I-k: W = R8,R9N I-l: W=R80 I-m: W = R8,R9N I-n: W = R8〇 I-o: W = R8,R9N I-p: W = R80 經濟部智慧財產局員工消費合作社印製I-k: W = R8, R9N I-l: W=R80 I-m: W = R8, R9N I-n: W = R8〇 I-o: W = R8, R9N I-p: W = R80 Printed by the Intellectual Property Office of the Ministry of Economic Affairs

XXVIXXVI

XXVIIXXVII

XXIII 所以,式I —k 一 1之四氫喹啉的製備可以藉著將式 XXVI之胺或醇(分別地Υ = ΝΗ或0)與式XXV之氯化 本纸張尺度適用中國國家標準(CNS ) /U規格(210X297公釐) -29- 1322144XXIII Therefore, the preparation of tetrahydroquinoline of formula I-k-1 can be applied to Chinese national standards by using the amine or alcohol of formula XXVI (Υ = ΝΗ or 0, respectively) and the chlorinated paper of formula XXV. CNS ) /U Specifications (210X297 mm) -29- 1322144

i-q Α7 Β7 五、發明説明(约 物於標準條件下縮合來製備。於類似的策略中,式XXVII 之胺或醇可被用來製備式I - m_ η之化合物。最後,利 用稍早提到的式XXIII之硼酸可以透過前述三菱偶合反應 來製備式I 一 〇 - ρ化合物》 本發明之式I _q化合物(其中X — Υ爲一鍵結)可 以直接商業性地購得或輕易地從式XXVIII苯胺透過反應順 序Skraup,醯化及Friedel-Crafts烷化作用來製得。 R6Iq Α7 Β7 V. Description of the invention (prepared by condensation under standard conditions. In a similar strategy, an amine or alcohol of formula XXVII can be used to prepare a compound of formula I - m η. Finally, use earlier mentioned The boronic acid of the formula XXIII can be prepared by the aforementioned Mitsubishi coupling reaction to prepare a compound of the formula I-〇ρ. The compound of the formula I_q of the present invention (wherein X-oxime is a bond) can be commercially obtained commercially or easily from the formula. XXVIII aniline is prepared by the reaction sequence Skraup, deuteration and Friedel-Crafts alkylation.

XXVIII 於另一策略中’式I 一 r化合物(其中X 一 γ爲一鍵 結且U =(具取代)雜芳香基或(具取代)苯基)可以透 過對應的式XXIX之6 -碘基四氫喹啉衍生物與式χχπι之 硼酸的前述三菱縮合作用來製得。 11 n Ί— 1« —^Ί n n I Ί-1 n (請先閲讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製XXVIII In another strategy, a compound of formula I-r (wherein X-γ is a bond and U = (substituted) heteroaryl or (substituted) phenyl) can be passed through the corresponding 6-iodoyl group of formula XXIX The tetrahydroquinoline derivative is obtained by the aforementioned Mitsubishi condensation of a boronic acid of the formula χχπι. 11 n Ί— 1« —^Ί n n I Ί-1 n (Please read the notes on the back and fill out this page) Printed by the Intellectual Property Office of the Ministry of Economic Affairs

22

+ XXIX ·Γ+ XXIX ·Γ

XXIII 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) '30- 1322144 Α7 Β7 五、發明説明(蹭 適當的式XXIX碘化物可以藉著習知的Sandmeijer反應 從對應的胺製得。 (請先聞讀背面y注意事項再填寫本頁) 本發明的某些化合物,其係呈游離鹼的形式,從反應 混合物中以藥學可接受鹽類的形式分離出來。該藥學可接 受鹽類可以藉著將式I的游離鹼與一種有機或無機酸如氫 氯酸、氫溴酸、氫碘酸、硫酸、磷酸、醋酸'丙酸、羥乙 酸、馬來酸、丙二酸、甲烷磺酸、富馬酸、琥珀酸、酒石 酸、甯檬酸、苯甲酸及抗壞血酸等處理來製得。 本發明之化合物具有至少一個掌徵性碳原子且所以可 以爲純對映異構物、對映異構物之混合物或非對映異構物 之混合物的形式獲得。獲得純對映異構物的方法爲此技術 所習知,例如可以從光學活性酸及消旋混合物中的鹽類進 行結晶,或例用掌徵性管柱作層析。對於非對映異構物而 言,可以使用垂直相管柱或逆相管柱。 經濟部智慧財產局員工消費合作社印製 本發明化合物可以形成水何物或溶劑合物。熟悉此技 術者習知當帶電化合物用水來冷凍乾燥時該化合物會形成 水合物,或者用適當的有機溶劑於溶液中濃縮時可以形成 溶劑化物種。本發明化合物包括所列化合物之水合物及溶 劑合物。 爲了選出活性化合物,測試化合物於1 〇_5m來測試 時其所產生的活性必需要大於以F S Η爲對照組時最大活 性的2 0%以上才視爲活性化合物。另一種條件可以用 E C5。値來考量,E C5〇値必須< 1 〇-5Μ,較佳地 < 1 0 _ 7 Μ。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -31 - 1322144 A7 B7 五、發明説明(2弓 (請先閱讀背面之注意事項再填寫本頁) 熟悉此技術人士應了解到所需的E C 5 D値將式測試化 合物而定。例如,E C 5 0値小於1 〇 _ 5 Μ之化合物通常 被認爲是可作爲藥物的適當選擇。較佳地該値宜低於 1 0_7Μ。不過,如果一個化合物雖然有較高的E C5〇値 但對特定的受器卻具有選擇性時,其可能爲更佳的選擇。 測定促性腺激素對受器的結合作用,以及測定生物活 性的試管內及活體內檢定都是習知之事。一般,將表現性 受器用測試化合物接觸,然後測量其結合情行及對功能性 反應的刺激或抑制作用。 爲了測量功能性的反應,會將編碼該F S Η受器(較 佳地人體受器)基因之DNA於適當的宿主細胞中表現。 此等宿主細胞可爲中國倉鼠卵巢細胞,不過其它細胞也適 合。較佳的細胞爲來自哺乳動物源的細胞(Jia et al,Mol. Endocrin_,5:759-776,1991)。 經濟部智慧財產局員工消費合作社印製 建構重組的F S H表現細胞株的方法爲此技術所習知 (Sambrook et al.,Molecular Cloning:a Laboratory Manual, Cold Spring Harbor Laboratory Press,Cold Spring Harbor,最 近版)。受器的表現係藉著表現編碼所需蛋白質之DNA 來得到。現在,針對特殊部位的突變技術、接合額外的序 列、P C R及建構適當的表現系統等,所有這些技術都爲 熟悉此技術者所習知。編碼所需蛋白質之部份或全部的 DNA可以使用標準固相技術來合成性地構築,較佳地宜 包括限制酶識別部位以易於接合。還可以對該D N A編碼 序列提·供適於所含編碼序列之轉錄及轉譯的控制元件。如 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -32- 1322144 A7 _B7 五、發明説明(3〇 (請先閲讀背面之注意事項再填寫本頁) 同習知般,現在已有許多表現系統,其可與許多宿主相容 ,包括原核宿主如細菌及真核宿主如酵母菌、植物細包、 昆蟲細包、哺乳動物細胞、鳥類細胞等。 表現出受器的細胞然後會與測試化合物接觸以觀察其 結合現象或功能性反應的刺激或抑制作用。 另一選擇地,可使用分離之含有表現受器之細胞膜來 測量化合物的結合作用。 爲了要測量結合作用,可以使用放射性標記或螢光標 記的化合物。可使用人類重組F S Η做爲對照化合物。另 外,還可以進行競爭性結合檢定。 另一種檢定則涉及藉由測定受器調制的c A Μ Ρ累積 現象來篩選F S Η受器激動劑化合物。故而此種方法涉及 將宿主細胞膜表面的受器加以表現且將細胞暴露到測試化 合物之下。然後測量c AMP的份量。該c AMP的量可 能增加或減少,將視該測試化合物結合到受器後的抑制或 刺激效果而定。 經濟部智慧財產局員工消費合作社印製 除了直接測量暴露細胞中例如c AMP的量以外,所 使用的細胞株除了轉染編碼受器之DNA以外,還可以轉 染有第二種編碼受器基因之DNA,該基因的表現係回應 c AMP的量。此等受器基因可以由c AMP所引發或者 是被構築成與新穎的c AMP反應元件連接在一起。一般 地,受器基因的表現可以由任合會反應c AMP份量變化 的反應元件來控制。適當的受器基因有例如LacZ,鹼式磷 酸酶,螢火蟲發光酶及螢光蛋白質等。此等轉活化檢定的 本纸張尺度適用中國國家標準(CNS ) A4規格(2丨〇><297公釐) -33- 1322144 A7 __B7 五、發明説明(3, 原理爲此技術所習知且係詳述於例如Strat〇wa,Ch.Himmler, A.and Czernilofsky,A.P.,(i995)Curr.Opin.Biotechnolo.6:574 » (請先閱讀背面之注意事項再填寫本頁) 本發明亦關於一種藥學組成物,其含有式I之四氫喹 啉衍生物或其藥學可接受鹽類,混合有藥學可接受輔劑及 任意地其它治療劑。該輔劑必需是”可以接受的”,其意 爲其可與組成物的其它成份互容且不會對接受者有不好的 影響。該藥學組成物亦可以含有四氫ϋ奎啉衍生勿1 一乙醯 基一 6-苯甲醯胺基一 4_ (4 —甲苯基)_1 ,2,3 ,4 —四氫一2 ’ 2 ,4 —三甲基喹啉,1—乙醯基一4 一苯基一1 ,2 ,3 ,4 —四氫 _2 ,2 ,4 ,6 —四甲 基喹啉,1—乙醯基一 4 一苯基一1 ,2,3 ,4 —四氫 -2,2,4 ,6 ,8-五甲基α奎啉,1-乙醯基一 6 — 甲氧基一4 —苯基一1 ,2 ,3 ,4 一四氫一 2 ,2,4 經濟部智慧財產局員工消費合作社印製 _三甲基喹啉,1—乙醯基一 6 —三氟乙醯胺基一 4一( 4 —甲苯基)一1 ,2 ,3 ,4 一四氫一2 ,2 ,4 —三 甲基鸣啉,1_乙醯基一 6 —三氟乙醯胺基一 4 一苯基-1 ,2 ,3 ,4一四氫一 2,2,4一三甲基π奎啉,1 — 乙醯基一 4— (4 —氯苯基)一1,2,3,4 —四氫— 2,2 ,4,6-四甲基喹啉及1-乙醯基-4— (4 — 溴苯基)一1,2,3,4_四氫一2,2,4,6-四 甲基喹啉。 組成物,包括例如適於口服、舌下、皮下、經靜脈、 經肌肉、局部或直腸投藥者,都呈投藥用的單位劑型。 口服投藥時,該活性成份可呈不連續單位,如錠劑、 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -34 - 1322144 A7 B7 五、發明説明(均 膠囊、散劑、九劑、溶液及懸浮液等。 非經腸投藥時,本發明之藥學組成物可於單位劑或於 複劑容器中,例如於密封小管或表玻離瓶中既定份量的注 射液,且可以冷凍乾燥的形式來儲存,僅需在使用前加入 無菌液體載劑如水。 其可與如下藥學可接受輔劑混合,例如述於標準參考 資料,Gennaro,A.R.et al.,Remington:The Science and Practice of Pharmacy (20th Edition. .Lippincott Willians & Wilkins,2000 ,特別參考第 5 部份:Pharmaceutical Manufacturing)者,該 活性成份可被壓縮成固體劑量單位,例如片劑、錠劑,或 被加工成膠囊或栓劑。藉由呈藥學可接受液體方式,該活 性劑可採液體組成物的形式的施用,例如注射用製劑,呈 溶液、懸浮液 '乳液或噴劑如鼻噴劑之形式。 製造固體劑量單位時,包含習知添加物如塡料、色料 、聚合性結合劑等之使用。一般任何不會干擾活性化合物 功能之藥學可接受之添加劑都可使用。可以適當的份量來 使用載劑,可使得本發明之活性劑得以呈固體組成物的形 式投與之適當載劑包括乳糖、澱粉、纖維素衍生物等,或 其混合物。在非經腸投藥時,可以使用水性懸浮液、等張 生理食鹽水溶液及無菌的注射溶液,其可含有藥學可接受 的分散劑及/或溼化劑如丙二醇或丁二醇。 本發明進一步包括一種藥學組成物,如前文所述般, 其可結合適於固體組成物之包裝材料,該包裝材料可包括 指示利用該組成物在前文所述之用途的說明。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝. 訂 經濟部智慧財產局員工消費合作社印製 -35- 1322144 Α7 Β7 五、發明説明(均 (請先閲讀背面之注意事項再填寫本頁) 本發明之四氫喹啉衍生物也可採植入藥學裝置的形式 來投藥,該裝置係由一層調節釋放速率的外膜及一個放置 在該膜內的活性材料核所組成。此等植入體可以皮下或局 部性地施用,且其可在相對較長的時期如數週到數年間以 近乎恆定的速度來釋出該活性成份。製備植入性藥學裝置 的方法爲此技術所習知,例如述於歐洲專利第0,303,306 ( AKZO Nobel N.V.)中。 該活性成份或其藥學組成物的確實劑量及投藥計劃將 必要地依所欲達到的治療效果(不孕的治療;避孕)而定 ’且可因所用特殊化合物、投藥途徑、藥物投與之患者個 人的年齡及狀況而有所不同。 經濟部智慧財產局員工消費合作社印製 —般地非經腸投藥需要的劑量比其它依賴吸收的投藥 方法所需劑量更低。然而,人類用的劑量較佳地爲每公斤 體重投與0 · 0 0 0 1 - 2 5mg的量。所需劑量可由單 獨一劑提供或以多劑細分小劑一天內以適當的間隔時間投 藥提供,或者於女性服用者之例中,所需劑量可於月經週 期中以適當的間隔日數投藥來提供。該劑量及投藥計劃在 女性及男性服藥者間可能有所不同。 故而,本發明化合物係可以用在治療上。 本發明再一項要點係關於利用式I之四氫π奎啉衍生物 來製造藥物,該藥物可用來治療對F S Η受器調制之路徑 有反應之異常疾病’較佳地可用來控制懷孕,更佳地可用 來治療不孕或預防懷孕。本發明之化合物亦可用來治療與 激素有關之異常如乳癌、前列腺癌及子宮內膜異位。 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) -36- 1322144 A7 ___ B7 五、發明説明( 本發明以如下實施例來顯示。 (請先閲讀背面之注意事項再填寫本頁) 實施例 實施例1 乙醯基一 R —(第三T氣羰某)胺基一 4—莱其—1 -1—2,3,4 —四氤一2,2,4 一二甲基哮啉 (a ) 6 —(第三丁氧羰基)胺某一 1 ,2 -二氤—?, _2_,4 —三甲某哮啉 將N — Boc — 1,4_苯二胺(5 · 0克)及碘( 1 · 3克)於氧化來基(25毫升)之混合物在1〇〇。(: 下攪拌2小時。將反應混何物於真空下濃縮且殘餘物在 A 1 2 〇 3 (氧化鋁b, act .III )於庚烷/二氯甲烷=8/2 作爲洗脫劑來層析。 產量:2 . 9克。 MS — ESI : 〔M+H〕+=289.2。 (b ) _1. _乙醯基-6—(第三丁氬羰某)胺基—1 經濟部智慧財產局員工消費合作社印製 —二氫—2,2,4 —三甲基喹啉 將乙醯基氯(11 . 1毫升)及醋酸酐(11 .丄毫 升)逐滴加到6 —(第三丁氧羰基)胺基一 1 ,2 —二氫 -2 ,2 ,4 一三甲基喹啉(8 . 5克)於吡啶(22毫 升)及二氯甲烷(2 1 2毫升)之溶液中。於攪拌1 8小 時後’將反應混合物用2M HC 1及水淸洗。將有機層 脫水(硫酸鎂)、過濾及真空濃縮。殘餘物在矽膠上以庚 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -37- 1322144 A7 __________B7_ 五、發明説明(1 2 3$ 烷/醋酸乙酯=8/2 (v/v)作爲洗脫劑來層析。 產量:6 · 7克。 (請先閲讀背面之注意事項再填寫本頁) MS-ESI : 〔M + H〕+=331.2 (c ) 1 一乙醯某——胺某一 4 —苯某—1 ,2,3, 經濟部智慧財產局員工消費合作社印製 -38- 1 四氤一2,2,4 —三甲某喹啉 將1—乙醯基—6_ (第三丁氧羰基)胺基-2,2 ,4_三甲基一1 ,2_二氫π奎啉(2 · 4克)及 A1C13(9 · 5克)於苯(150毫升)混合物於70 °C下攪拌1小時。將反應混合物冷卻(0 t )且用水驟冷 且額外加入2M Na 0H溶液。分離有機層,以硫酸鎂 脫水、過濾且真空濃縮。殘餘物在矽膠上以庚烷/醋酸乙 酯=8/2 (v/v)作爲洗脫劑來層析。 產量:1 . 6克。 2 MS — ESI : 〔M+H〕+=309.2 (d ) 1—乙醯基_ 6 —(第二丁氧簾基)胺基_ 4 一苯 3 某—1 ,2,3,4-四氤—2,2,4 —三甲基哇啉 將1 一乙醯基—6_胺基—4_苯基_1 ,2,3, 1322144 A7 _B7___ 五、發明説明(约 洗脫劑來層析。 產量:8毫克。 (請先閲讀背面之注意事項再填寫本頁) MS-ESI : 〔M+H〕+=409.2 實施例2 ft—胺某—1— 丁醯某—4一苯某一 1 ,2,3,4 —四 氤一 2,2,4 —三甲某哮啉 (a ) 6_ (第三丁氣羰某)胺某一 1 — 丁醯基—1,2 —二氤—2,2,4 —三甲某哮啉 將丁醯基氯(185微升)逐滴加到6 -(第三丁氧 羰基)胺基一 1 ,2 —二氫_2,2,4 —三甲基喹啉( 5 Omg )及觸媒份量之N,N —二甲胺基吡啶於吡啶( 4毫升)之溶液中。於攪拌1 8小時後,將反應混合物於 真空下濃縮。將殘餘物溶於醋酸乙酯中且用水洗。將有機 層分離、脫水(硫酸鎂)及真空濃縮。殘餘物在矽膠上以 庚烷/醋酸乙酯=1/0 = > 7/3 ( v/v )作爲洗脫 劑來層析。 產量:4 7毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI : 〔Μ+Η〕+=359·4 (b ) 6 —胺基-]一 丁炔某—4 —苯某—1 ,9,q , 4 一四氣_2,2,4 一三甲基哮啉 將1 一 丁醯基—6 -(第三丁氧羰基)胺基一 1 , 2 一二氣-2,2,4 一三甲基喹啉(4 7mg)及A1C1;( 本纸張尺度適用中國國家標準(CNS ) A4規格< 210X297公釐) -39- 1322144 A7 B7 五、發明説明( (請先閲讀背面之注意事項再填寫本頁) 5 2mg)於苯(2ml )之混合物於60 °C下攪拌6小 時。將反應混合物冷卻(0 °C )且用水驟冷且額外加入 2 Μ N a Ο Η溶液。分離有機層,用硫酸鎂脫水且於真 空濃縮。殘餘物用預備性Η P L C來純化。 產釐:1 0毫克。 MS — ESI :〔M + H〕+ =337. 2; 1^?乙(::111 = 6_97分鐘(方法1) 實施例3 乙醯某-6—胺基—4— (4 —氡苯某)_1 ,2, 1,4_四氤一2,2,4 —三甲某晬做 將1_乙醯基_6 —(第三丁氧羰基)胺基-1,2 —二氫-2,2,4 —三甲基嗤啉(25mg)及AlCh ( 35mg)於氯苯(2m1)之混合物攪拌1小時。將反 應混合物用水驟冷且額外加入2M N a OH溶液及醋酸 乙酯。分離有機層,用硫酸鎂脫水且於真空濃縮》 產量:2 0毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI: 〔M+H〕+=343.4; HPLC : Rt = 6 · 16 分鐘(方法 1) 實施例4 1—乙釀基—6_胺基一 4 一(4 —氨苯基)—1 , 2, 3,4 一四氤一2,2,4 —三甲某哮啉 根據實施例3所述方法於A 1 C 1 3存在下以氟苯(2 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -40- 1322144 A7 B7___ 五、發明説明(3$ 毫升)與1_乙醯基一 6_ (第三丁氧羰基)胺基—1 , (請先閱讀背面之注意事項再填寫本頁) 2 —二氫一 2 ,2 ’ 4一三甲基π奎啉(25mg)進行 Friedel-Craft 院化作用。 產量:1 5毫克。 MS — ESI : 〔Μ+Η〕+=327·4; HPLC : Rt = 5 . 6 3分鐘(方法1) 實施例5 _1一 -乙醯基 — 6 —肢基一 1 ,,〜土,4 _四氤—4 _ ( j —甲苯基)_一 2,2,4 -三甲笔_£奎琳 根據實施例3所述方法於A 1 c 1 3 (3 5mg)存在 下以甲本(2竜;升)與1 _乙醯基〜6 _(第三丁氧羰基 )胺基—1 ,2 —二氫一2,2 ,4 —三甲基d奎啉(25 m g )進行Friedel-Craft烷化作用。 產量:2 2毫克。 MS — ESI: 〔M+H〕+ =323. 2 經濟部智慧財產局員工消費合作社印製 實施例6 J —乙隨基-6 —__( 4 一氯苯甲醯巷)胺某一 4 一苯基_ -i~^—2_:__3__1 4 —四氤一 2,2_三甲基 p 奎琳 將1 一乙酿基—6—胺基一 4~~苯基_i , 2,3, 4 一四氫一2 ,2 ,4 一三甲基鸣% (1〇毫克),4一 氯苯甲醢基氯(1 lmg)及N ’ N —二異丙基乙基胺( 2 2微升)於四氫咲喃(1毫升)混合物擾拌1 8小時。 本纸張尺度適用中國國家標準(CNS } A4規格(2丨0><297公釐_^ ' -41 - 1322144 A7 B7__ 五、發明説明( (請先閲讀背面之注意事項再填寫本頁} 將反應混合物於真空下濃縮,殘餘物溶於醋酸乙酯中且用 0 . 5 N HC 1 ,水,5%碳酸氫鈉水溶液,水及食鹽 水淸洗。分離有機層,以硫酸鎂脫水且真空濃縮。殘餘物 在矽膠上以庚烷/醋酸乙酯=1/0 = >〇/1 (v/v )作爲洗脫劑來層析。 產量:9 . 5毫克。 MS — ESI : [M+H] + =447 . 4 ; HPLC : Rt=10 . 87 分鐘(方法 1) 實施例7 1_乙醯某一 6 —苯甲醯胺基一 4 —茉其一 1 , p , Q, 4 —四氣—2,2,4 —三甲基哮啉 根據實施例6所述方法以1 -乙醯基—6 —胺4 _苯基一1 ,2 ,3 ,4 —四氣_2,2 ,4 —三甲基[I奎 琳(10毫克)’本甲釀基氯(9.img)及 二異丙基乙基胺(22微升)於四氫呋喃(i毫升)之混 合物進行醯化反應。 產量:1 . 2毫克β 經濟部智慧財產局員工消費合作社印製 MS-ESI: 〔Μ + Η〕+=413.4; HPLC : Rt=10 . 01分鐘(方法工) 實施例8 1—乙醯基一4一苯基一 1 , 2 , 4 —四氤—β —( 4一 [三氟甲基〕苯甲醯基)胺基—_2 , 二 基 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -42- 1322144 A7 B7 五、發明説明(岣 p奎啉 (請先閱讀背面之注意事項再填寫本頁) 根據實施例6所述方法以1 _乙醯基一 6 -胺基一 4 —苯基_ 1 ,2 ,3 ,4 —四氫_2 ,2 ,4 一三甲基喹 啉(10毫克),4 —三氟甲基苯甲醯基氯(14mg) 及N,N_二異丙基乙基胺(2 2微升)於四氫呋喃(1 毫升)進行醯化反應。 產量:8 . 9毫克。 MS — ESI: 〔M+H〕+=481_4; HPLC : Rt=l〇 . 76 分鐘(方法 1) 實施例9 1 —乙醯基—6— (4-硝苯甲醯某)胺某-4-苯某-1 ,2,3,4 —四氣一2,2,4-三甲基喹啉 根據實施例6所述方法以1 -乙醯基- 6 -胺基_ 4 —苯基—1 ,2 ,3 ,4-四氫一2,2 ,4 —三甲基喹 啉(10毫克),4_硝苯甲醯基氯(12mg)及N, N -二異丙基乙基胺(2 2微升)於四氫呋喃(1毫升) 進行醯化反應。 經濟部智慧財產局員工消費合作社印製 產量:8 . 2毫克。 MS — ESI: 〔M+H〕+ =458. 4; HPLC :Rt=l〇 . 02 分鐘(方法 1) 實施例1 0 1 一乙醯基一 4_苯基_6_ (4 -正丙基苯甲醯基)胺 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -43- 1322144 甲某哮啉 A7 B7 五、發明説明(4今 基一1 ' 2 ' 3 ' 4 — £3 Μ ~ 根據實施例6所述方法以1 ~乙n g _ 6 胺基_ 4 一苯基—1 ,2,3 ,4 —四氫一 2,2, 琳(1 0毫克)’ 4_正丙基苯甲醯基氯(1 2mg)及 …-二異丙基乙基胺(2 2微升)於四氫呋喃"毫 升)進行醯化反應。 產量:6 . 7毫克。 4 _三甲基α奎 MS — ESI : [ M + Η ] 4 5 4 ;XXIII This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) '30- 1322144 Α7 Β7 5. Inventive Note (蹭 Appropriate formula XXIX iodide can be made from the corresponding amine by the conventional Sandmeijer reaction (Please read the back y note first and then fill out this page) Certain compounds of the invention, which are in the form of the free base, are isolated as pharmaceutically acceptable salts from the reaction mixture. Salts can be obtained by reacting the free base of formula I with an organic or inorganic acid such as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, acetic acid 'propionic acid, glycolic acid, maleic acid, malonic acid, Prepared by treatment with methanesulfonic acid, fumaric acid, succinic acid, tartaric acid, citric acid, benzoic acid, ascorbic acid, etc. The compound of the present invention has at least one palmitic carbon atom and thus may be a pure enantiomer, A mixture of enantiomers or a mixture of diastereomers is obtained. Methods for obtaining pure enantiomers are known in the art, for example from optically active acids and salts in racemic mixtures. get on Crystallization, or by chromatography with a palm column. For diastereomers, vertical phase column or reverse phase column can be used. The Ministry of Economic Affairs Intellectual Property Office employee consumption cooperative prints the compound of the invention. It is known to those skilled in the art that the compound may form a hydrate when the charged compound is lyophilized with water, or may form a solvated species when concentrated in a solution with a suitable organic solvent. Including the hydrates and solvates of the listed compounds. In order to select the active compound, the activity of the test compound when tested at 1 〇 5 m must be greater than 20% of the maximum activity when FS Η is used as the control group. It is regarded as an active compound. Another condition can be considered by E C5. EE C5〇値 must be < 1 〇-5Μ, preferably < 1 0 _ 7 Μ. This paper scale applies to Chinese national standard (CNS) A4 size (210X297 mm) -31 - 1322144 A7 B7 V. Invention description (2 bow (please read the back note first and then fill out this page) Those who are familiar with this technology should know the required EC 5 D値 will depend on the test compound. For example, a compound having an EC 50 値 less than 1 〇 5 Μ is generally considered to be a suitable choice for the drug. Preferably, the 値 is less than 10 7 Μ. However, if one Compounds, although having a higher E C5 oxime but being selective for a particular receptor, may be a better choice. Measuring the binding of gonadotropins to the receptor, as well as measuring the biological activity of the in vitro and live In vivo assays are common. In general, the expression receptor is contacted with the test compound, and then the binding sensation and the stimulation or inhibition of the functional response are measured. In order to measure the functional response, the FS is encoded. The DNA of the gene, preferably the human receptor, is expressed in a suitable host cell. These host cells may be Chinese hamster ovary cells, although other cells are also suitable. Preferred cells are cells derived from mammalian sources (Jia et al, Mol. Endocrin, 5: 759-776, 1991). The method of constructing a recombinant FSH expressing cell strain by the Ministry of Economic Affairs Intellectual Property Office employee consumption cooperative is known in the art (Sambrook et al., Molecular Cloning: a Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, recent edition) ). The performance of the receptor is obtained by expressing the DNA encoding the desired protein. Now, all of these techniques are known to those skilled in the art for mutation techniques for specific sites, joining additional sequences, P C R, and constructing appropriate performance systems. The DNA encoding part or all of the desired protein can be synthetically constructed using standard solid phase techniques, preferably including a restriction enzyme recognition site for easy ligation. The D N A coding sequence can also be provided with control elements suitable for transcription and translation of the contained coding sequences. For example, this paper scale applies Chinese National Standard (CNS) A4 specification (210X297 mm) -32- 1322144 A7 _B7 V. Invention description (3〇 (please read the note on the back and fill in this page) There are many expression systems that are compatible with many hosts, including prokaryotic hosts such as bacteria and eukaryotic hosts such as yeasts, plant packets, insect packets, mammalian cells, avian cells, etc. Cells that exhibit receptors The test compound is then contacted to observe its binding or stimulatory or inhibitory effects of the functional response. Alternatively, a separate cell membrane containing the expression receptor can be used to measure the binding of the compound. Use radiolabeled or fluorescently labeled compounds. Human recombinant FS Η can be used as a control compound. In addition, competitive binding assays can be performed. Another assay involves the accumulation of c A Μ 调制 accumulated by the receiver. Screening of FS receptor agonist compounds. Therefore, this method involves expressing the receptor on the surface of the host cell membrane and will Exposure to the test compound. The amount of c AMP is then measured. The amount of c AMP may increase or decrease depending on the inhibitory or stimulating effect of the test compound after binding to the receptor. Ministry of Economic Affairs Intellectual Property Office Staff Consumption Cooperative Printing In addition to directly measuring the amount of c AMP in exposed cells, the cell line used can be transfected with the DNA encoding the second receptor gene in addition to the DNA encoding the receptor, and the expression of the gene is Responding to the amount of c AMP. These receptor genes may be primed by c AMP or constructed to be linked to a novel c AMP response element. Generally, the expression of the acceptor gene may be c AMP by the reaction of any combination. Appropriate receptor genes are controlled by changing reaction elements such as LacZ, basic phosphatase, firefly luciferase, fluorescent protein, etc. The paper size of these transactivation assays is applicable to the Chinese National Standard (CNS) A4 specification ( 2丨〇><297 mm) -33- 1322144 A7 __B7 V. Description of the invention (3, Principles are known to the art and are detailed, for example, in Strat〇wa, Ch. Himmler, A. Czernilofsky, AP, (i995) Curr. Opin. Biotechnolo. 6: 574 » (Please read the notes on the back and fill out this page) The invention also relates to a pharmaceutical composition comprising a tetrahydroquinoline derivative of the formula I Or a pharmaceutically acceptable salt thereof, in admixture with a pharmaceutically acceptable adjuvant and optionally other therapeutic agents. The adjuvant must be "acceptable" in the sense that it is compatible with the other ingredients of the composition and does not The recipient may have a bad influence. The pharmaceutical composition may also contain tetrahydrofurfuryl quinoline-derived hexamethylene-6-benzamide- 4-(4-tolyl)_1, 2,3,4 —tetrahydro-2' 2 ,4-trimethylquinoline, 1-ethenyl- 4-phenyl-1,2,3,4-tetrahydro-2,2,4,6-tetramethylquina Porphyrin, 1-ethenyl- 4-phenyl- 1 ,2,3,4-tetrahydro-2,2,4,6,8-pentamethyl-α-quinoline, 1-ethylindenyl- 6-A Oxygen 4- 4-phenyl- 1 , 2 , 3 , 4 - tetrahydro - 2 , 2 , 4 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing _ trimethylquinoline, 1-ethyl sulfonyl one 6 - three Fluoroacetamido- 4-one (4-tolyl)-1,2,3,4-tetrahydro-2,2,4-trimethyl sinine, 1-ethylidene-6-trifluoroacetamido- 4-phenyl- 1 , 2 , 3 , 4 - tetrahydro - 2 , 2 , 4 - trimethyl π - quinoline , 1 - ethyl - 4 - ( 4 - chlorophenyl ) - 1,2,3,4 - tetrahydrogen — 2,2,4,6-tetramethylquinoline and 1-ethylindolyl-4—(4-bromophenyl)-1,2,3,4_tetrahydro-2,2,4,6- Tetramethylquinoline. Compositions, including, for example, those suitable for oral, sublingual, subcutaneous, intravenous, intramuscular, topical or rectal administration, are all pharmaceutically acceptable unit dosage forms. When administered orally, the active ingredient may be in discrete units, such as tablets, paper size applicable to Chinese National Standard (CNS) Α4 size (210X297 mm) -34 - 1322144 A7 B7 V. Invention Description (all capsules, powders) , nine doses, solutions and suspensions, etc. When administered parenterally, the pharmaceutical composition of the present invention may be administered in a unit dose or in a multi-agent container, for example, in a sealed vial or a watch glass vial, and It can be stored in lyophilized form by adding a sterile liquid carrier such as water prior to use. It can be mixed with pharmaceutically acceptable adjuvants such as those described in standard references, Gennaro, AR et al., Remington: The Science and Practice of Pharmacy (20th Edition. . Lippincott Willians & Wilkins, 2000, with particular reference to Section 5: Pharmaceutical Manufacturing), the active ingredient can be compressed into solid dosage units, such as tablets, lozenges, or processed into Capsule or suppository. The active agent can be administered in the form of a liquid composition, for example, an injection preparation, in the form of a pharmaceutically acceptable liquid. Suspension 'emulsions or sprays, for example in the form of nasal sprays. In the manufacture of solid dosage units, the use of conventional additives such as tanning materials, colorants, polymeric binding agents, etc., generally any pharmacy which does not interfere with the function of the active compound Acceptable additives can be used. The carrier can be used in a suitable amount to allow the active agent of the present invention to be administered as a solid composition, including lactose, starch, cellulose derivatives, etc., or In the case of parenteral administration, aqueous suspensions, isotonic saline solutions and sterile injectable solutions may be employed which may contain pharmaceutically acceptable dispersing agents and/or wetting agents such as propylene glycol or butylene glycol. Further included is a pharmaceutical composition which, as hereinbefore described, may be combined with a packaging material suitable for the solid composition, the packaging material may include instructions indicating the use of the composition in the foregoing. National Standard (CNS) A4 Specification (210X297 mm) (Please read the note on the back and fill out this page) - Install. Bureau employee consumption cooperative printing -35- 1322144 Α7 Β7 V. Invention description (both (please read the back note first and then fill out this page) The tetrahydroquinoline derivative of the present invention can also be implanted in the form of a pharmacy device. For administration, the device consists of a layer of outer membrane that regulates the release rate and a core of active material placed in the membrane. These implants can be administered subcutaneously or locally, and can be administered over a relatively long period of time. The active ingredient is released at a nearly constant rate over the course of several weeks. Methods of preparing implantable pharmacy devices are known in the art and are described, for example, in European Patent No. 0,303,306 (AKZO Nobel N.V.). The exact dose and administration schedule of the active ingredient or its pharmaceutical composition will necessarily depend on the desired therapeutic effect (treatment of infertility; contraception) and may be due to the particular compound used, the route of administration, and the patient to whom the drug is administered. The age and condition of the individual vary. Printed by the Ministry of Economic Affairs, the Intellectual Property Office, the Consumer Cooperative, the dose required for parenteral administration is lower than that required for other absorption-dependent methods of administration. However, the dose for human use is preferably an amount of from 0. 00 to 155 mg per kilogram of body weight. The required dose may be provided by a single dose or by sub-division of multiple doses of the agent at appropriate intervals within one day, or in the case of a female user, the required dose may be administered at appropriate intervals in the menstrual cycle. provide. This dose and dosing schedule may vary between female and male takers. Thus, the compounds of the invention may be used therapeutically. A further aspect of the invention relates to the use of a tetrahydro π-quinoline derivative of the formula I for the manufacture of a medicament which can be used to treat an abnormal disease responsive to the path modulated by the FS receptor, which is preferably used to control pregnancy, More preferably used to treat infertility or prevent pregnancy. The compounds of the invention may also be used to treat hormone-related abnormalities such as breast cancer, prostate cancer and endometriosis. This paper scale applies to Chinese National Standard (CNS) Α4 specification (210X 297 mm) -36- 1322144 A7 ___ B7 V. Description of the invention (The present invention is shown in the following example. (Please read the notes on the back and fill in the form) This Example 1 Example Ethyl-R-(Third T-Carbonyl) Amino- 4-Leic- 1 -1, 2, 4, 4, 2, 2, 4 Methyl porphyrin (a) 6 - (t-butoxycarbonyl) amine 1 , 2 - bis-?, _2_, 4 - trimethyl porphyrin N- Boc-1, 4-phenylenediamine (5 · 0 g) and iodine (1.3 g) in a mixture of oxidized radicals (25 ml) at 1 Torr. (: stirring for 2 hours. The reaction mixture was concentrated under vacuum and the residue was at A 1 2 〇3 (aluminum oxide b, act. III) was chromatographed eluting with Heptane / methylene chloride = 8/2. (b) _1. _ 醯 -6 -6 - (Third argon carbonyl) amine - 1 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing - dihydro - 2,2,4 -trimethylquinoline Ethyl chloroform (11. 1 ml) and acetic anhydride (11. 丄Add dropwise to 6-(t-butoxycarbonyl)amino-1,2-dihydro-2,2,4-trimethylquinoline (8.5 g) in pyridine (22 ml) and dichloro In a solution of methane (2 1 2 mL). After stirring for 18 hours, the reaction mixture was washed with 2M EtOAc and water. The organic layer was dried (MgSO4), filtered and concentrated in vacuo. Gengben paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -37- 1322144 A7 __________B7_ V. Description of invention (1 2 3$ alkane / ethyl acetate = 8/2 (v / v) as a wash Deprotection to chromatography. Yield: 6 · 7 g. (Please read the notes on the back and fill out this page) MS-ESI : [M + H]+=331.2 (c ) 1 A 4-Benzene-1, 2,3, Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumption Cooperative, Printed - 38-1, 4, 2, 2, 4 - Trimethyl, a quinoline, 1-ethylenyl-6_ (third Butoxycarbonyl)amino-2,2,4-trimethyl-1,2-dihydroπ-quinoline (2 · 4 g) and A1C13 (9 · 5 g) in benzene (150 ml) mixture at 70 ° Stir for 1 hour at C. Mix the reaction It was cooled (0 t) and quenched with water and EtOAc EtOAc EtOAc EtOAc EtOAc. v) Chromatography as an eluent. Yield: 1.6 g. 2 MS — ESI : [M+H]+=309.2 (d) 1—Ethyl _ 6 —(2nd butyloxy)amino _ 4 Benzene 3 ——1 , 2, 3, 4- 4氤—2,2,4 —trimethyl morpholine 1 ethoxycarbonyl-6-amino-4_phenyl_1, 2,3, 1322144 A7 _B7___ V. Description of the invention (about eluent layer Yield: 8 mg. (Please read the notes on the back and fill out this page.) MS-ESI : [M+H]+=409.2 Example 2 ft-amine one-1—Ding醯—4-Benzene a 1, 2, 3, 4 - 4, 2, 2, 4 - trimethyl porphyrin (a) 6_ (third butyl carbonyl) amine 1 - butyl sulfhydryl - 1,2 - bismuth - 2, 2,4 - Trimethyl porphyrin Adds butyl hydrazine chloride (185 μl) dropwise to 6 -(t-butoxycarbonyl)amino-1,2-dihydro-2,2,4-trimethylquinoline (5 Omg) and a catalytic amount of N,N-dimethylaminopyridine in a solution of pyridine (4 ml). After stirring for 18 hours, the reaction mixture was concentrated in vacuo. The ester was washed with water. The organic layer was separated, dried (MgSO4) and evaporated. Chromatography with heptane/ethyl acetate = 1/0 = > 7/3 (v/v) as eluent. Yield: 4 7 mg. Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, MS-ESI : [Μ+Η]+=359·4 (b) 6—Amino-]-butyne-—4—Benzene—1,9,q,4—four gas_2,2,4-trimethyl Rotary porphyrin will be 1-butyryl-6-(t-butoxycarbonyl)amino-1, 2,2-di-2,2,4-trimethylquinoline (47 mg) and A1C1; China National Standard (CNS) A4 Specification < 210X297 mm) -39- 1322144 A7 B7 V. Description of Invention ((Please read the note on the back and fill out this page) 5 2mg) Mixture of Benzene (2ml) at 60 After stirring for 6 hours at ° C. The reaction mixture was cooled (0 ° C) and quenched with water and EtOAc EtOAc EtOAc (EtOAc m. Purification by PLC. Production: 10 mg. MS - ESI: [M + H] + = 337. 2; 1^? B (:: 111 = 6_97 minutes (method 1) Example 3 醯 -6 - Amino-4-(4-indolyl)_1,2, 1,4_ 4氤2,2,4—三甲晬晬1_乙醯基_6 —(Tertidinoxycarbonyl)amino-1,2-dihydro-2,2,4-trimethylporphyrin (25 mg) and a mixture of AlCh (35 mg) in chlorobenzene (2 ml) were stirred for 1 hour. The reaction mixture was quenched with water and an additional 2M aqueous solution of EtOAc and ethyl acetate. The organic layer was separated, dried over magnesium sulfate and concentrated in vacuo. MS-ESI: [M+H]+=343.4; HPLC: Rt = 6 · 16 minutes (Method 1) Example 4 1 - Ethyl- 6-Amino- 4 One (4-aminophenyl)-1, 2,3,4-tetradecyl-2,2,4-trimethyl-rotorine according to the method described in Example 3 in the presence of A 1 C 1 3 with fluorobenzene (2 This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -40- 1322144 A7 B7___ V. Description of invention (3$ ml) and 1_Ethyl- 6-(t-butoxycarbonyl)amino group —1 , (Please read the note on the back and then fill out this page) 2 —Dihydro-2,2′ 4-trimethyl π-quinoline (25mg) for Friedel-Craft hospitalization. Yield: 15 mg. MS - ESI : [Μ+Η]+=327·4; HPLC: Rt = 5 . 6 3 minutes (method 1) Example 5 _1 1-ethylidene- 6 - limbs-1, ~ soil, 4 _四氤—4 _ ( j —tolyl) — a 2, 2, 4 — trigram — _ queline according to the method described in Example 3 in the presence of A 1 c 1 3 (3 5 mg) with a copy (2竜; 升) with 1 _ acetyl group ~ 6 _ (t-butoxycarbonyl) amine group - 1 2 - Dihydro-2,2,4-trimethyl d-quinoline (25 mg) for Friedel-Craft alkylation Yield: 2 2 mg. MS - ESI: [M+H]+ = 323. 2 Economy Ministry of Intellectual Property, Staff Consumer Cooperatives, Printing Example 6 J—B with the base-6 —__( 4 chlorobenzidine) amine 4 phenyl _ -i~^—2_:__3__1 4 —four 氤A 2,2_trimethyl p-quine will be 1-ethyl aryl-6-amino- 4~~phenyl-i, 2,3, 4-tetrahydro- 2,2,4-trimethyl-methyl % (1 mg), 4-chlorobenzhydryl chloride (1 lmg) and N'N-diisopropylethylamine (22 μl) in a mixture of tetrahydrofuran (1 ml) 8 hours. This paper scale applies to Chinese national standard (CNS } A4 specification (2丨0><297 mm_^ ' -41 - 1322144 A7 B7__ V. Invention description (please read the notes on the back and fill in the form) The reaction mixture was concentrated in vacuo and the residue was taken in ethyl acetate and washed with EtOAc EtOAc EtOAc Magnesium is dehydrated and concentrated in vacuo. The residue is on silicone. Heptane / ethyl acetate = 1/0 = > square / 1 (v / v) as the eluent for chromatography. Yield: 9.5 mg. MS - ESI : [M+H] + =447. 4 ; HPLC : Rt = 10. 87 minutes (method 1) Example 7 1 _ 醯 醯 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 , p, Q, 4 - four gas - 2, 2, 4 - trimethyl porphyrin according to the method described in Example 6 with 1-ethyl fluorenyl-6-amine 4 _ phenyl- 1 , 2 , 3 , 4 - four gas 2,2,4-trimethyl [I-quine (10 mg)' of the present brewyl chloride (9.img) and diisopropylethylamine (22 microliters) in tetrahydrofuran (i ml The mixture is subjected to a deuteration reaction. Yield: 1.2 mg β Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed MS-ESI: [Μ + Η]+=413.4; HPLC: Rt=10. 01 min (method) Example 8 1-Ethyl 4-41-phenyl-1, 2,4-tetraindole-β-(4-mono[trifluoromethyl]benzylidene)-amino-2, 2 basic paper scales applicable to Chinese National Standard (CNS) Α4 Specifications (210Χ297 mm) -42- 1322144 A7 B7 V. Description of the invention (岣p-quinoline (please read the back note first and then fill out this page) According to the method described in Example 6 with 1 _ acetyl- 6-amine 4-Phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg), 4-trifluoromethylbenzimidyl chloride (14 mg) and N , N-diisopropylethylamine (2 2 μL) was subjected to oximation in tetrahydrofuran (1 mL). Yield: 8.9 mg. MS - ESI: [M+H]+=481_4; HPLC: Rt = l〇. 76 minutes (method 1) Example 9 1 - Ethyl- 6-(4-nitrobenzidine) Amine-4-Benzene-1, 2, 3, 4 - 4 gas-2 , 2,4-trimethylquinoline according to the method described in Example 6 with 1-acetamidine - 6 -Amino-4-phenyl- 1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg), 4-nitrobenzoguanidino chloride (12 mg) and N,N-diisopropylethylamine (2 2 μL) was subjected to deuteration reaction in tetrahydrofuran (1 ml). Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed yield: 8.2 mg. MS — ESI: 〔 M+H]+ = 458. 4; HPLC: Rt = 1 〇. 02 min (Method 1) Example 1 0 1 -Ethylamino-4-phenyl- 6-(4-propenylbenzylidene) The size of the amine paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -43- 1322144 A. Rosin A7 B7 V. Invention Description (4 Jinji 1 ' 2 ' 3 ' 4 — £3 Μ ~ According to the method described in Example 6, 1 ~ ng _ 6 amine _ 4 phenyl - 1 , 2, 3 , 4 - tetrahydro - 2, 2, Lin (10 mg) ' 4 - n-propyl benzene Metformyl chloride (1 2 mg) and ...-diisopropylethylamine (2 2 μl) were subjected to a oximation reaction in tetrahydrofuran < cc. Yield: 6.7 mg. 4 _ trimethyl alpha quinone MS — ESI : [ M + Η ] 4 5 4 ;

Η P L CΗ P L C

R 1 9分鐘(方法 (請先閱讀背面之注意事項再填寫本頁) 實施例1 1 1—乙醯某一 6 - (3 —溴— 2 )胺基一 4 一苯某—1 ~~甲氣某茉甲醯某 氤一?,?,4 一三甲某啐啉 將1—乙醯基—6 -4—四氫一2 ,2 ,4 — 溴_2 ,6 —二甲氧基苯 經濟部智慧財產局員工消費合作社印製 氮雜苯并三 脲鑰六氟磷 異丙基乙基 攪拌1 8小 醋酸乙酯中 溶液,水及 。殘餘物在 唑一 1 —基) 酸鹽(H A Τ 胺(3 2微升 時。將反應混 且用0 . 5 Μ 食鹽水淸洗。 矽膠上以庚烷 月女基一 4-苯基一 1,2,3, 三甲基11奎啉(25毫克),3_ 甲酸(23mg) , 〇 _ (7 — —N,N,n, > n '—四甲基 ϋ) (68mg)及 ν,Ν -二 )於二氯甲烷(4毫升)混合物 合物於真空下濃縮,殘餘物溶於 H C 1 ,水,5 %碳酸氫鈉水 有機層以硫酸鎂脫水且真空濃縮 /醋酸乙酯=1/0=>0/1 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -44- 1322144 A7 B7 五、發明説明(鸽 (V/V)作爲洗脫劑來層析。 產量:2 8毫克。 (請先閱讀背面之注意事項再填寫本頁) MS — ESI: 〔M + H〕+ =551. 4; HPLC : Rt = 3 . 75 分鐘(方法 2) 實施例1 2 1 _乙醯基_4_苯基一 6—(4 一苯基苯甲醯基)胺基 -1,2,3,4 —四氤一2,2,4 —三甲基喹啉 根據實施例6所述方法以1 _乙醯基_ 6 _胺基_ 4 —苯基一1 ,2 ,3 ,4 —四氫一 2 ,2 ,4 一三甲基喹 啉(11毫克),4一二苯羰基氯(16mg)及N,N -二異丙基乙基胺(2 2微升)於四氫呋喃(1毫升)進 行醯化反應。 產量:1' 0毫克。 MS — ESI: 〔M+H〕+ =489.4; HPLC : Rt=l 1 . 62 分鐘(方法 1) 實施例1 3 經濟部智慧財產局員工消費合作社印製 1 一乙醯基一 6 (4 - ί 4 —氯苯某1苯甲醯基)胺基_ 4 —苯基-1 ,2 ,3 ,4 一四氤一2 ,2 ,4 —三甲基 D奎啉 a ) 1 一乙醯基_6_ (4_碘苯甲醯基)胺基_4_苯 基一 Γ,2,3,4-四氫一 2,2,4 —三甲基喳啉 將1一乙醯基—6 —胺基—4 —苯基_1 ,2,3, 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -45- 1322144 A7 __B7_ 五、發明説明(4$ (請先閱讀背面之注意事項再填寫本頁) 4 —四氫一 2 ,2 ’ 4 —三甲基喹啉(300mg) ,4 一碘苯甲醯基氯(5 2 Omg )及觸媒份量之N,N —二 甲胺基吡啶於吡啶(4毫升)之混合物攪拌1 8小時。將 反應混合物於真空下濃縮。將殘餘物溶於醋酸乙酯中且用 飽和碳酸氫鈉水溶液、水及食鹽水淸洗。將有機層脫水( 硫酸鎂)及真.空濃縮。 產量:4 6 0毫克。 MS — ESI : 〔M+H〕+=539.4; HPLC : Rt = l〇 . 98 分鐘(方法 1) (b ) 1—乙醯基—6 (4 — 1:4—氯苯某1苯甲醯某) 胺基—4 一苯基—1 ,2,3,4 —四氫一 2,2,4 — 三甲基哮啉 將1_乙醯基_6 — (4_碘苯甲醯基)胺基一4_ 苯基-1 ,2 ,3 ,4 —四氫-2 ,2 ,4 —三甲基喹啉 C 2 5 m g ) ,4-氯苯硼酸(22mg),氟化鉋( 經濟部智慧財產局員工消費合作社印製 1 4 m g )、三苯基瞵(5. Omg)及參(二苯叉丙酮 )二鈀(0) (4.3mg)於二甲氧基乙烷/乙醇4: 1 ( 5毫升)之混合物於氮氣冒泡通過溶液下攪拌1 5分 鐘。置於8 0°C下3小時後,將反應混合物於真空下濃縮 ,殘餘物溶於醋酸乙酯中且用0 . 5M HC 1 ,水,5 %碳酸氫鈉水溶液,水及食鹽水淸洗。有機層以硫酸鎂脫 水且真空濃縮。殘餘物在矽膠上以庚烷/醋酸乙酯= 1/0 = >0/1 (v/v)作爲洗脫劑來層析。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -46 - 1322144 A7 B7 五、發明説明(44 產量:1 6毫克。 MS-ESI: (M + H)+=523 . 4 ; (請先聞讀背面之注意事項再填寫本頁) HPLC : Rt = 4 · 40 分鐘(方法 2) 實施例1 4 1—乙醯基一 4 —苯基_6 (4_〔3_吡啶基〕苯甲醯 某)胺某一 1 ,2,3,4 —四氤_2,2,4_三甲基 η奎啉 根據實施例13所述方法,以1—乙醯基一 6— (4 一碘苯甲醯基)胺基-4-苯基—1 ,2,3 ,4 一四氫 —2,2,4 —三甲基喹啉(25mg),吼啶一3-硼 酸一 1,3 —丙二醇一環狀酯(23mg),氟化鉋( 1 4 m g )、三苯基瞵(5. Omg)及參(二苯叉丙酮 )二鈀(〇) (4.3mg)於二甲氧基乙烷/ .乙醇4: 1(v/v)(5毫升)來進行三菱交叉偶合反應。 產量:1 7毫克。 MS - ESI : 〔M + H〕+=490.4; ^1?1^<::1^ = 7.11分鐘(方法1) 經濟部智慧財產局員工消費合作社印製 實施例1 5 Ί 一乙醯基一4 一苯基_6_ (2_苯基_5_甲氧苯甲 醯基)胺基一 1 ,2 ,3 ,4 —四氣—2 ,2 ,4 —三甲 基喹啉 (a ) 1 _乙醯基一6— (2 —溴—5 —甲氧苯甲醯某) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -47 - 1322144 A7 B7 五、發明説明(4$ 胺基-4—苯基-1 ,2,3,4 —四氤-2,2,4一 三甲基喹啉 (請先閱讀背面之注意事項再填寫本頁) 根據實施例1 1所述方法,將1 一乙醯基一 6 —胺基 —4 —苯基一1 ,2 ,3 ,4 —四氨一2 ,2 ,4 —二甲 基喹啉(25毫克)與2 -溴_5 —甲氧基苯甲酸(2 1 mg)於HATU (6 8mg)及N,N —二異丙基乙基 胺(3 2微升)於二氯甲烷(4毫升)之媒介下進行縮合 作用。 產量:31毫克。 MS — ESI : 〔M+H〕+=521 · 4 ; HPLC : Rt = 3 · 74 分鐘(方法 2) (b ) 1 —乙醯基—4 —苯基_6— ( 2 —苯基—5 _甲 氧苯甲醯基)胺某一1 ,2,3,4_四氣一2,2,4 一三甲基d奎啉 經濟部智慧財產局員工消費合作社印製 根據實施例1 3所述方法’以1 一乙醒基一 4 一苯基 一 6 - (2 —溴一 5-甲氧苯甲醯基)胺基_1 ,2,3 ,4_四氫一2 ,2 ,4_三甲基喹啉(30mg),苯 硼酸(25mg),氟化鉋(21mg)、三苯基瞵( 7 · Omg)及參(二苯叉丙酮)二鈀(0) (6 · 0 mg)於二甲氧基乙烷/乙醇4 : 1 (v/v) (5毫升 )來進行三菱交叉偶合反應。 產量:2 3毫克。 MS-ESI: 〔Μ + Η〕+=519·4; 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -48- 1322144 A7 B7 五、發明説明(4$ HPLC : Rt = l〇 . 87 分鐘(方法 1) (請先閲讀背面之注意事項再填寫本頁) 實施例1 6 1 -乙醯基-4 —苯某一 6- (2-苯基一3 _甲某苯甲 β 基 ) 胺 基 1 9 2 > 3 j 4 —四 氤- 2 2 9 4 二 甲 基 哮 啉 ( a ) 1 — 乙 醯 基 _ 4 — 苹 基 一 6 -( 2 一 溴 _ 3 _ 甲 基 苹 甲 醯 基 ) 肢 基 1 > 2 > 3 ,4 -四 氫 2 2 9 4 二 甲 基 D奎啉 根 據 實 施 例 1 1 所 述 方 法 ,將 1 - 乙 醯 基 — 6 — 胺 基 — 4 — 苯 基 — 1 5 2 5 3 f 4 一四 氫- 2 j 2 ) 4 — 三 甲 基 口奎 啉 ( 2 5 毫: 克) 與2 - -溴- 3 — 甲基苯 甲 丨酸 ( 1 9 m g ) 於 Η A T U ( 6 8 m S )及 N, N — 二 異 丙 基 乙 基 胺 ( 3 2 微 升 ) 於 二 氯 甲 院 ( 4毫 升) 之 媒 介 下 進 行 縮 合 作 用 〇 產 量 ; 1 6 • 3毫克 〇 Μ S — E S I ; [Μ + η : 1 + = 5 0 5 . 2 t Η P L C * R t 二 :3 • 8 0 分 鐘 (方 法2 ) ( b ) 1 乙 醯 基 4 苹 基 -6 -( 2 苹 基 3 甲 基 苹 甲 基 ) 胺 基 1 2 > 3, 4 - 四 氫 2 j 2 9 4 — 一- 甲 基 喹1 咐 根 據 實 施 例 1 3 所 述 方 法 ,以 1 - 乙 醯 基 — 4 — 苯 基 —6 -(2 —溴一 3_甲基苯甲醯基)胺基一 1 ,2,3 經濟部智慧財產局員工消費合作社印製 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -49- 1322144 A7 B7 五、發明説明(邛 (請先閱讀背面之注意事項再填寫本頁) ,4 —四氫一 2 ,2,4 —三甲基喹啉(16mg),苯 砸酸(25mg),氟化鉋(21mg)、三苯基瞵( 7.0mg)及參(二苯叉丙酮)二鈀(0)(6.0 mg)於二甲氧基乙烷/乙醇4 : 1 (v/v) (5毫升 )來進行三菱交叉偶合反應。 產量:4 . 9毫克。 MS — ESI: 〔M + H〕+ =503. 3; HPLC:Rt=4.61分鐘(方法2) 實施例1 7 1-乙醯基—4 一苯基-1 ,2,3,4 —四氤-6—( α —甲苯磺醯基)胺基一 2,2,4_三甲基啐啉 根據實施例6所述方法以1 -乙醯基一 6 -胺基-4 —苯基一1 ,2 ,3 ,4一四氫一 2,2 ,4 —三甲基喹 啉(1 0毫克)與甲苯磺醯基氯(1 2mg)及Ν, N -二異丙基乙基胺(2 2微升)於四氫呋喃(2 5毫升 )進行磺醯化反應。 產量:9 . 8毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI: 〔Μ + Η〕+=463·4; HPLC : Rt = 9 · 49 分鐘(方法 1) 實施例1 8 1 _乙醯基—4 —苯基—6_ (苯胺羰基)胺某一 1 、 ,3,4一四氫一 2,2,4 —三甲基喹啉 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -50 - 1322144 A7 ___B7_ 五、發明説明( 將1 一乙醯基一 6 -胺基—4_苯基一 1 ,2,3, (請先閱讀背面之注意事項再填寫本頁) 4一四氫一 2 ’2 ’4 一三甲基喹啉(10毫克),異氰 酸苯基酯(8 · Omg)及N,N —二異丙基乙基胺( 2 2微升)於四氫呋喃(1毫升)混合物攪拌1 8小時。 將反應混合物於真空下濃縮,殘餘物溶於醋酸乙酯中且用 〇 · 5 M HC 1 ,水,5%碳酸氫鈉水溶液,水及食鹽 水淸洗。有機層以硫酸鎂脫水且真空濃縮。殘餘物在矽膠 上以庚烷/醋酸乙酯=1/〇 = >〇/1 (ν/ν)作爲 洗脫劑來層析。 產量:3 . 8毫克。 MS-ESI: CM + H) + =428 . 4 ; ^^?二(::1^ = 1〇.39分鐘(方法1) 實施例1 9 1 一乙醯基_6_ (第三丁胺硫羯某)胺某—4 一苯基— 1,2,3,4 —四氫—2,2,4 一二甲基喹琳 經濟部智慧財產局員工消費合作社印製 根據實施例1 8所述方法以1 —乙醯基—6 -胺基-4 一苯基—1 ,2 ,3 ,4 一四氫,2,4_三甲基 喹啉(1 0毫克)與異氰酸第三丁基酯(7 . 5mg)及 N,N —二異丙基乙基胺(2 2微升)於四氫呋喃(1毫 升)進行硫脲形成作用》 產量:0 . 5 0毫克。 MS-ESI: 〔M + H〕+=424.4; 1^?]^(::尺1 = 5.90分鐘(方法1) 本纸張尺度適用中國國家標準(CNS > A4規格(210X297公釐) -51 - 1322144 A7 __B7___ 五、發明説明(4令 實施例2 0 (請先聞讀背面之注意事項再填寫本頁) 1—乙醯基-6—(第三T苯某)胺基一 4 一苯某_1 , 2,2,4 —四氤一 2,2,4 —三甲基啐啉.三氩酷醅 將1—乙釀基—6 —胺基_4一苯基一 1 ,2,3, 4 一四氫—2 ,2,4_三甲基喳啉(10毫克),4 一 (第三丁基)苯基氯(6 . 5mg)及N,N —二異丙基 乙基胺(1 0微升)於四氫呋喃(1毫升)混合物於5 0 °C下攪拌1 8小時。將反應混合物於真空下濃縮,殘餘物 溶於醋酸乙酯中且用0 _ 5M HC 1 ,水,5%碳酸氫 鈉水溶液,水及食鹽水淸洗。有機層以硫酸鎂脫水且真空 濃縮。殘餘物在矽膠上以庚烷/醋酸乙酯=I/O = >0/1 (v/v)作爲洗脫劑來層析。 產量:3.1毫克。 MS-ESI: 〔M + H〕+=455.4; HPLC : Rt = 10 · 00 分鐘(方法 1) 實施例2 1 經濟部智慧財產局員工消費合作社印製 1 一乙_基—4_苹基—gT_. (3二苯丙醯某)腌某一 ·| ,2 , 3 ,4_四氫一 2 ,2 , 4 —三甲每u奎啉 根據實施例6所述方法以1 -乙醯基—6 -胺基-4 —苯基一1 ,2 ,3 ,4 —四氫一2 ’ 2,4 —三甲基π奎 啉(1 0毫克)與3 -苯丙驢基氯(1 img)及Μ,N 一二異丙基乙基胺(2 2微升)於四氫呋喃(2 5毫升) 本纸張尺度適用中賴家標準(咖)A4規格(2削297公董) 1322144 A7 B7 五、發明説明(的 進行醯化反應。 產量:1 . 2毫克。 (請先閱讀背面之注意事項再填寫本頁) MS — ESI : 〔Μ + Η〕+=441·4; HPLC : Rt=10 . 25 分鐘(方法 1) 實施例2 2 ]—乙醯基-6— (2 -呋喃甲醯基)胺某一 4-苯基— ],2,3,4 —四氤一2,2,4 —三甲基哮啉 根據實施例6所述方法以1 -乙醯基一 6 -胺基-4 —苯基一1 ,2 ,3 ,4 —四氫一2 ,2 ,4 —三甲基喹 啉(10毫克)與2 —呋喃甲醯基氯(8 · 5mg)及N ,N-二異丙基乙基胺(2 2微升)於四氫呋喃(1毫升 )進行醯化反應。 產量:7 . 7毫克。 MS — ESI: 〔M+H〕+ =403. 4; HPLC:Rt=8.91分鐘(方法1) 實施例2 3 經濟部智慧財產局員工消費合作社印製 1_乙醯某一 6-(異戊醯某)胺基一 4_苯基,2 ,:3,4-四氤-2,2,4 —三甲基喹啉 根據實施例6所述方法以1 一乙醯基-6 -胺基- 4 一苯基—1 ,2 ,3 ,4 —四氫一 2 ,2 ,4 —三甲基喹 啉(10毫克)與異戊醯基氯(7·8mg)及N,N— 二異丙基乙基胺(2 2微升)於四氫呋喃(1毫升)進行 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -53- 1322144 A7 B7 五、發明説明(5) 醯化反應。 產量:5 · 3毫克。 (請先閱讀背面之注意事項再填寫本頁) MS — ESI : 〔Μ + Η〕+=393·4; 1^尸1^(::1^ = 9.35分鐘(方法1) 實施例2 4 1 -乙醯基一 6 -( 3 - ί金剛烷—1 —基]丙醯基)胺 基—4 —苯基—1 ,2,3,4-四氣—2,2,4 —三 甲基喹啉 根據實施例1 1所述方法,將1 一乙醯基_ 6 -胺基 —4 —苯基—1 ,2 ,3 ,4一 四氫一 2 ,2 ,4-三甲 基鸣啉(10毫克)與3_ (金剛烷—1—基)丙酸(1 Omg)於 HATU (25mg)及 Ν,Ν -二異丙基乙 基胺(2 2微升)於二氯甲烷(1毫升)之媒介下進行縮 合作用。 產量:6 . 7毫克。 MS-ESI: [Μ+Η] + =499 · 4 ; HPLC:Rt=12.43分鐘(方法2) 經濟部智慧財產局員工消費合作社印製 實施例2 5 1 _乙醯某——(乙某丙二醯某)胺某_4一苯某一 1 ,2,3,4_四氤—2,2,4_三甲某哮啉 根據實施例6所述方法以1 -乙醯基—6 —胺基- 4 -苯基-1 ,2 ,3 ,4 —四氫一2,2 ,4 —三甲基卩奎 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -54 - ^22144 A7 —--- B7 ___________ 五、發明説明(珀 琳(1 5 0毫克)與乙基丙二醯基氯(1 4 7m g )及N ’ N —二異丙基乙基胺(3 1 4微升)於四氫呋喃(8毫 升)進行醯化反應。 (請先閲讀背面之注意事項再填寫本頁) 產量:1 6 3毫克。 MS-ESI:〔M + h〕+=423_2; ΙΊΡι^(::Ι11 = 8.48 分鐘(方法 1) 實施例2 6 丄_二乙醯基_6_ ( ί一4~甲氬茏胺基〕羰甲羰某、β右:y: d —苹基二 1 ,2,3 ,4-四氤—2,2,d —二〒 基啤_ (a ) 1 —乙酶基一 羥羰甲羰基)胺基 二—1 , 2,一3_ , 4 —四氫~ , , 4 —三甲基啐啉 經濟部智慧財產局員工消費合作社印製 將2M Na〇H溶液逐滴加到ι_乙醯基一 6一( 乙基丙二醯基)胺基一 4 —苯基-1,2,3,4 一四氫 —2,2,4 —二甲基π奎啉(i6img)於二_院/水 4:1(v/v)(12毫升)之攪拌溶液直到達到pH 1 4爲止。於攪拌3 . 5小時後,將反應混合物傾倒入水 中且用知酸乙酯於ρ Η 2下萃取。有機層用水及食鹽水淸 洗,脫水(硫酸鎂)且於真空濃縮。 產量:1 6 3毫克。 MS — ESI · [Μ + Η] + =3 9 5 2; HPLC : Rt = 7 . 43 分鐘(方法 1) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) -55- 1322144 A7 B7 所述方法’將4 —甲氧苯基胺 苯基 2 五、發明説明(5$ (b ) 1 ~ ^ - 6 申茏胺基]羰甲羰基 )胺基一 4 —苯基—1,〇.〇 . _ >- „ η λ -4--&__’ 3 ,_4 —四氤—2 ,2,4 _三甲某P奎啉 根據實施例1 2mg)與1 一乙醯基一 6—(羥羰甲羰基)胺基— 4 —四氫—2,2 ,4 —三甲基 D奎啉(10¾ 克)於 HATU (l9mg)及 N,N — 二 異丙基乙基胺(1 6微升)於四氫呋喃(2毫升)之媒介 下進行縮合作用。 產量:7 . 3毫克。 (請先閱讀背面之注意事項再填寫本頁) MS — ESI : [M + H] 5 4.4; 經濟部智慧財產局員工消費合作社印製 HPLC : Rt = 8 . 80 分鐘(方法 實施例2 7 1-乙醯基一 6 — Γ 「7.氧羰甲胺某Ί锱甲羰某)胺某- 4 一苯基—1 ,2,3 ,4 —四氤一?. ,2,4 -三甲基 D奎啉 根據實施例11所述方法,將甘油乙酯.HC1 ( 5 _ 3mg)與1 一乙醯基—6-(羥羰甲羰基)胺基一 4—苯基一1 ,2,3 ,4 一四氫一2 ,2,4 —三甲基 喹啉(10 毫克)於 HATU (19mg)及 N,N —二 異丙基乙基胺(1 6微升)於四氫呋喃(2毫升)之媒介 下進行縮合作用。 產量:4 · 6毫克。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1322144 A7 B7 五、發明説明(5今 MS-ESI : [M + H] + =480 · 6 ; 1^卩1^(::1^ = 7.94分鐘(方法1) (請先閲讀背面之注意事項再填寫本頁) 實施例2 8 ]_乙醯基_6— ( ίΝ —乙基一 N —苯胺基〕羰甲羰基 )胺基一 4-苯基-1 ,2,3 ,4-四氫-2 ,2,4 -三甲基D奎啉 根據實施例1 1所述方法,將Ν —乙基苯胺(5 . 2 mg)與1一乙醯基_6_ (羥羰甲羰基)胺基_4_苯 基—1 ,2 ,3 ,4 一四氫-2,2,4 —三甲基喹啉( 10毫克)於HATU (19mg)及N,N -二異丙基 乙基胺(16微升)於四氫呋喃(2毫升)之媒介下進行 縮合作用。 產量:7 · 3毫克。 MS-ESI: [Μ+Η]+=512· 6 ; HPLC:Rt=9.36分鐘(方法1) 實施例2 9 經濟部智慧財產局員工消費合作社印製 1—乙醯某—( ί2 ,4_二氟苯胺基]甲羰基)胺 基一4-苯基一1 ,2,3 ,4-四氤-2 ,2,4 —三 甲基ρ奎啉 (a ) 1—乙酸基—6— (y臭乙隨基)胺基一 4 —苯基— 1 ,2,3,4 —四氤一2,2,4 —三甲基哮啉 根據實施例6所述方法以1 -乙醯基一 6 -胺基-4 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -57 - 1322144 A7 B7 ___ 五、發明説明(5$ (請先閲讀背面之注意事項再填寫本頁) —苯基一1 ,2,3 ,4 一四氫一2 ,2,4 -三甲基11奎 啉(1 3 0毫克)與溴乙醯基氯(6 9微升)及N,N -二異丙基乙基胺(1 2 1微升)於二氯甲烷(1 0毫升) 進行醯化反應。 產量:151毫克。 MS-ESI: 〔Μ + Η〕+=431·2 (b ) 1 —乙醯某一6_ ( ί2 ,4 —二氩茏胺某1甲盤 基)胺基-4 一苯基-1 ,2 ,3,4 -四氤,2,._ 4 _三甲基Ρ奎啉 將1_乙醯基一 6—(溴乙醯基)胺基一 4 —苯基— 1 ’ 2 ,3 ,4 —四氫-2,2,4 —三甲基喹啉(1〇 mg) ,2,4 一二氟苯胺(6 . Omg)及 N,N —二 異丙基乙胺(1 0微升)於二-烷(2毫升)之混合物於 4 0 °C下攪拌1 8小時。將反應混合物於真空下濃縮。殘 餘物於矽膠上以二氯甲烷/甲醇=1/〇 = > 9 5 /5 ( v/v)作爲洗脫劑來層析。 經濟部智慧財產局員工消費合作社印製 產量:5 · 5毫克。 MS- ESI : 〔Μ + Η〕+=492 HPLC:Rt = 6.74 分鐘(方法 實施例3 0R 1 9 minutes (method (please read the note on the back and then fill out this page) Example 1 1 1 - Ethyl 6 - (3 - bromo - 2 ) Amino - 4 - Benzene - 1 ~ ~ A A certain scorpion scorpion scorpion scorpion scorpion scorpion scorpion sulphur porphyrin 1 - acetyl sulfonyl 6 - 4 - tetrahydro - 2 , 2 , 4 - bromo 2 , 6 - dimethoxybenzene Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative, printed aza-benzotrisyl hexafluorophosphate, isopropylethyl, 1 8 small ethyl acetate solution, water and residue in the oxazol-1 -yl acid salt HA Τ Amine (3 2 μL. Mix the reaction and wash with 0.5 Μ brine. 矽 上 庚 庚 庚 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- (25 mg), 3_ formic acid (23 mg), 〇_(7 — —N,N,n, > n '-tetramethylhydrazine) (68 mg) and ν,Ν-di) in dichloromethane (4 ml) The mixture was concentrated under vacuum, and the residue was dissolved in EtOAc (EtOAc). Water, EtOAc, EtOAc. Applicable to China National Standard (CNS) Α4 Specifications (210Χ297 PCT) -44- 1322144 A7 B7 V. Description of the invention (Voice (V/V) as eluent for chromatography. Yield: 2 8 mg. (Please read the notes on the back and fill out this page) MS — ESI: [M + H]+ = 551. 4; HPLC: Rt = 3 . 75 min (Method 2) Example 1 2 1 _Ethyl 4-ylphenyl-6-(4-phenylbenzylidene) Amino-1,2,3,4-tetradecyl 2,2,4-trimethylquinoline according to the method described in Example 6 with 1 _ acetyl group -6-amino group 4 - phenyl- 1 , 2,3,4-tetrahydro-2,2,4-trimethylquinoline (11 mg), 4-diphenylcarbonyl chloride (16 mg) and N,N-diisopropylethylamine (2 2 The oximation reaction was carried out in tetrahydrofuran (1 ml). Yield: 1' 0 mg. MS - ESI: [M+H]+ = 489.4; HPLC: Rt = l 1 . 62 min (method 1) Example 1 3 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed 1 Ethyl ketone-6 (4 - ί 4 - chlorobenzene 1 benzylidene) Amine _ 4 phenyl-1, 2, 3, 4氤2,2,4-trimethyl D-quinoline a) 1-ethyl fluorenyl _6_(4_iodobenzylidene)amino group _4_phenyl fluorene 2,3,4-tetrahydro-2,2,4-trimethylporphyrin 1-Ethylamino-6-amino-4-phenyl_1,2,3, this paper size is applicable to China Standard (CNS) A4 size (210X 297 mm) -45- 1322144 A7 __B7_ V. Invention description (4$ (please read the note on the back and fill out this page) 4 —Tetrahydrogen 2,2 ' 4 —3 A mixture of methylquinoline (300 mg), 4-iodobenzylidene chloride (52Omg) and a catalyst portion of N,N-dimethylaminopyridine in pyridine (4 ml) was stirred for 18 hours. The reaction mixture was concentrated in vacuo. The residue was dissolved in ethyl acetate and washed with saturated aqueous sodium bicarbonate, water and brine. The organic layer was dehydrated (MgSO4) and concentrated in vacuo. Yield: 460 mg. MS — ESI : [M+H]+=539.4; HPLC: Rt = l 〇. 98 min (method 1) (b) 1 -ethinyl-6 (4 - 1:4 - chlorobenzene 1 benzamidine) A) 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl porphyrin 1_ethyl hydrazine _6 — (4_iodobenzylidene) Amino- 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline C 2 5 mg ), 4-chlorophenylboronic acid (22 mg), fluorinated planing Intellectual Property Bureau employee consumption cooperative printed 14 mg), triphenylsulfonium (5. Omg) and ginseng (diphenylacetone) dipalladium (0) (4.3 mg) in dimethoxyethane/ethanol 4: A mixture of 1 (5 ml) was stirred under nitrogen for 15 minutes through a solution of bubbling nitrogen. After being placed at 80 ° C for 3 hours, the reaction mixture was concentrated in vacuo. EtOAc m m m m m m m m . The organic layer was dehydrated with magnesium sulfate and concentrated in vacuo. The residue was chromatographed on silica gel using heptane / ethyl acetate = 1 / 0 = > 0/1 (v / v) as eluent. This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -46 - 1322144 A7 B7 V. Description of invention (44 Yield: 16 mg. MS-ESI: (M + H) +=523 . 4 ; (Please read the precautions on the back and fill out this page.) HPLC : Rt = 4 · 40 minutes (method 2) Example 1 4 1 - Ethyl 4- 4 -phenyl - 6 (4_[3_pyridyl) Benzoquinone a certain amine 1, 2, 3, 4 - tetradecyl 2, 2, 4 - trimethyl η quinoline according to the method described in Example 13, 1-ethylidene- 6-(4 Iodophenylmercapto)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (25 mg), acridine-3-borate-1 3-propanediol-cyclic ester (23mg), fluorinated planing (14 mg), triphenylsulfonium (5.0 mg) and ginseng (diphenylacetone) dipalladium (〇) (4.3 mg) in dimethoxy Methyl ethane / . ethanol 4: 1 (v / v) (5 ml) for the Mitsubishi cross-coupling reaction. Yield: 1 7 mg. MS - ESI : [M + H] + = 490.4; ^1? 1 ^ <;::1^ = 7.11 minutes (method 1) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing example 1 5 Ί 一乙醯基一一一Base_6_(2_phenyl_5_methoxybenzoindolyl)amino-1,2,3,4-tetra--2,2,4-trimethylquinoline (a) 1 _ acetamidine Base 6—(2-Bromo-5-methoxybenzoquinone) This paper scale applies to Chinese National Standard (CNS) A4 Specification (210X297 mm) -47 - 1322144 A7 B7 V. Description of Invention (4$ Amine 4--4-phenyl-1,2,3,4-tetraindole-2,2,4-trimethylquinoline (please read the back note first and then fill out this page) according to the method described in Example 1 , 1-ethyl fluorenyl-6-amino-4-phenyl-1,2,3,4-tetraamino-2,2,4-dimethylquinoline (25 mg) and 2-bromo-5 -Methoxybenzoic acid (21 mg) was condensed under a medium of HATU (6 8 mg) and N,N-diisopropylethylamine (32 μL) in dichloromethane (4 mL). Yield: 31 mg. MS - ESI : [M+H]+ = 521 · 4 ; HPLC : Rt = 3 · 74 min (method 2) (b) 1 -ethinyl-4-phenyl-7-(2) -Phenyl-5-methoxybenzoguanidino)amine 1 , 2,3,4_tetraki- 2,2,4-trimethyl d-quinoline economic ministry The property bureau employee consumption cooperative printed according to the method described in Example 1 3 '1 乙 一 一 -4- phenyl 1-6-(2-bromo-5-methoxybenzhydryl)amine _1, 2 , 3,4_tetrahydro-2,2,4-trimethylquinoline (30mg), phenylboronic acid (25mg), fluorinated planer (21mg), triphenylsulfonium (7 · Omg) and ginseng (diphenyl) Fork acetone) dipalladium (0) (6 · 0 mg) in dimethoxyethane / ethanol 4: 1 (v / v) (5 ml) for Mitsubishi cross coupling reaction. Yield: 2 3 mg. MS-ESI: [Μ + Η]+=519·4; This paper scale applies to Chinese National Standard (CNS) Α4 specification (210X297 mm) -48- 1322144 A7 B7 V. Description of invention (4$ HPLC : Rt = L〇. 87 minutes (method 1) (Please read the notes on the back and fill out this page) Example 1 6 1 -Ethyl-4 - Benzene 6-(2-phenyl-3-methylbenzene Aβ group) Amino group 1 9 2 > 3 j 4 —tetraki- 2 2 9 4 dimethyl porphyrin ( a ) 1 — acetyl _ 4 — yl 1 - ( 2 bromo _ 3 _ Methylglycidyl) Limb 1 > 2 > 3 ,4 -tetrahydro 2 2 9 4 Dimethyl D-quinoline 1 - Ethyl-6-amine according to the method described in Example 1 Base - 4 - phenyl - 1 5 2 5 3 f 4 - tetrahydro - 2 j 2 ) 4 - trimethyl hydroxyquinoline (25 g: g) with 2 - bromo-3-methylbenzhydrazide Acid (19 mg) was condensed in a medium of ΗATU (6 8 m S ) and N, N-diisopropylethylamine (32 μL) in a solution of dichlorocarbyl (4 ml) Yield; 1 6 • 3 mg 〇Μ S — ESI ; [Μ + η : 1 + = 5 0 5 . 2 t Η PLC * R t 2: 3 • 8 0 minutes (method 2) ( b ) 1 acetyl group 4 propyl-6-(2 benzyl 3-methyl-p-methyl)amino 1 2 > 3, 4 -tetrahydro 2 j 2 9 4 - mono-methyl quinone 1 咐 according to the method described in Example 1 3 , 1 - Ethyl 4- 4 - phenyl-6-(2-bromo-3-methylbenzhydryl)amine- 1 , 2, 3 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed this paper The scale applies to China National Standard (CNS) A4 specification (210X 297 mm) -49- 1322144 A7 B7 V. Invention description (邛 (please read the note on the back and fill in this page), 4 —Tetrahydrogen-2,2 , 4-trimethylquinoline (16mg), benzoic acid (25mg), fluorinated (21mg), triphenylsulfonium (7.0mg) and ginseng (diphenylacetone) dipalladium (0) (6.0 mg The Mitsubishi cross-coupling reaction was carried out in dimethoxyethane/ethanol 4:1 (v/v) (5 ml). Yield: 4.9 mg. MS - ESI: [M + H] + = 503. 3; HPLC: Rt = 4.61 min (Method 2) Example 1 7 1-Ethyl- 4 -phenyl-1,2,3,4 - -6-(α-toluenesulfonyl)amino- 2,2,4-trimethylporphyrin according to the method described in Example 6 with 1-ethenyl-6-amino-4-phenyl-1 , 2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) and toluenesulfonyl chloride (1 2 mg) and hydrazine, N-diisopropylethylamine (2 2 μl of sulfonation reaction in tetrahydrofuran (25 ml). Yield: 9.8 mg. MS-ESI: [Μ + Η]+=463·4; HPLC: Rt = 9 · 49 minutes (method 1) Example 1 8 1 _Ethyl 4- 4 - benzene Base-6-(anilinecarbonyl)amine A 1,3,4-tetrahydro-2,2,4-trimethylquinoline paper size applicable to China National Standard (CNS) A4 specification (210X 297 mm) -50 - 1322144 A7 ___B7_ V. INSTRUCTIONS INSTRUCTIONS (1 醯 醯 一 -6-amino- 4-phenyl- 1 , 2, 3, (please read the notes on the back and fill out this page) 4 Hydrogen-2'2 '4-trimethylquinoline (10 mg), phenyl isocyanate (8 · Omg) and N,N-diisopropylethylamine (22 μL) in tetrahydrofuran ( 1 ml) The mixture was stirred for 18 hours. The reaction mixture was concentrated in vacuo. EtOAc EtOAc m. The organic layer was dried over MgSO.sub.sub.sub.sub.sub.sub.sub.sub.sub.sub.sub.sub.sub. Mg. M S-ESI: CM + H) + = 428 . 4 ; ^^? 2 (:: 1^ = 1 〇. 39 minutes (method 1) Example 1 9 1 醯 醯 _6_ (Third butyl sulphide羯 ) ) — — 一 一 一 一 一 一 一 一 一 一 一 一 一 一 一 一 一 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济 经济Method: 1-Ethyl-6-amino-4-phenyl-1,2,3,4-tetrahydro, 2,4-trimethylquinoline (10 mg) and tributyl isocyanate The ester (7.5 mg) and N,N-diisopropylethylamine (22 μL) were subjected to thiourea formation in tetrahydrofuran (1 ml). Yield: 0.50 mg. MS-ESI: ??? M + H]+=424.4; 1^?]^(:: Ruler 1 = 5.90 minutes (method 1) This paper scale applies to Chinese national standards (CNS > A4 specification (210X297 mm) -51 - 1322144 A7 __B7___ V. Description of the invention (4 Orders Example 2 0 (please read the notes on the back and fill in the page again) 1 - Ethyl-6-(T-T benzene) Amine- 4 Benzene _1 2,2,4 —tetrakis-2,2,4-trimethylporphyrin. Tri-argon-hydrogen hydrazine 1-ethoxyphenyl-6-amino-4-phenylene a 1,2,3,4-tetrahydro-2,2,4-trimethylporphyrin (10 mg), 4-(t-butyl)phenyl chloride (6.5 mg) and N,N-II Isopropylethylamine (10 μL) was stirred in a mixture of tetrahydrofuran (1 mL) at 50 ° C for 18 h. The reaction mixture was concentrated in vacuo. EtOAc m. The organic layer was dried over magnesium sulfate and concentrated in vacuo. The residue was chromatographed on silica gel using heptane / ethyl acetate = I / O = > 0/1 (v / v) as eluent. Yield: 3.1 mg. MS-ESI: [M + H]+=455.4; HPLC: Rt = 10 · 00 min (method 1) Example 2 1 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed 1 乙_基—4_苹基— gT_. (3 diphenylpropanoid) marinate a certain ·| , 2 , 3 , 4_ tetrahydro - 2 , 2 , 4 - trimethyl per u - quinoline according to the method described in Example 6 with 1-ethylenyl - 6-Amino-4-phenyl-1,2,3,4-tetrahydro-2' 2,4-trimethyl π-quinoline (10 mg) and 3-phenylpropenyl chloride (1 img) And hydrazine, N-diisopropylethylamine (2 2 μl) in tetrahydrofuran (25 ml) This paper scale is suitable for Laijia standard (coffee) A4 specification (2 cut 297 dong) 1322144 A7 B7 five The invention is described as the deuteration reaction. Yield: 1.2 mg. (Please read the notes on the back and fill out this page.) MS — ESI : 〔Μ + Η〕+=441·4; HPLC : Rt=10 25 minutes (method 1) Example 2 2]-Ethyl-6-(2-furanylmethyl)amine 4- 4-phenyl-], 2,3,4-tetraindole-2,2, 4-trimethyl porphyrin according to the method described in Example 6 with 1-ethyl fluorenyl-6-amino-4-phenyl-1,2 , 3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) with 2-furylmethyl chlorohydrin (8 · 5 mg) and N,N-diisopropylethylamine (2 2 liters of the oximation reaction in tetrahydrofuran (1 ml). Yield: 7. 7 mg. MS - ESI: [M+H]+ = 403. 4; HPLC: Rt = 8.91 min (Method 1) Example 2 3 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 1_ 醯 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 Methylquinoline according to the method described in Example 6 as 1-ethinyl-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) with isoamyl chloride (7.8 mg) and N,N-diisopropylethylamine (22 μL) in tetrahydrofuran (1 ml) for this paper scale applicable to Chinese national standard (CNS) A4 size (210X 297 mm) -53- 1322144 A7 B7 V. Description of invention (5) Deuteration reaction. Yield: 5 · 3 mg. (Please read the notes on the back and fill out this page) MS — ESI : [Μ + Η]+=393·4; 1^ 尸1^(::1^ = 9.35 minutes (method 1 Example 2 4 1 -Ethylamino-6-(3 - ί adamantane-1-yl)propanyl)amino-4-phenyl- 1, 2, 3, 4-tetra--2,2 , 4-trimethylquinoline, according to the method described in Example 11, 1 1-ethylindolyl-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4 - Trimethyl morphine (10 mg) and 3 (adamantane-1-yl)propionic acid (1 Omg) in HATU (25 mg) and hydrazine, hydrazine-diisopropylethylamine (2 2 μL) The condensation was carried out under a medium of dichloromethane (1 ml). Yield: 6.7 mg. MS-ESI: [Μ+Η] + =499 · 4 ; HPLC: Rt = 12.43 minutes (method 2) Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing example 2 5 1 _ 醯 醯 - (B a certain amine, a certain 1,4-phenylene, a 1, 2, 3, 4 _ tetra- 2, 2, 4 _ trimethyl porphyrin according to the method described in Example 6 with 1-ethyl fluorenyl-6-amine Base - 4 -phenyl-1 , 2 , 3 , 4 - tetrahydro - 2,2 , 4 - trimethyl sulfonium paper scale applicable to Chinese National Standard (CNS ) A4 specification (210X297 mm) -54 - ^22144 A7 —--- B7 ___________ V. INSTRUCTIONS (Pelin (1,500 mg) and ethylpropanediyl chloride (1,7 mg) and N'N-diisopropylethylamine (3 1 4 μl) deuteration reaction in tetrahydrofuran (8 ml) (Please read the note on the back and fill out this page) Yield: 1 6 3 mg. MS-ESI: [M + h]+=423_2; ^(::Ι11 = 8.48 minutes (method 1) Example 2 6 丄_二乙醯基_6_ ( ί 4 4~ arginylamino)carbonyl carbonyl carbonyl, β right: y: d — pingji II 1 , 2,3 , 4-tetrazole — 2, 2, d — dimercapto basal beer _ (a ) 1 —ethylenyl hydroxycarbonyl Carbonyl)amine bis-1,2,3,4,tetrahydro-, ,4-trimethyl porphyrin, Ministry of Economic Affairs, Intellectual Property Office, employee consumption cooperative, printing 2M Na〇H solution dropwise to ι_B Sulfhydryl- 6-(ethylpropanediyl)amine- 4-phenyl-1,2,3,4-tetrahydro-2,2,4-dimethyl quinolate (i6img) 4/1 (v/v) (12 ml) of the stirred solution until the pH reached 14. After stirring for 3.5 hours, the reaction mixture was poured into water and the ethyl acetate was used under ρ Η 2 The organic layer was washed with water and brine, dried (MgSO.sub.sub.sub.sub.sub.sub.sub.sub. 43 minutes (method 1) This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) -55- 1322144 A7 B7 The method described as '4-methoxyphenylamine phenyl 2 V. Description of the invention (5$ (b) 1 ~ ^ - 6 茏 茏 ] ] 羰 羰 羰 一 一 一 4 4 , _4 - four 氤 - 2, 2, 4 _ trimethyl PF quinolin according to Example 1 2mg) 1-Ethyl fluorenyl-6-(hydroxycarbonylmethylcarbonyl)amino-4-tetrahydro-2,2,4-trimethyl D-quinoline (103⁄4 g) in HATU (l9mg) and N,N - diiso The propylethylamine (16 μL) was condensed under a medium of tetrahydrofuran (2 ml). Yield: 7.3 mg. (Please read the notes on the back and fill out this page) MS — ESI : [M + H] 5 4.4; Intellectual Property Intelligence Bureau Staff Consumer Cooperative Printed HPLC: Rt = 8. 80 minutes (Method Example 2 7 1 -乙醯基一6 — Γ "7. Oxycarbonylmethylamine, a certain carbonyl, a certain amine, a certain amine - 4 - phenyl - 1, 2, 3, 4 - four 氤 one?., 2, 4 - three Base D-quinoline according to the method described in Example 11, glyceryl ethyl ester. HC1 (5 _ 3 mg) and 1-ethyl fluorenyl-6-(hydroxycarbonylmethylcarbonyl)amino group 4-phenyl- 1 , 2, 3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) in HATU (19 mg) and N,N-diisopropylethylamine (16 μl) in tetrahydrofuran (2 ml) The condensation is carried out under the medium. Yield: 4 · 6 mg. This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 1322144 A7 B7 V. Invention description (5 MS-ESI: [M + H] + =480 · 6 ; 1^卩1^(::1^ = 7.94 minutes (method 1) (Please read the notes on the back and fill out this page) Example 2 8 ]_乙醯基_6— ( Ν -ethyl-N-anilino)carbonylmethylcarbonyl Amino- 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl D-quinoline oxime-ethylaniline according to the method described in Example 11. 2 mg) with 1-ethyl fluorenyl _6_(hydroxycarbonylmethylcarbonyl)amino _4_phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg Condensation was carried out in a medium of HATU (19 mg) and N,N-diisopropylethylamine (16 μL) in tetrahydrofuran (2 mL). Yield: 7 · 3 mg. MS-ESI: [Μ+ Η]+=512· 6 ; HPLC: Rt=9.36 minutes (method 1) Example 2 9 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed 1-Ethyl-( ί2 ,4-difluoroanilino)methylcarbonyl Amino- 4-phenyl-1,2,3,4-tetraindole-2,2,4-trimethyl-p-quinoline (a) 1-acetoxy-6-(y odorantyl)amine Benzyl 4-phenyl- 1 , 2,3,4-tetradecyl 2,2,4-trimethyl porphyrin according to the method described in Example 6 with 1-ethyl fluorenyl-6-amino-4 Paper scale applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) -57 - 1322144 A7 B7 ___ V. Invention description (5$ (please read the back) Note: Please fill in this page) —Phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl-11-quinoline (1,300 mg) and bromoethylidene chloride (6 9 μm) The oximation reaction was carried out with methylene chloride (10 mL) in N,N-diisopropylethylamine (1 2 1 μL). Yield: 151 mg. MS-ESI: 〔Μ + Η〕+=431·2 (b) 1 —Ethyl 6-( ί2 ,4-diarsenylamine 1 A-decyl)Amino-4-phenyl-1,2 , 3,4 -tetrakis, 2,._ 4 _ trimethyl hydrazine quinone 1_ethyl fluorenyl-6-(bromoethenyl)amine- 4-phenyl- 1 ' 2 , 3 , 4 - tetrahydro-2,2,4-trimethylquinoline (1 〇 mg), 2,4 difluoroaniline (6.0 g) and N,N-diisopropylethylamine (10 μL) The mixture in di-alkane (2 ml) was stirred at 40 ° C for 18 hours. The reaction mixture was concentrated in vacuo. The residue was chromatographed on silica gel eluting with dichloromethane/methanol = 1 / s = > 9 5 /5 (v/v) as eluent. Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed output: 5 · 5 mg. MS-ESI: [Μ + Η]+=492 HPLC: Rt = 6.74 min (Method Example 3 0

~ 58« 叫144 A7~ 58« Call 144 A7

根據實施例2 9所述之方法,使1 _苯基哌嗦( (請先閲讀背面之注意事項再填寫本頁) 7 _ 0微升)與1—乙醯基一 6-(溴乙醯基)胺基—4 〜苯基—1 ,2 ,3,4 一四氫-2,2,4 —三甲基d奎 啉(1 Omg )及N,N —二異丙基乙胺(i 〇微升)於 二喟烷(2毫升)進行N -烷化作用。 產纛:8 . 4毫克。 MS — ESI:〔M + H〕+ =511. 4; HPLC : Rt = 7 _ 〇1 分鐘(方法 i) 實施例3 1 經濟部智慧財產局員工消費合作社印製 丄二二乙醯基二及二-I.…〔N —嗎啉碁丄甲羰某)胺其一 /1 — 变羞~~1,2,3’.4_四氫—2_1_2,4—三_其卩李啉 根據實施例2 9所述之方法,使嗎啉(4 . 〇微升) 與1—乙醯基一 6—(溴乙醯基)胺基一 4 —苯基―工, 2 ,3 ,4一四氫一2 ,2,4 —三甲基曈啉(1〇mg )及N,N — 一異丙基乙胺(9微升)於二氯甲烷(2毫 升)進行N _烷化作用。 產量:1 0毫克。 MS-ESI: 〔M + H〕+=436.4; HPLC : Rt = 5 · 64 分鐘(方法 1) 實施例3 2 1—乙醯基—6— (2 —噻吩甲胺某)锶其一 4~苹1 — 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -59- 1322144 A7 _B7_ 五、發明説明( 1 ,?,,3,4 —四氣一 2,2,4 —三甲甚晬啉 (a) 1 ,2 —二氫—2 ,2 ,4 —三甲某晬啉一 -羧 (請先閱讀背面之注意事項再填寫本頁) 酸甲酯 根據實施例1所述方法以甲基4 -胺基苯甲酸酯( 5 . 0克)及碘(1 . 7克)於氧化釆(25毫升)進行 Skraup 反應。 產量:2 . 3克。 MS-ESI : [M + H] + =232 · 2 (b) 1 —乙醯基—1 ,2 —二氤—2 ,2,4 —三甲某 鸣啉—6 —羧酸甲酯 將1 ,2 —二氫一2 ,2 ,4 一三甲基喹啉—6 —羧 酸甲酯(2 · 3 g)及觸媒份量之N,N —二甲胺基吡啶 於醋酸酐(6 0毫升)之混合物在1 0 0 °C下攪拌1 8小 時。反應混合物於真空下濃縮。將殘餘物溶於醋酸乙酯中 且用水及食鹽水淸洗。將有機層脫水(硫酸鎂)及真空濃 縮。殘餘物在矽膠上以庚烷/醋酸乙酯=1 / 1 = 經濟部智慧財產局員工消費合作社印製 >1/9 (v/v)作爲洗脫劑來層析。 產量:2 . 3克 (c ) 1—乙酿—4_ 苯某 一1 , 2 , 3,4 —四氣—2 ,2,4_三甲基喹啉一羧酸甲酯 根據實施例3所述方法於A 1 C 13 (4 . 4克)存在 下以苯(6 0毫升)與1—乙醯基—1 ,2 —二氫一 2, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐〉 -60- 1322144 Α7 Β7 五、發明説明(5$ 2,4 一三甲基0奎琳—6_殘酸甲酯(2 . 3g)進行According to the method described in Example 29, 1 _ phenylpiperazin ((Please read the back of the note before refilling this page) 7 _ 0 μl) and 1-ethyl sulfonyl- 6-(bromoacetamidine) Amino-4-yl-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl d-quinoline (1 Omg) and N,N-diisopropylethylamine (i N-alkylation was carried out in dioxane (2 mL). Calving: 8.4 mg. MS — ESI: [M + H]+ = 511. 4; HPLC: Rt = 7 _ 〇 1 min (method i) Example 3 1 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 丄二二乙醯基二II-I....[N-morpholinium carbamoyl)amine 1/1 — shame~~1,2,3'.4_tetrahydro-2_1_2,4—three _ 卩 卩 啉 根据In the method described in Example 2, the morpholine (4. 〇 microliter) and 1-ethyl fluorenyl-6-(bromoethenyl)amine group are 4-phenylene, 2, 3, 4-14 Hydrogen 2,2,4-trimethylporphyrin (1 〇 mg) and N,N-isopropylethylamine (9 μL) were subjected to N-alkylation in dichloromethane (2 mL). Yield: 10 mg. MS-ESI: [M + H]+=436.4; HPLC: Rt = 5 · 64 min (method 1) Example 3 2 1 -ethylthiol-6-(2-dithiopheneamine) 锶一一~ Ping 1 — This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -59- 1322144 A7 _B7_ V. Description of invention (1,?,,3,4—four gas one 2,2,4 — Trimethyl porphyrin (a) 1 , 2 - dihydro - 2 , 2 , 4 - trimethyl porphyrin mono-carboxy (please read the back of the note before refilling this page) methyl ester according to the method described in Example 1. The Skraup reaction was carried out with methyl 4-aminobenzoic acid ester (5.0 g) and iodine (1.7 g) in yttrium oxide (25 ml). Yield: 2.3 g. MS-ESI: [M + H] + = 232 · 2 (b) 1 - ethyl hydrazino - 1 , 2 - diterpene - 2 , 2, 4 - trimethyl morphine - 6 - carboxylic acid methyl ester will be 1, 2 - dihydro - 2 , a mixture of 2,4-trimethylquinolin-6-carboxylate (2·3 g) and a catalytic amount of N,N-dimethylaminopyridine in acetic anhydride (60 ml) at 1 0 0 Stir for 18 hours at ° C. The reaction mixture was concentrated in vacuo. The organic layer was dehydrated (magnesium sulphate) and concentrated in vacuo. The residue was purified by heptane / ethyl acetate = 1 / 1 = printed by the Intellectual Property Office of the Ministry of Economic Affairs. >1/9 (v/v) as an eluent for chromatography. Yield: 2. 3 g (c) 1 - B-- 4 Benzene 1 , 2 , 3, 4 - 4 - 2 , 2 , 4_trimethylquinoline monocarboxylic acid methyl ester according to the method described in Example 3 in the presence of A 1 C 13 (4.4 g) with benzene (60 ml) and 1-ethylenyl-1, 2 - Dihydrogen-2, the paper scale applies to China National Standard (CNS) A4 specification (210X 297 mm) -60-1322144 Α7 Β7 V. Invention description (5$ 2,4 - trimethyl 0 quinine - 6_ Residual methyl ester (2.3 g)

Friedel-Craft 烷化作用。 產量:1 . 2克。 MS- ESI : 〔M + H〕+ =352. 4; HPLC : Rt = 9 . 72分鐘(方法工) (d )_1—乙醯-4 一苯基—1 ,?.,q ,4 —四氤一 2 ,2,4 —三甲某晻啉—6 -雜醅 將2M NaOH溶液逐滴加到1_乙醯基_4_苯 基—1 ,2 ,3 ’ 4 -四氫—2 ’ 2,4 —三甲基ti奎啉-6 —羧酸甲酯(1 . 2g)於二噚烷/水4 : 1 (v/v )(5 0毫升)之攪拌溶液直到達到PH 1 2爲止。於攪 拌1 8小時後,將反應混合物傾倒入水中且用醋酸乙酯於 P Η 2下萃取。有機層用水及食鹽水淸洗,脫水(硫酸鎂 )且於真空濃縮。 產量:8 9 1毫克。 MS - ESI:〔M + H〕+ =338. 2 (e )丄· ~乙_基一6 -_L2 —噻吩甲胺某)锻基_ 4 _ 本基--~~~~2__:_3__:_4 -四氫一2,2,4~ 二.甲基[1 奎琳 根據實施例1 1所述方法,將2 —噻吩甲胺(5 . 〇 mg)與1_乙醯_4_苯基_1 , 2 ,3 ,4 —四氫— 2,2,4 —三甲基哇啉—6 —羧酸(1〇毫克)於 HATU (2 3mg )及Μ,N —二異丙基乙基胺(1 g 本纸張尺度適用中^^^準(CNS )八4胁(21〇χ297公釐) (請先閲讀背面之注意事項再填寫本頁) 【裝· 訂 經濟部智慧財產局員工消費合作社印製 -61 - 1322144 A7 B7 五、發明説明(5今 微升)於二氯甲烷(2毫升)之媒介下進行縮合作用。 產量:3 · 0毫克。 (請先閱讀背面之注意事項再填寫本頁) MS-ESI: 〔M+H〕+=433.4; HPLC : Rt = 9 . 28 分鐘(方法 1) 實施例3 3 1 —乙醯基_6-(2 - [4 一甲氧苯基]乙胺某)羰某 一 4 —苯基一 1 ,2 ,3 ,4 —四氫一 2 ,2 ,4 -三甲 基喹啉 根據實施例1 1所述方法,將2 —(4 一甲氧苯基) 乙胺(6 · lmg)與1-乙醯-4 —苯基一1 ,2,3 ,4 —四氫一 2 ,2 ,4一三甲基喹啉一 6 -羧酸(10 毫克)於HATU (23mg)及N,N—二異丙基乙基 胺(19微升)於二氯甲烷(2毫升)之媒介下進行縮合 作用。 產量:9 . 9毫克。 MS-ESI: 〔Μ+Η〕+=457·4; HPLC : Rt = 9 · 34 分鐘(方法 1) 經濟部智慧財產局員工消費合作社印製 實施例3 4 1 _乙醯某_6_ ( 3 -異丙氣丙胺某)羰某一 4 —苯某 一 1 ,2,3,4 —四氫—2,2,4_三甲基p奎啉 根據實施例1 1所述方法,將3 -異丙氧丙胺( 5 . 2mg)與 1-乙醯-4 —苯基—1 ,2 ,3 ,4一 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -62- 1322144 A7 B7 五、發明説明(6〇 四氫—2 ,2 ,4 —三甲基d奎啉—6 —羧酸(1〇毫克) 於HATU ( 2 3mg )及n,N —二異丙基乙基胺( (請先閱讀背面之注意事項再填寫本頁) 19微升)於一氯甲院(2毫升)之媒介下進行縮合作用 〇 產量:8 · 8毫克。 MS — ESI: 〔Μ + Η〕+=437·4; HPLC : Rt = 8 . 80 分鐘(方法 i) 實施例3 5 1 —乙醯基—6 — (2 —〔甲硫某1乙胺某)羰某—4 一 苹基-」_,2 ’_3 ’ 4 —四氫一2,?.,4 —三甲某晻啉 根據實施例1 1所述方法’將2 —(甲硫基)乙胺( 4 . lmg)與 1 一 乙醯一 4 —苯基—1 ,2,3,4 一 四氫_2 ,2 ,4一三甲基d奎啉—6 —羧酸(1〇毫克) 於HATU (2 3mg )及Μ,N —二異丙基乙基胺(1 9微 升)於二氯甲烷(2毫升)之媒介下進行縮合作用。 產量:1 0毫克。 經濟部智慧財產局員工消費合作社印製 MS — ESI : 〔M + H〕+=4ll . 4; HPLC : Rt = 3 . 33 分鐘(方法 2) 實施例3 6 1—乙醯基一6 —(甲氧苯氧基)_某—4 —苯某一1·, 2,3,4 —四氫一 2,2,4—〒甲某α奎琳 根據實施例1 1所述方法,將4 -甲氧苯醇(6 . 2 本纸張尺度適用肀國國家標準(CNS ) Α4規格(210Χ297公釐) -63- 1322144 A7 ____ B7 五、發明説明(6) (請先閱讀背面之注意事項再填寫本頁) mg)與1—乙醯一 4 一苯基一1 ,2 ,3 ,4 —四氫— 2,2,4 —三甲基α奎啉—6 —羧酸(1〇毫克)於 HATU (2 3mg)及Ν,Ν—二異丙基乙基胺(1 9 微升)於二氯甲烷(2毫升)之媒介下進行縮合作用。 產量:7 . 2毫克。 MS- ESI:〔M+H〕+ =458. 4; HPLC : Rt = 3 . 90 分鐘(方法 2) 實施例3 7 乙醯基—ft — ( 4 —苯基苯甲醯某)氧某—4 —苹甚 二1 ,2 ,3 ,4 一四氤, 2,=甲某啐瞅 L a ) 1 ,__2 —二氤一6 —甲氧某-2,2,4- = D奎啉 根據實施例1所述方法以4 ~茴香胺(5 . 0克)及 峨(1 . 7克)於氧化釆(25毫升)進行Skraup反應。 產量:2 . 3克。 MS- ESI :〔M+H〕+ =204. 2 經濟部智慧財產局員工消費合作社印製 (b ) _1_—乙酿基一1 ’ 2 — 一氣一 R —甲氧基—2m, 2,4 —三甲某晻瞅 將乙醯氯(8毫升)逐滴加到1,2 —二氫—6-甲 氧基一 2,2,4 —三甲基d奎啉(1 . 7g)及觸媒份量 之N,N—二甲胺基吡啶於吡啶(6 0毫升)之冷卻(〇 °C)溶液。於攪拌1 8小時後,將反應混合物於真空下濃 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 64 - 1322144 A7 _B7_ 五、發明説明(呦 (請先閱讀背面之注意事項再填寫本頁) 縮。將殘餘物溶於二氯甲烷中且用1M HC 1 ,水,5 %碳酸氫鈉水溶液、水及食鹽水淸洗。將有機層脫水(硫 酸鎂)及真空濃縮。殘餘物於矽膠上以二氯甲院爲洗脫劑 來層析。 產量:1 . 8克。 MS-ESI: (M+H) + =246 . 2 (c ) 1—乙醯基—6 —甲氧基—4 一苯某—1 ,2,卩 ,4 —四氤一 2,2,4 —二甲基[1奎啉 根據實施例3所述方法於A 1 C 1 3 (3 . 〇克)存在 下以本(2 5笔升)與1 一乙釀基—1 ,2 —二氫一 6 一 甲氧基一2 ,2 ,4 —三甲基哇啉(1 · 8g)進行Friedel-Craft alkylation. Yield: 1.2 g. MS-ESI: [M + H]+ = 352. 4; HPLC: Rt = 9. 72 min (method) (d) _1 - acetonitrile - phenyl - 1 , ? ., q , 4 — 四氤一 2 , 2, 4 — Trimethyl porphyrin — 6 — Heteroquinone Add 2M NaOH solution dropwise to 1_Ethyl _4_phenyl-1, 2, 3 ' 4 a stirred solution of tetrahydro-2' 2,4-trimethyl ti quinolin-6-carboxylate (1.2 g) in dioxane/water 4:1 (v/v) (50 ml) Until the PH 1 2 is reached. After stirring for 18 hours, the reaction mixture was poured into water and extracted with ethyl acetate (EtOAc). The organic layer was washed with water and brine, dried (MgSO4) Yield: 8 9 1 mg. MS - ESI: [M + H]+ = 338. 2 (e ) 丄 · ~ B - yl - 6 - _L2 - thiophene methylamine) forging base _ 4 _ base -~~~~~2__:_3__: _4-tetrahydro-2,2,4~di-methyl [1 quinine] according to the method described in Example 11, 1 2-thiophenemethylamine (5. 〇mg) and 1_acetamidine_4_phenyl _1, 2,3,4-tetrahydro-2,2,4-trimethylmorpholine-6-carboxylic acid (1 mg) in HATU (2 3 mg) and hydrazine, N-diisopropylethyl Amine (1 g of this paper size is applicable to ^^^ (CNS) 八4 threat (21〇χ297 mm) (Please read the notes on the back and fill out this page) [Installation · Ministry of Economic Affairs Intellectual Property Bureau employees Consumer Cooperatives Printed -61 - 1322144 A7 B7 V. Description of the invention (5 microliters) Condensation in a medium of dichloromethane (2 ml) Yield: 3 · 0 mg. (Please read the notes on the back first) MS-ESI: [M+H]+=433.4; HPLC: Rt = 9 . 28 min (Method 1) Example 3 3 1 -ethylamino-6-(2 - [4-methoxy] Phenyl]ethylamine) carbonyl some 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline according to Example 1 1 method, 2-(4-methoxyphenyl)ethylamine (6 · lmg) and 1-ethylindole-4-phenyl-1,2,3,4-tetrahydro-2,2,4 Condensation of a trimethylquinoline-6-carboxylic acid (10 mg) in a medium of HATU (23 mg) and N,N-diisopropylethylamine (19 μL) in dichloromethane (2 mL) Yield: 9. 9 mg MS-ESI: [Μ+Η]+=457·4; HPLC: Rt = 9 · 34 minutes (Method 1) Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed Example 3 4 1 _ 醯 醯 _6_ (3 -isopropyl amphetamine) carbonyl a 4-benzene certain 1, 2, 3, 4 - tetrahydro - 2, 2, 4 - trimethyl p-quinoline according to the embodiment 1 1 method, 3 - isopropoxypropylamine ( 5.2 mg) and 1- acetyl -4-phenyl -1, 2, 3, 4 paper size applicable to China National Standard (CNS) A4 specifications (210X 297 mm) -62- 1322144 A7 B7 V. Description of the invention (6〇tetrahydro-2,2,4-trimethyl d-quinoline-6-carboxylic acid (1〇mg) in HATU ( 2 3mg ) And n,N-diisopropylethylamine ((Please read the back of the note before you fill out this page) 19 micro ) For condensation at a square Yield hospital chloroformate (2 ml) Media: 8.8 mg. MS - ESI: [Μ + Η]+=437·4; HPLC: Rt = 8 . 80 min (method i) Example 3 5 1 - ethyl hydrazine - 6 - (2 - [methylthiol 1 ethylamine ) Carbonyl - 4 - A group - "_, 2 '_3 ' 4 - Tetrahydrogen 2,? , 4 - trimethyl a dark porphyrin according to the method described in Example 1 '2 - (methylthio) ethylamine (4.1 mg) and 1 acetoin-4-phenyl-1, 2, 3, 4 a tetrahydro-2,2,4-trimethyl d-quinoline-6-carboxylic acid (1 mg) in HATU (2 3 mg) and hydrazine, N-diisopropylethylamine (19 μL) The condensation was carried out under a medium of dichloromethane (2 ml). Yield: 10 mg. Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed MS — ESI : [M + H]+=4ll . 4; HPLC : Rt = 3 . 33 minutes (Method 2) Example 3 6 1 - Ethyl group 6 - ( Methoxyphenoxy) _ -4- benzene a certain 1, 2, 3, 4 - tetrahydro-2, 2, 4 - 〒 A certain acetaine according to the method described in Example 1-1, 4 - Methoxol (6.2) This paper scale applies to National Standards (CNS) Α4 (210Χ297 mm) -63- 1322144 A7 ____ B7 V. Inventions (6) (Please read the notes on the back first) Complete this page) mg) with 1-ethylindole 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl alpha quinolate-6-carboxylic acid (1 mg) The condensation was carried out in a medium of HATU (2 3 mg) and hydrazine, hydrazine-diisopropylethylamine (19 μL) in dichloromethane (2 mL). Yield: 7.2 mg. MS-ESI: [M+H]+ = 458. 4; HPLC: Rt = 3 . 90 min (method 2) Example 3 7 ethyl hydrazide - ft - (4 - phenyl benzophenone) oxygen - 4—Pinger 2, 2, 3, 4-14, 2, = A 啐瞅L a ) 1 , __2 — 氤 6 6 — methoxy 2,2,4- = D quinoline according to The method described in Example 1 carried out a Skraup reaction with 4 ~ anisidine (5.0 g) and hydrazine (1.7 g) in cerium oxide (25 ml). Yield: 2.3 g. MS- ESI :[M+H]+ =204. 2 Printed by the Intellectual Property Office of the Ministry of Economic Affairs, Consumers' Cooperatives (b) _1_—Ethylene-based 1' 2 — one gas-R-methoxy- 2m, 2,4 - a triterpenoid, a solution of ethyl chloroform (8 ml) was added dropwise to 1,2-dihydro-6-methoxy-2,2,4-trimethyl d-quinoline (1.7 g) and catalyst. A solution of a portion of N,N-dimethylaminopyridine in pyridine (60 mL) cooled (〇 ° C). After stirring for 18 hours, the reaction mixture is diluted under vacuum to the Chinese National Standard (CNS) A4 specification (210X297 mm) 64 - 1322144 A7 _B7_ V. Invention description (呦 (Please read the back of the note first) The residue is dissolved in dichloromethane and washed with 1M HCl, water, 5% aqueous sodium bicarbonate, water and brine. The residue was chromatographed on silica gel eluting with dichloromethane. Yield: 1.8 g. MS-ESI: (M+H) + =246. 2 (c) 1 -ethylhydrazine-6 —Methoxy—4 Benzene—1,2,卩,4-tetradecyl-2,2,4-dimethyl [1 quinoline according to the method described in Example 3 for A 1 C 1 3 (3 . In the presence of 〇克), this (25 liters) and 1 ethane-based 1,2-dihydro-6-methoxy-2,2,4-trimethylmorpholine (1 · 8g)

Friedel-Craft 烷化作用。 產量:1 · 9克。 HPLC : Rt = 9 . 62 分鐘(方法 1) (d ) 1 —乙醯基一 -羥基—4 —苯甚-1 , 〇 , 〇 經濟部智慧財產局員工消費合作社印製 4 —四氫_2,2,4 —二甲某p奎啉 將三溴化硼(1 · 3 0毫升)逐滴加到1 —乙醯基一 6 —甲氧基一4 —苯基—1 ,2,3 ,4~四氫一 2,2 ’ 4_三甲基卩奎啉(0 . 9g)於二氯甲烷之冷卻(〇〇c )溶液。於攪拌1 8小時後,將反應混合物傾倒入水中且 以醋酸乙酯來萃取。有機層用水,5%碳酸氫鈉水溶液及 水淸洗且於真空濃縮。 本纸張尺度適用中國國家標準(CNS )八4規格(210X297公釐) -65- 1322144 A7 B7 五、發明説明(钤 產量:9 5 0毫克。 MS — ESI: 〔M+H〕+ =310.2: (請先閱讀背面之注意事項再填寫本頁) HPLC : Rt = 8 . 41 分鐘(方法 1) (e ) 1—乙醯基_6_ (4_苯基苯甲醯基)氧基_4 —苯基—1 ,2 ,3 ,4 —四氫一2 ,2 ,4-三甲基喹 根據實施例6所述方法以1 一乙醯基一 6 —羥基-4 —苯基一1 ,2 ,3 ,4 —四氫—2 ,2 ,4 —三甲基喹 啉(1 0毫克)與4 一二苯羰基氯(1 4mg )及N,N 一二異丙基乙基胺(2 8微升)於四氫呋喃(1毫升)進 行醯化反應。 產量:8 . 2毫克。 MS — ESI: CM + H] + =490 · 4 ; HPLC : Rt=12 . 81 分鐘(方法 1) 實施例3 8 經濟部智慧財產局員工消費合作社印製 1 —乙醯基一 6 _ (第三丁基乙醯基)氧基_ 4 _苯基一 1 ,2,3,4 —四氤一2,2,4-三甲基喹啉 根據實施例6所述方法以1 -乙醯基_6 _羥基一 4 —苯基_ 1 ,2 ,3 ,4_四氫一 2,2 ,4 —三甲基喹Friedel-Craft alkylation. Yield: 1 · 9 grams. HPLC : Rt = 9 . 62 minutes (method 1) (d ) 1 —ethylidene-hydroxy- 4-benzox-1 , 〇, 〇 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed 4 - tetrahydro 2 , 2,4—Dimethyl p-quinoline, boron tribromide (1·30 ml) was added dropwise to 1-ethylidene-6-methoxy-4-phenyl-1, 2,3 A solution of 4~tetrahydro-2,2'4-trimethylhydrazine quinine (0.9 g) in dichloromethane (〇〇c). After stirring for 18 hours, the reaction mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with water, aq. This paper scale applies to China National Standard (CNS) VIII 4 specifications (210X297 mm) -65- 1322144 A7 B7 V. Description of invention (钤 yield: 950 mg. MS — ESI: [M+H]+ =310.2 : (Please read the precautions on the back and fill out this page) HPLC : Rt = 8 . 41 minutes (method 1) (e ) 1 - ethyl hydrazine _6_ (4 phenylbenzimidyl)oxy _4 —Phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinine according to the method described in Example 6 as 1-ethyl fluorenyl-6-hydroxy-4-phenyl-1. 2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) with 4-diphenylcarbonyl chloride (14 mg) and N,N-diisopropylethylamine (2 The oximation reaction was carried out in tetrahydrofuran (1 ml). Yield: 8.2 mg. MS - ESI: CM + H] + = 490 · 4 ; HPLC : Rt = 12. 81 minutes (method 1) 3 8 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed 1 - Ethyl-based 6 _ (Tertiary butyl ethinyl)oxy _ 4 _ Phenyl-1, 2, 3, 4 - 4 氤 1 2,4-Trimethylquinoline according to the method described in Example 6 with 1-ethylenyl _6 _ A group 4 - phenyl _ 1, 2, 3, 4 _ tetrahydro-2,2 a, 4 - trimethyl quinoline

啉(10毫克)與第三丁基乙醯基氯(9 . 0微升)及N ,N -二異丙基乙基胺(2 8微升)於四氫呋喃(1毫升 )進行醯化反應。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -66 - 1322144 A7 _B7_ ___ 五、發明説明(匈 產量:3 · 9毫克。 MS - ESI :〔M + H〕+ =408. 4; (請先閱讀背面之注意事項再填寫本頁) HPLC : Rt=l 1 · 28 分鐘(方法 1) 實施例3 9 1 一乙輸某—6 _ (環丙基甲基)氣甚—4 —苹某—1 ’ 2 , 3 , 4·—四氣一2 , 2 ’ 4_二甲某d奎琳 將1—乙醯基一 6 —羥基一 4 —苯基一 1 ,2,3, 4-四氫-2 ,2 ,4 —三甲基喹啉(20mg),碳酸 絶(6 3mg ) ’溴化四丁基銨(29mg)及氯甲基環 丙烷(8 · 4微升)於乙腈(1毫升)之混合物於5 q〇c 下攪拌1 8小時。將反應混合物於真空下濃縮。殘餘物於 矽膠上以庚烷/醋酸乙酯=1/〇=&gt;6/4 (v/v) 作爲洗脫劑來層析。 產量:1 0毫克。 MS — ESI: 〔M + H〕+ =364. 2; HPLC : Rt = 1〇 · 73 分鐘(方法 1) 經濟部智慧財產局員工消費合作社印製 實施例4 〇 -J—6 -(3 -吡啶甲某)氬基 ] -~-~~~2;__4 —四氣 _2,2 , 4 —三甲某 d 奎咐 根據實施例3 9所述方法,以1 一乙醯基_ 6 ~經基 一 4 一本基—1 ,2 , 3 ,4_ 四氫 _2 , 2 ’ 4-二甲 基哇琳(2〇mg),與3 —吡啶甲基氯.He 1 (is? 本纸張尺度適用til國家縣(CNS)八4驗(2丨0&gt;&lt;297公楚) -67- 1322144 A7 _____B7_ 五、發明説明(的 mg),碳酸絶(63mg)及溴化四丁基銨(29mg )於乙腈(1毫升)來進行烷化作用。 產量:1 0毫克◊ MS-ESI: 〔Μ+Η〕+=401·2; HPLC : Rt = 8 . 40 分鐘(方法 1) 實施例4 1 1 _7,醯基一6 -乙基—4 —宏基一Ί ,2 , 3 ,4 —四The porphyrin (10 mg) was tritylated with tert-butylethenyl chloride (9.0 μl) and N,N-diisopropylethylamine (28 μL) in tetrahydrofuran (1 mL). This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -66 - 1322144 A7 _B7_ ___ V. Description of invention (Hungarian production: 3 · 9 mg. MS - ESI : [M + H] + =408 4; (Please read the notes on the back and fill out this page) HPLC : Rt=l 1 · 28 minutes (method 1) Example 3 9 1 One B loses a certain 6-(cyclopropylmethyl) gas —4 — 青一—1 ' 2 , 3 , 4·—four gas one 2 , 2 ' 4 — dimethyl d quinine will be 1-ethenyl- 6-hydroxy- 4-phenyl- 1 , 2, 3, 4-tetrahydro-2,2,4-trimethylquinoline (20 mg), carbonic acid (6 3 mg) 'tetrabutylammonium bromide (29 mg) and chloromethylcyclopropane (8 · 4 μl The mixture was stirred at 5% EtOAc (1 mL) over EtOAc (EtOAc)EtOAc. (v/v) Chromatography as eluent. Yield: 10 mg. MS - ESI: [M + H]+ = 364. 2; HPLC: Rt = 1 〇 · 73 min (method 1) Ministry of Economics Property Bureau Staff Consumer Cooperative Printed Example 4 〇-J-6-(3-pyridine a) argon group] -~-~~~2; __4 - four gas_2, 2, 4 - trimethyl y ku 咐 according to the method described in Example 39, with 1-ethyl fluorenyl -6 ~ 4 a base —1 , 2 , 3 , 4 — tetrahydro 2 , 2 ' 4-dimethylwine (2〇mg), and 3-pyridine methyl chloride. He 1 (is? This paper scale applies Til National County (CNS) eight 4 test (2丨0&gt;&lt;297 public Chu) -67- 1322144 A7 _____B7_ V. Description of the invention (mg), carbonic acid (63mg) and tetrabutylammonium bromide (29mg) Alkylation was carried out in acetonitrile (1 mL). Yield: 10 mg ◊ MS-ESI: </RTI> </RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> <RTIgt; _7, fluorenyl-6-ethyl-4, Acer, 2, 2, 3, 4 - 4

根據實施例1所述方法以對位-乙基苯胺(1 · 〇克 )及碘(0 . 34克)於氧化来(5毫升)進行Skraup反 應。 產量:8 0 0毫克。 2 0 2.2 (請先閲讀背面之注意事項再填寫本頁) MS-ESI : 〔M+H〕 (b ) 1 一乙醯 4 —四氣一 2 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 _乙某一1 , 2 ,2,4 —三甲基喹啉 根據實施例3 7所述方法,以1,2 —二氫_6 -乙 基_2,2,4 —三甲基π奎啉(800mg)及觸媒份量 之N,N -二甲胺基吡啶於吡啶(2 5毫升)進行醯化反 應。 產量:4 1 0毫克。 本紙張尺度適用中國國家標隼(CNS ) Μ規格(2丨0 X 297公釐) 68- 1322144 A7 B7 五、發明説明(6$ MS — ESI : 〔M + H〕+ =244. 2 (請先閲讀背面之注意事項再填寫本頁) (c ) 1—乙醯-6-乙基一4 —苯基-1 ,2,3 ,4 —四氣,2,4_三甲基喹啉 根據實施例3所述方法於A 1 C 1 3 (7 1 0毫克)存 在下以苯(10毫升)與1一乙醯基_6 —乙基_1 ,2 ,3 ,4 —四氫一2 ,2 ,4 —三甲基喹啉(410mg )進行Friedel-Craft院化作用。 產量:4 0 7毫克。 MS-ESI: 〔M+H〕+ =322.4 實施例4 2 1—乙醯基—6— (1 ,1’ —二苯某)-4 —苯某一 1 ,2,3,4_四氫一2,2,4_三甲基喹啉 (a ) 1 一乙醯—6 -碘基—1 ,2,3 ,4 —四氤-2 ,2,4_三甲基喹啉 經濟部智慧財產局員工消費合作社印裂 將亞硝酸鈉溶液(3 1 m g )逐滴加到1 _乙醯基一 6-胺基一 4 —苯基—1 ,2 ,3 ,4-四氫-2 ,2 , 4_三甲基喹啉(1 28mg)及硫酸(8 2mg)於水 (2毫升)之冷卻(CKC)溶液中。於0°C下攪拌1 5分 鐘後,加入碘化鉀溶液(105mg)。於攪拌18小時 後,將反應混合物傾倒到二氯甲烷中。分離有機層且用5 %硫代硫酸鈉水溶液及水來淸洗,脫水(硫酸鎂)且於真 空濃縮。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -69- 1322144 A7 B7 五、發明説明(6? 產量:1 6 0毫克。 MS-ESI : 〔M+H〕+ =420.0 (請先閱讀背面之注意事項再填寫本頁) (b ) 1-乙醯基 _6_ (1 ,1’ 一 二苯基)一 4 一苯 基—1 ,2,3,4 —四氫-2,2,4-三甲基喹啉 根據實施例1 3所述方法,以1 一乙醯基一 6 -碘基 —4-苯基 _1 ,2 ,3 ,4-四氫 _2 ,2 ,4 -三甲 基d奎琳(2〇mg) , (1 ,1 ——苯基—4_基)砸 酸(28mg),氟化絶(15mg)、三苯基瞵( 5.0mg)及參(二苯叉丙酮)二鈀(〇) (4.5 mg)於二甲氧基乙烷/乙醇4 : 1 (v/v) (5毫升 )來進行三菱交叉偶合反應。 產量:1 6毫克。 MS-ESI: (M+H) + =446 · 4 ; HPLC : Rt = 6 · 84 分鐘(方法 2) 實施例4 3 1_乙醯基一 6- (4 —氯苯基)_4_苯基_1 ,2, 經濟部智慧財產局員工消費合作社印製 3,4 一四氤一2,2,4-三甲基喹啉 根據實施例1 3所述方法,以1—乙醯基_6_碘基 —4 -苯基一1 ,2 ,3 ,4 —四氫一2 ,2 ,4 —三甲 基喹啉(20mg) ,4一氯苯基硼酸(22mg),氣 化絶(15mg)、三苯基瞵(5.0mg)及參(二苯 叉丙酮)二鈀(0) (4.5mg)於二甲氧基乙烷/乙 本纸張尺度適用中國國家標準(CNS &gt; A4規格(210X297公釐) -70 - 1322144 A7 B7__ 五、發明説明(的 醇4:1(v/v)(5毫升)來進行三菱交叉偶合反應 〇 (請先閲讀背面之注意事項再填寫本頁) 產量:8 . 6晕克。 MS-ESI: [M + H] + =404 . 4 ; HPLC:Rt=5.94分鐘(方法2) 實施例4 4 ]—乙醯某—-胺某—4 -苯基—1 ,?.,3,4 —四 氤一?.,2,4,7 —四甲某晬啉 (a ) 1 一乙醯基一_6 —胺某—1 ,2 —二氣—2,2, 4,7 —四甲某哮啉 將 N— Boc-2 —甲基一 1 ,4 —苯二胺(2 . 3 克),硫酸鎂(6.3克),4 —第三丁基鄰苯二酚( 100毫克)及碘(3〇〇mg)於丙酮(15毫升)之 混合物於回流下攪拌2 0小時。將反應混合物冷卻至室溫 且過濾。過濾物於真空下濃縮且殘餘物用二氧化矽上層析 且以庚烷/醋酸乙酯=1/0 = &gt;3/1 (v/v)作爲 經濟部智慧財產局員工消費合作社印製 洗脫劑。該產物,6 —(第三丁氧羰基)胺基_1,2_ 二氫—2 ,2 ,4 ,7 —四甲基ti奎啉,用乙醯氯(1 · 0 毫升)於吡啶(1 . 0毫升)及甲苯(10毫升)之混合 物中醯化。於攪拌1小時後,將反應混合物用3%檸檬酸 水溶液及水來淸洗。將有機層脫水(硫酸鎂)及於真空濃 縮。將殘餘物用矽膠層析,以庚烷/醋酸乙酯=1 / 0 = &gt;3/1(v/v)作爲洗脫劑。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1322144 A7 B7 五 '發明説明( 產量 5 0毫克。 MS-ESI : 〔M+H〕 3 4 5 (b ) 1 一乙醯某_6_胺某—4 —苯甚—1 2The Skraup reaction was carried out according to the method described in Example 1 with p-ethylaniline (1 · gram) and iodine (0.33 g) in oxidized (5 ml). Yield: 800 mg. 2 0 2.2 (Please read the notes on the back and then fill out this page) MS-ESI : [M+H] (b ) 1 一乙醯4 — 四气一 2 Printed by the Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperatives_B a certain 1, 2, 2, 4 -trimethylquinoline according to the method described in Example 37, with 1,2-dihydro-6-ethyl-2,2,4-trimethyl π-quinoline ( 800 mg) and a catalytic amount of N,N-dimethylaminopyridine were subjected to a oximation reaction in pyridine (25 ml). Yield: 4 10 mg. This paper scale applies to China National Standard (CNS) Μ Specifications (2丨0 X 297 mm) 68- 1322144 A7 B7 V. Invention Description (6$ MS — ESI : [M + H]+ =244. 2 (Please Read the precautions on the back and fill out this page. (c) 1-Ethyl-6-ethyl-4-phenyl-1,2,3,4-tetragen, 2,4-trimethylquinoline The method described in Example 3 is in the presence of A 1 C 1 3 (7 10 mg) in benzene (10 ml) and 1-ethylindenyl-6-ethyl-1,2,3,4-tetrahydro-2 , 2,4-trimethylquinoline (410 mg) was subjected to Friedel-Craft laboratoryization. Yield: 407 mg. MS-ESI: [M+H]+ = 322.4 Example 4 2 1 -ethylhydrazine 6-(1 ,1'-diphenyl)-4-benzene a 1,2,3,4_tetrahydro-2,2,4-trimethylquinoline (a) 1 -ethyl hydrazine - 6 - Iodo-I, 2,2,3,4-tetradecane-2,2,4_trimethylquinoline Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperatives Printed Sodium Nitrate Solution (3 1 mg) Dropped to 1 _Ethyl benzyl-6-amino-4-phenyl- 1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (1 28 mg) and sulfuric acid (82 mg) (2 ml) in a cooled (CKC) solution. After stirring at 0 ° C for 15 minutes, a potassium iodide solution (105 mg) was added. After stirring for 18 hours, the reaction mixture was poured into dichloromethane. Wash with 5% aqueous sodium thiosulfate solution and water, dehydrate (magnesium sulfate) and concentrate in vacuo. This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -69- 1322144 A7 B7 V. Description of the invention (6? Yield: 1 60 mg. MS-ESI: [M+H]+ = 420.0 (Please read the back note first and then fill out this page) (b) 1-Ethyl _6_ (1, 1'-diphenyl)-4-phenyl- 1 ,2,3,4-tetrahydro-2,2,4-trimethylquinoline according to the method described in Example 13 a 6-iodo-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl d-quine (2〇mg), (1,1-phenyl-4 _) decanoic acid (28 mg), fluorinated (15 mg), triphenyl sulfonium (5.0 mg) and ginseng (diphenylacetone) dipalladium (〇) (4.5 mg) in dimethoxyethane/ethanol 4 : 1 (v/v) (5 ml) for Mitsubishi cross-coupling reaction Yield: 16 mg. MS-ESI: (M+H) + = 446 · 4; HPLC: Rt = 6 · 84 min (Method 2) Example 4 3 1 -ethylamino-6-(4-chlorophenyl)-4-phenyl _1 , 2, Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative, Printed 3,4, 4,4,2,4-trimethylquinoline, according to the method described in Example 1-3, with 1-ethyl fluorenyl -6 _Iodo-4-yl-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (20mg), 4-chlorophenylboronic acid (22mg), gasification (15mg ), triphenylsulfonium (5.0mg) and ginseng (diphenylacetone) dipalladium (0) (4.5mg) applied to China National Standard (CNS &gt; A4 specification) on dimethoxyethane/b paper scale (210X297 mm) -70 - 1322144 A7 B7__ V. Description of the invention (alcohol 4:1 (v/v) (5 ml) for Mitsubishi cross-coupling reaction 请 (please read the notes on the back and fill out this page) Yield: 8.6 sm. MS-ESI: [M + H] + = 404 . 4 ; HPLC: Rt = 5.94 min (Method 2) Example 4 4 - Ethyl--amine 4- 4-benzene Base—1,?.,3,4—four氤一?.,2,4,7—tetramethyl porphyrin (a) 1 ethyl sulfonyl -6-amine 1, 2 - 2 gas - 2, 2, 4, 7 - tetramethyl porphyrin N- Boc-2 - methyl-1,4-phenylenediamine (2.3 g), magnesium sulfate (6.3 g) , a mixture of 4 - butyl catechol (100 mg) and iodine (3 mM) in acetone (15 ml) was stirred at reflux for 20 h. The reaction mixture was cooled to room temperature and filtered. The material was concentrated under vacuum and the residue was chromatographed with cerium chloride and was washed with heptane/ethyl acetate = 1/0 = &gt; 3/1 (v/v) as the consumer property cooperative of the Ministry of Economic Affairs. Deprotection. The product, 6-(t-butoxycarbonyl)amino-1,2-dihydro-2,2,4,7-tetramethylti-quinoline, with ethyl chloroform (1 · 0 mL) The mixture was deuterated in a mixture of pyridine (1.0 ml) and toluene (10 ml). After stirring for 1 hour, the reaction mixture was washed with 3% aqueous citric acid and water. Concentrate in vacuo. The residue was chromatographed eluted with EtOAc/EtOAc (EtOAc/EtOAc). Specifications (210X2 97 mm) 1322144 A7 B7 Five 'Inventive Description (Production 50 mg. MS-ESI: [M+H] 3 4 5 (b) 1 乙乙醯_______ Benzene-1 2

A 2,2,4,7 —四甲基喹啉 將A 1 C 13 (266mg)加到1—乙醯基—6 —胺 基~1,2 —二氫一2,2,4,7_四甲基π奎琳( lOOmg)於苯(10毫升)之加熱(70°C)溶液中 。於3小時後,將混合物冷卻且於真空濃縮。將殘餘物溶 於醋酸乙酯中且用水洗。分離有機層,脫水(硫酸鎂)且 於真空濃縮。殘餘物於矽膠上以庚烷/醋酸乙酯=1 / 〇 =&gt;3/1(v/v)爲洗脫劑來層析。 產量:7 5毫克。 M S - E S I : 〔Μ+Η〕+=323.4 實施例4 5 1—乙醯基—6— (4 —苯基苯甲醯基)胺基—苯某 (請先閱讀背面之注意事項再填寫本頁) 經 濟 部 智 慧 財 產 局 員 X 消 合 作 社 印 製 -1 2 4 —四氤_2,2,4,7_四甲某晬啉 根據實施例6所述方法以1 一乙醯基_ 6 —胺基一 4 —苯基一1 ’ 2 ,3 ,4 一四氫一2 ,2 ,4 ,7 -四甲 基鸣啉(2 0毫克)與4 一二苯羰基氯(1 0 〇mg )及 吡啶(1 0 0微升)於四氫呋喃(5毫升)進行醯化反應 產量:2 4晕克 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 72 1322144 A7 B7 五、發明説明(Μ (請先閲讀背面之注意事項再填寫本頁) MS — ESI : 〔M+H〕+ =503. 4 實施例4 6 1_乙醯基_6_ (4 -苯基苯甲醯基)胺基—8 —甲氧 基-4 —苯基—1 ,2,3,4 一四氤-2,2,4 —三 甲基喹啉 (a ) 1 _乙醯基一 6_胺基_8 —甲氧基一 4 一苯基_ 1 ,2,3,4 —四氣一2,2,4 —三甲基P奎啉 根據實施例44所述的方法,以N_Bo c - 3 —甲 氧基一 1 ,4_苯二胺(450毫克),硫酸鎂(1 . 0 克),4 一第三丁基鄰苯二酚(10毫克)及碘(20 mg)於丙酮(10毫升)進行Skraup反應,將該產物用 乙醯氯(2 5 0微升)及吡啶(2 5 0微升)於甲苯( 1 0毫升)來醯化且接著與A 1 C 13 (26 6mg)進行 Friede卜Crafts 院化。 產量:71毫克。 MS — ESI : 〔M + H〕+=339.4 經濟部智慧財產局員工消費合作社印製 (b ) 1 一乙酿基—6 — ( 4 —苯基苯甲驢基)胺基—8 -甲氧基一4 —苯基一1 ,2 ,3 ,4_四氤—2 ,2 , 4 _三甲基喹啉 根據實施例6所述方法以1 —乙醯基_ 6 -胺基一 8 —甲氧基—4-苯基一1 ,2 ,3 ,4 —四氫—2,2 , 4 —三甲基喹啉(2 0毫克)與4_二苯羰基氯(1 0 0 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -73- 1322144 A7 B7 五、發明説明(7) mg )及吡啶(1 0 0微升)於四氫呋喃(5毫升)進行 醯化反應。 (請先閲讀背面之注意事項再填寫本頁) 產量:2 5毫克。 MS — ESI : 〔M+H〕+ =519. 4 實施例4 7 1 _乙醯基_6 — (2 —呋喃甲醯基)胺基一 1 ,2,3 ,4 —四氤一 4_甲苯基一 2,2,4 一三甲基喹啉 根據實施例6所述方法以1 -乙醯基- 6 -胺基- 4 一甲苯基—1 ,2 ,3 ,4 —四氫一2 ,2 ,4 —三甲基 鸣啉(10毫克)與2 -呋喃甲醯基氯(8 · lmg)及 N,N —二異丙基乙胺(2 0微升)於四氫呋喃(1毫升 )進行醯化反應。 產量:1 2毫克。 MS — ESI: 〔M+H〕+ =417. 4; HPLC:Rt=4.90分鐘(方法2) 實施例4 8 經濟部智慧財產局員工消費合作社印製 Ί_乙醯基_6_ (4_苯基苯甲醯基)胺基_1,2 , 3,4 一四氤_4_甲苯基一 2,2,4 —三甲基喹啉 根據實施例6所述方法以1 -乙醯基-6 -胺基-4 —甲苯基一 1 ,2 ,3 ,4 一四氫一2 ,2 ,4_三甲基 d奎啉(1 0毫克)與4_二苯基羰基氯(1 4mg)及Ν ,N—二異丙基乙胺(2 0微升)於四氫呋喃(1毫升) 本纸張尺度適用中國國家標準(CNS &gt; A4規格(210X297公釐) -74 - 1322144 A7 B7 五、發明説明( 進行醯化反應。 產量:9 . 3毫克。 (請先閱讀背面之注意事項再填寫本頁) MS-ESI : 〔M+H〕+=503.4; HPLC : Rt = 6 · 08 分鐘(方法 2) 實施例4 9 1_乙醯基一 6_ (乙基丙二醯基)胺基_1 ,2 ,3 , 4_四氤一4 —甲苯基_2,2,4_三甲基喹啉 根據實施例6所述方法以1 -乙醯基- 6 -胺基-4 —甲苯基一1 ,2 ,3 ,4-四氫一 2 ,2 ,4 —三甲基 喹啉(10毫克)與乙基丙二醯基氯(9 . 4mg)及N ,N —二異丙基乙胺(2 0微升)於四氫呋喃(1毫升) 進行醯化反應。 產量:1 2毫克。 MS — ESI : 〔M + H〕+=437 · 4 ; HPLC : Rt = 4 . 71 分鐘(方法 2) 實施例5 0 經濟部智慧財產局員工消費合作社印製 1 一乙醯基一 6 — (3 ,5_二溴苯甲醯基)胺基-4-苯基一 1,2,3,4 —四氫—2,2,4 —三甲基喹啉 根據實施例1 1所述方法,使1-乙醯基_6_胺基 —4 一苯基一1 ,2,3 ,4一 四氫一 2 ,2 ,4 —三甲 基喹啉(10毫克)與3 ,5 —二溴苯甲酸(10mg) 及N,N -二異丙基乙基胺(2 2微升)於四氫呋喃(1 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -75- 1322144 A7 B7 五、發明説明( 毫升)進行HATU縮合作用。 產量:1 5 . 9毫克。 (請先閲讀背面之注意事項再填寫本頁) MS-ESI : 〔M+H〕+=470.9; 11?]^(::1^=1〇.11分鐘(方法1) 實施例5 1 1一乙醯某一6—(5_溴一2-甲胺某苯甲醯基)胺基 —4 —苯基一1 ,2 ,3 ,4-四氣一2 ,2 ,4 -三甲 基喹啉 根據實施例1 1所述方法,使1_乙醯基一 6 -胺基 -4 —苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4 —三甲 基喹啉(1 0毫克)與5 —溴-2-甲胺基苯甲酸( 8 . 4mg)及N,N-二異丙基乙基胺(2 2微升)於 四氫呋喃(1毫升)進行HATU縮合作用。 產量:1 3 . 2毫克。 MS — ESI : 〔Μ + Η〕+=522· 1 ; 11卩1^(::1^ = 8.95分鐘(方法1) 經濟部智慧財產局員工消費合作社印製 實施例5 2 1 _乙醯基一 6-(3 ,4,5 -三甲氧基苯甲醯基)胺 基—4 -苯基-1 ,2,3,4 —四氤-2,2,4 —三 甲基喹啉 根據實施例6所述方法以1 -乙醯基-6 -胺基- 4 —苯基—1 ,2 ,3 ,4—四氫—2,2,4 —三甲基喹 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) -76- 1322144 A7 B7 五、發明説明(74 啉(10毫克)與3,4,5 —三甲氧基苯甲醯基氯( (請先閱讀背面之注意事項再填寫本頁) 1 2mg)及N,N—二異丙基乙胺(22微升)於四氫 呋喃(1毫升)進行醯化反應。 產量:1 4 · 5毫克。 MS — ESI : 〔M + H〕+=5〇3.2; HPLC : Rt=l 1 . 26 分鐘(方法 i) 實施例5 3 1—乙輸基_6 -(3,5 —二氯二2 , 6 —二甲氧基苯 甲醯某)胺基一 4 _苯基—1__’ 2」3 ,4 -四氤-P!, ?.,4 一三甲基喹啉 根據實施例1 1所述方法,使1〜乙醯基一 6 一胺基 一 4_ 苯基一1 ,2 , 3 ,4 —四氫一 2 ,2 ,4_ 三甲 基Q奎啉(10毫克)與3 ,5_二氯—2 ,6 —二甲氧基 苯甲酸(9 〇mg)及N,N —二異丙基乙基胺(22 微升)於四氫呋喃(1毫升)進行HatU縮合作用。 產量:15.1毫克。 經濟部智慧財產局員工消費合作社印製 MS — ESI : 〔M+H〕+=54l . 1 ; HPLC : Rt = 10 · 92分鐘(方法丄) 實施例5 4 1—乙_基一 _6_ (2_乙醯氧基_專甲醯基)胺基—4_ 苹基—1,2_ι 3,4 —四氫二2 ;_2,4 一三甲甚盹啉 根據實施例1 1所述方法’使i 一乙醯基一 6 一胺基 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' -- -77- 1322144 A7 B7 五、發明説明(7今 (請先閲讀背面之注意事項再填寫本頁) -4 —苯基-1 ,2 ,3 ,4 一四氫一2 ,2 ,4-三甲 基卩奎啉(10毫克)與2_乙醯氧基苯甲酸(6 · Omg )及N,N -二異丙基乙基胺(2 2微升)於四氫呋喃( 1毫升)進行HATU縮合作用。 產量:1.1毫克。 MS-ESI: (M+H)+=471 . 2 ; HPLC : Rt = 14 · 35 分鐘(方法 1) 實施例5 5 1 一乙醯基一 6 — (2 -乙醯胺基一 5 -溴苯甲醯基)胺 基—4 —苯基一1 ,2,3 ,4 —四氤—2 ,2,4 —三 甲基喹啉 根據實施例1 1所述方法,使1 _乙醯基_ 6 -胺基 -4-苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4 —三甲 基π奎啉(1 0毫克)與2-乙醯胺基一 5-溴苯甲酸( 6 · Omg)及N,N -二異丙基乙基胺(2 2微升)於 四氫呋喃(1毫升)進行HATU縮合作用。 產量:2 . 3毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI: 〔Μ+Η〕+=530·2; HPLC : Rt=12 . 01 分鐘(方法 1) 實施例5 6 1 一乙醯某一6 -( 5 —溴一 2_N,N —二甲基胺甲醯 基苯甲醯基)胺基一 4_苯基—1 ,2 ,3 ,4_四氤— 本纸張尺度適用中國國家標準(CNS )八4規格(210X297公釐) -78- 1322144 A7 B7 五、發明説明( 2,2,4 —三甲基d奎琳 (請先閲讀背面之注意事項再填寫本頁) 根據實施例11所述方法,使1一乙醯基一6-胺基 -4-苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4 一三甲 基鸣啉(10毫克)與5_溴水楊酸(8 . Omg)及N ,N-二異丙基乙基胺(2 2微升)於四氫呋喃(1毫升 )進行HATU縮合作用。 產量:3 . 0毫克。 MS-ESI : 〔M + H〕+=580.2; HPLC : Rt=12 · 53 分鐘(方法 1) 實施例5 7 1 一乙醯某一 (2_ ί4_甲苯氧基]苯甲醯基)胺 基—4 —苯基一1 ,2 ,3 ,4 一四氤—2,2,4 一三 甲基ti奎啉 根據實施例1 1所述方法,使1 -乙醯基- 6 -胺基 —4-苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4 -三甲 基喹啉(1 0毫克)與5 -溴一 2 -甲胺基苯甲酸( 經濟部智慧財產局員工消費合作社印製 8 . 4mg)及N,N -二異丙基乙基胺(22微升)於 四氫呋喃(1毫升)進行HATU縮合作用。 產量:1 3 . 2毫克。 MS — ESI : 〔 M + H〕+ =522. 1 ; HPLC:Rt=8·95分鐘(方法l) 實施例5 8 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -79- 1322144 Α7 ________Β7 五、發明説明( 丄二~ 7,崢基—6 — (2 —甲基碏酹氧基苯甲醪甚)胺基— 苯基-」__’ 2,3 ’_4~~四,-2 ,2 ,4 —三甲基 (請先閲讀背面之注意事項再填寫本頁) (a ) 1 一乙醯基—6- (2-甲氧某苯甲醯某)胺基一 苯某一 1 ,2 ,3 ,4 —四氣—2,2,4 —三甲基 Ηϋ 根據實施例1 1所述方法,使1 一乙釀基一 6 -胺基 —4一 苯基一 1 ,2 ,3 ,4~ 四氫一 2,2 ,4_ 三甲 基0奎啉(0 · 6克)與2 —甲氧苯甲醯氯(1 . 〇g)及 N ’ N —二異丙基乙基胺(1 · 7毫升)於四氣咲喃( 6 0毫升)進行HATU縮合作用。 產量:0 . 6 5克。 M S - E S I : 〔Μ + Η〕+=443.4 (b ) 1—乙醯基—6— (2 —羥苯甲醯某)胺某—4 — 苯基—1 ,2,3,4 —四氤—2 ,2 ,4 -:甲某 經濟部智慧財產局員工消費合作社印製 將BBr3 (〇 . 69毫升)逐滴加到1 一乙醯基一 6 一(2-甲氧苯甲醯基)胺基一 4 一苯基一1 ,2 , 3 , 4 —四氬—2,2,4一二甲基π奎啉(〇 . 64克)於二 氯甲烷(4 0毫升)之溶液中。於攪拌4小時後,TL C 指示完成轉化。將水加到反應混合物中且持續攪拌1 5分 鐘。將混合物用5%碳酸氫鈉水溶液及水淸洗。將有機層 脫水(硫酸鎂)且於真空濃縮。所得產物無需進一步純化 便可使用。 本纸張尺度適用中國國家標準(CNS ) A4規格(21〇Χ:297公釐) ~ 1322144 A7 B7 五、發明説明( 產量:0 . 6 2克。 MS-ESI : 〔M+H〕+=429.4 經濟部智慧財產局員工消費合作社印挺 ( C ) 1 — 乙 醯基 — 6 — C 2 — 甲 基 磺 醯 氧 基 苹 甲 醯 基 ) 胺 基 4 苯 基— 1 2 5 3 j 4 四 氫 2 &gt; 2 4 二 甲 基 Q奎 啉 以 1 — 乙 醯基 — 6 — ( 2 — 羥 基 苯 甲 醯 基 ) 胺 基 — 4 — 苯 基 — 1 &gt; 2, 3 9 4 — 四 氫 — 2 9 2 3 4 — 二 甲 基 Q奎 啉 ( 1 2 m g )與 甲 基 磺 醯 基 氯 ( 6 • 5 微 升 ) 於 吡 啶 中 進 行 磺 醯 化 作 用。 於 攪 拌 1 6 小 時 後 進 行 Τ L C 分 析 顯 示 轉 化 成 較 局 流 動性 產 物 〇 將 混 合 物 濃 縮 &gt; 殘 餘 物 溶 於 二 氯 甲 院 中 且 用 水 洗。 將 有 機 層 脫 水 ( 硫 酸 鈉 ) 且 於 真 空 濃 縮 〇 粗 產 物 用 矽 氧凝 膠 管 柱 層 析 純 化 〇 洗 脫 劑 ; 庚 院 / 醋 酸 乙 酯 = 8 / 2 (V / / V ) 1 C &gt; 產 量 8 • 0 ί 毫克 〇 Μ S — Ε S I :〔Μ - 七Η〕 + = 5 0 7 * 4 t Η Ρ L C R t = 5 • 0 3 分 鐘 ( 方 法 2 ) 實 施 例 5 9 1 — 乙 酶 基 _ 6 — ( 2 _ c 3 5 _ 二 甲 基 異 哼 唑 — 4 一 碌 醯 基 1 氧 基 苹甲 醯 基 ) 胺 基 4 苹 基 1 2 3 4 四 氫 2 ,2 , ‘ 4 - 三甲基 ;〇1 根據實施例58所述方法,以1_乙醯基—6—(2 -羥基苯甲醯基)胺基-4-苯基—1 ,2,3 ,4 一四 (請先閲讀背面之注意事項再填寫本頁) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -81 - 1322144 A7 B7 五、發明説明(7令 (請先閲讀背面之注意事項再填寫本頁) 氫—2,2 ,4 -三甲基喹啉(20mg)與3 ,5-二 甲基異噚唑-4-磺醯基氯(27mg)於吡啶(2ml )中進行磺醯化作用 產量:1 4毫克。 MS-ESI : 〔M + H〕+=588.4; HPLC : Rt=14 · 46 分鐘(方法 1) 實施例6 0 1 一乙醯基一 6 —(2 -甲氧羰基乙羰氧某苯甲醯某)胺 基—4 一苯基-1 ,2,3,4-四氫-2,2,4 一三 甲基[1奎啉 根據實施例6.所述方法以1 一乙醯基一 6 — (2 —羥 基苯甲醯基)胺基-4—苯基一 1 ,2,3,4-四氫― 2,2,4 一三甲基喹啉(2 0毫克)與甲酯基丙醯基氯 (1 4mg)及N,N —二異丙基乙胺(4 0微升)於四 氫呋喃(2毫升)進行醯化反應。 產量:2 1 . 4毫克。 MS — ESI: 〔M+H〕+ =543. 6; 經濟部智慧財產局員工消費合作社印製 1^卩1^(::111 = 6.98分鐘(方法1) 實施例6 1 1 一乙醯基_6_ (2_ ί5_甲基異腭唑—3 —羰基] 氧基苯甲醯某)胺基_4_苯基—1 ,2,3 ,4_四氤 —2,2,4_三甲基卩奎啉 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) -82- 1322144 A7 B7 五、發明説明(的 (請先閲讀背面之注意事項再填寫本頁) 根據實施例6所述方法以1—乙醯基-6 -(2 -羥 基苯甲醯基)胺基—4-苯基_1 ,2,3 ,4一四氫-2,2,4_三甲基喹啉(1 5毫克)與5 -甲基異噚唑 -3—羰基氯(1 Omg)及N,N-二異丙基乙胺( 3 0微升)於四氫呋喃(1毫升)進行醯化反應。 產量:4 . 0毫克。 MS — ESI : 〔M+H〕+=538.4; HPLC : Rt = 9 · 84 分鐘(方法 1) 實施例6 2 1 —乙醯某—6 -(2_ ί2 -腭唑啶酮—[5 —甲某〕氣 基苯甲醯基)胺基—4_苯基一 1 ,2 ,3 ,4 —四氤— 2,2,4 —三甲基哮啉 根據實施例39所述方法以1 一乙醯基-6 —(2-羥基苯甲醯基)胺基—4-苯基—1,2,3 ,4 —四氫 _2 ,2 ,4_三甲基卩奎啉(20毫克)與5_氯甲基一 經濟部智慧財產局員工消費合作社印製 2 —腭唑啶酮(7mg),碳酸鉋(63mg)及溴化四 丁基銨(3 Omg)於乙腈(1毫升)來進行烷化作用。 產量:2 5毫克。 MS — ESI : 〔M + H〕+ =542. 4; ^1?匕(::1^ = 8.21分鐘(方法1) 實施例6 3 1 —乙醯某_6_ (2—[嗎啉—4 —羰基]氧基苯甲醯 本纸張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) -83- 1322144 A7 B7 五、發明説明(8) 基)胺基—4_苯基—1 ,2,3,4_四氤_2,2, 4 一三甲基喳啉 (請先閲讀背面之注意事項再填寫本頁) 根據實施例6所述方法以1一乙醯基一6_(2—羥 基苯甲醯基)胺基一4 —苯基一1 ,2 ,3 ,4-四氫— 2 ,2,4_三甲基喹啉(1 5毫克)與嗎啉_4_羰基 氯(1 2微升)及N,N_二異丙基乙胺(3 0微升)於 四氫呋喃(1毫升)進行醯化反應。 產量:5 . 4毫克。 MS — ESI: [Μ+Η]+=542·4; HPLC : Rt=10 · 02 分鐘(方法 1) 實施例6 4 1 一乙醯基-6— (2-苯胺基苯甲醯基)胺基一 4 一苯 基—1 ,2,3,4-四氣—2,2,4-三甲基喹啉 經濟部智慧財產局員工消費合作社印製 根據實施例1 1所述方法,使1 -乙醯基- 6 -胺基 一4_ 苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4 一三甲 基喹啉(1 5毫克)與N-苯基氨茴酸(2 lmg)及N ,N -二異丙基乙基胺(3 3微升)於四氫呋喃(1毫升 )進行HATU縮合作用。 產量:5 . 8毫克。 MS-ESI: 〔Μ+Η〕+=504·4; HPLC : Rt = 13 42 分鐘(方法 1) 實施例6 5 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -84- 1322144 A7 _B7_ 五、發明説明(珣 1一乙醯基-6— (2 —毗咯啶酮-N-乙羰某)胺某― 4 一苯基—1 ’ 2,3 ,4 —四氤一 2,2,4 一 二甲其 (請先閲讀背面之注意事項再填寫本頁) 咱啉 (3 ) 1—乙釀基一 6 —丙燃釀胺某~ 4 一苯某一 1 ,2 ,:^},4 一四氤一2,?,4 一三甲某晻啉 根據實施例6所述方法以1 -乙醯基- 6 -胺基-4 一苯基一1 ,2 ’ 3 ,4 -四氫一 2 ,2 ’ 4 —三甲基[I奎 啉(0. 12克)與丙烯醯基氯(39微克)及N,N — 二異丙基乙胺(0 . 2 1毫升)於四氫呋喃(1 〇毫升) 進行醯化反應。 產量:0 . 1 3克。 MS - ESI : 〔M + H〕+=363.2 (b ) 1—乙醯基—( 2 —吡咯啶酮基—N — ?·,某锱 基)胺基_4 —苯某—1 ’ 2 , 3 , 4_四氤—2,2, 4 —三甲基喹啉 經濟部智慧財產局員工消費合作社印製 在2 —吡咯啶酮(19mg)及氫化鈉(18mg, 60%於油)於THF (lml)之混合物中加入1 一乙 醯基_6_丙烯醯胺基—4 —苯基_1 ,2,3,4 —四 氫-2,2,4 —三甲基π奎啉(8mg)於THF (1 ml)。於攪拌18小時後,TLC分析顯示轉化成較高 流動性產物。混合物用醋酸乙酯來稀釋且用水,〇 . 5 N HC 1及水淸洗。將有機層脫水(硫酸鈉)且於真空 濃縮。用矽氧凝膠管柱層析來純化,使用庚烷/醋酸乙酯 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -85- 1322144 A7 B7 五、發明説明(的 = 8/ 2 = &gt;l/l (v/v)作爲洗脫劑。 產量:4 . 6毫克。 (請先閲讀背面之注意事項再填寫本頁) MS — ESI : 〔M + H〕+ =448.4; HPLC:Rt=4.51分鐘(方法2) 實施例6 6 1 一乙醯基一 6 -(乙氧乙氧乙羰某)胺某_4 —苯某一 1 ,2,3,4-四氣一2,2,4 —三甲基喹啉 根據實施例6 5所述方法,以2 —乙氧基乙醇(1 9 mg)及1-乙醯基—6 —丙烯醯胺基一 4 一苯基一 1 , 2 ,3 ,4 —四氫一 2 ,2 ,4 —三甲基喹啉(8mg) 於THF (lml)中進行Michael加成作用。 產量:1 . 0毫克。 MS — ESI: 〔Μ + Η〕+=453·4; HPLC : Rt = 5 . 03 分鐘(方法 2) 實施例6 7 1—乙醯基一 6— (2 —吡咯啶酮_N_甲氧羰基甲羰基 經濟部智慧財產局員工消費合作社印製 )胺基一 4-苯基—1 ,2,3,4-四氫-2,2,4 _三甲基p奎啉 根據實施例1 1所述方法,將N-羥甲基一 2 -吡咯 啶酮(22mg)及1-乙醯基—6_ (羥羰甲羰基)胺 基—4-苯基一 1 ,2 ,3 ,4 —四氫—2,2,4 一三A 2,2,4,7-tetramethylquinoline A 1 C 13 (266 mg) is added to 1-ethylenyl-6-amino~1,2-dihydro-2,2,4,7_ Tetramethyl π-quineline (100 mg) in a heated (70 ° C) solution of benzene (10 ml). After 3 hours, the mixture was cooled and concentrated in vacuo. The residue was dissolved in ethyl acetate and washed with water. The organic layer was separated, dried (MgSO4) The residue was chromatographed on silica gel eluting with heptane / ethyl acetate = 1 / s = &gt; 3/1 (v/v). Yield: 7 5 mg. MS - ESI : [Μ+Η]+=323.4 Example 4 5 1 -Ethyl- 6-(4-phenylbenzylidene)-amino-benzene (please read the notes on the back and fill in the form) Page) Ministry of Economic Affairs Intellectual Property Officer X Consumer Cooperative Printed - 1 2 4 - 4 氤 2, 2, 4, 7_ tetramethyl porphyrin according to the method described in Example 6 as 1-ethyl fluorenyl-6-amine 4-yl-phenyl- 1 ' 2 , 3 , 4 - tetrahydro - 2 , 2 , 4 , 7 - tetramethyl - morphine ( 20 mg ) and 4 - diphenylcarbonyl chloride ( 10 〇 mg ) Pyridine (100 μl) in tetrahydrofuran (5 ml) for deuteration reaction yield: 2 4 halo paper scale applicable to Chinese national standard (CNS) A4 specification (210X297 mm) 72 1322144 A7 B7 V. Description of invention (Μ (Please read the precautions on the back and fill out this page) MS — ESI : [M+H]+ =503. 4 Example 4 6 1_Ethyl _6_(4-Phenylbenzylidene) Amino-8-methoxy-4-phenyl-1,2,3,4 tetradecano-2,2,4-trimethylquinoline (a) 1 _ acetyl group 6-amino group _ 8-methoxy-4-phenylene_ 1 , 2, 3, 4 — four gas one 2, 2 4-trimethyl P-quinoline according to the method described in Example 44, using N_Bo c - 3 -methoxy-1,4-phenylenediamine (450 mg), magnesium sulfate (1.0 g), 4 Skraup reaction of tert-butyl catechol (10 mg) and iodine (20 mg) in acetone (10 ml) using ethyl chloroform (250 μL) and pyridine (250 μl) Purified in toluene (10 ml) and then subjected to Friedeb Crafts with A 1 C 13 (26 6 mg). Yield: 71 mg. MS — ESI : [M + H]+=339.4 Ministry of Economics Intellectual Property Printed by the Bureau of Staff Consumer Cooperatives (b) 1 Ethyl- 6-(4-phenylbenzhydryl)amino-8-methoxy-4-phenyl- 1, 2, 3, 4_4氤-2,2,4 _trimethylquinoline according to the method described in Example 6 as 1-ethenyl-6-aminol-8-methoxy-4-phenyl-1,2,3,4 - tetrahydro-2,2,4-trimethylquinoline (20 mg) and 4_diphenylcarbonyl chloride (100% paper size applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) - 73- 1322144 A7 B7 V. INSTRUCTIONS (7) mg ) and pyridine (1 The oximation reaction was carried out in tetrahydrofuran (5 ml). (Please read the notes on the back and fill out this page) Yield: 2 5 mg. MS - ESI : [M+H]+ = 519. 4 Example 4 7 1 _Ethyl -6 - (2 - furanyl) Amino 1, 2, 3, 4 - 4 - 4_ Tolyl-2,2,4-trimethylquinoline according to the method described in Example 6 as 1-ethylindolyl-6-amino-4-methylphenyl-1,2,3,4-tetrahydro-2 , 2,4-trimethylsodium morpholine (10 mg) with 2-furopyryl chloride (8 · 1 mg) and N,N-diisopropylethylamine (20 μL) in tetrahydrofuran (1 ml) The deuteration reaction is carried out. Yield: 12 mg. MS - ESI: [M+H]+ = 417. 4; HPLC: Rt = 4.90 min (Method 2) Example 4 8 Ministry of Economic Affairs Intellectual Property Bureau Employees Consumption Cooperative Printed Ί_乙醯基_6_ (4_Benzene Benzobenzhydryl)amino-1,2,3,4 tetrahydro-4-yl-tolyl-2,2,4-trimethylquinoline according to the method described in Example 6 with 1-ethylenyl- 6-Amino-4-tolyl-1,2,3,4-tetrahydro-2,2,4-trimethyl d-quinoline (10 mg) and 4-diphenylcarbonyl chloride (1 4 mg) And Ν, N-diisopropylethylamine (20 μl) in tetrahydrofuran (1 ml) This paper scale applies to Chinese national standards (CNS &gt; A4 specification (210X297 mm) -74 - 1322144 A7 B7 V. DESCRIPTION OF THE INVENTION (The deuteration reaction was carried out. Yield: 9.3 mg. (Please read the notes on the back and fill out this page.) MS-ESI : [M+H]+=503.4; HPLC: Rt = 6 · 08 min ( Method 2) Example 4 9 1_Ethylamino-6-(ethylpropanediyl)aminol-1,2,3,4_tetradecyl-4-tolyl-2,2,4-trimethyl Quinoline according to the method described in Example 6 as 1-ethylindolyl-6-amino-4-tolyl-1,2,3,4-tetra Hydrogen-2,2,4-trimethylquinoline (10 mg) and ethylpropanediyl chloride (9.4 mg) and N,N-diisopropylethylamine (20 μl) in tetrahydrofuran ( 1 ml) The deuteration reaction was carried out. Yield: 12 mg. MS - ESI : [M + H] + = 437 · 4 ; HPLC : Rt = 4 . 71 min (method 2) Example 5 0 Ministry of Economic Affairs Intellectual Property Office Employees' Consumption Cooperatives Printed 1-Ethyl sulfonyl-6-(3,5-dibromobenzylidene)amino-4-phenyl- 1,2,3,4-tetrahydro-2,2,4 — Trimethylquinoline according to the method described in Example 11 to give 1-ethylindolyl-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl Base quinoline (10 mg) with 3,5-dibromobenzoic acid (10 mg) and N,N-diisopropylethylamine (22 μL) in tetrahydrofuran (1 paper scale applicable to Chinese national standard ( CNS ) A4 size (210X297 mm) -75- 1322144 A7 B7 V. Description of the invention (ml) for HATU condensation. Yield: 15.9 mg. (Please read the notes on the back and fill out this page) MS- ESI : [M+H]+=470.9; 11?]^(::1^=1 .11 minutes (method 1) Example 5 1 1 -ethyl hydrazine 6-(5-bromo-2-methylamine benzothymidine)amino-4-phenyl- 1, 2, 3, 4- Tetrahydrate- 2,2,4-trimethylquinoline according to the method described in Example 11 to give 1-ethylamino-6-amino-4-phenyl-1,2,3,4-tetrahydrogen a 2,2,4-trimethylquinoline (10 mg) with 5-bromo-2-methylaminobenzoic acid (8.4 mg) and N,N-diisopropylethylamine (2 2 micron) HCl was subjected to HATU condensation in tetrahydrofuran (1 ml). Yield: 13.2 mg. MS — ESI : 〔Μ + Η〕+=522· 1 ; 11卩1^(::1^ = 8.95 minutes (method 1) Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed Example 5 2 1 _Ethyl a 6-(3,4,5-trimethoxybenzylidene)amino-4-phenyl-1,2,3,4-tetradecane-2,2,4-trimethylquinoline according to the implementation The method described in Example 6 is applied to the Chinese country on the scale of 1-acetamido-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline paper. Standard (CNS) Α4 size (210X 297 mm) -76- 1322144 A7 B7 V. Description of the invention (74 morphine (10 mg) and 3,4,5-trimethoxybenzimidyl chloride (please read the back first) Note: Refill this page) 1 2 mg) and N,N-diisopropylethylamine (22 μl) in tetrahydrofuran (1 mL) for purification. Yield: 1 4 · 5 mg. MS - ESI : [M + H]+=5〇3.2; HPLC: Rt=l 1 . 26 min (method i) Example 5 3 1-ethyl-trans-yl-6-(3,5-dichlorodi 2,6-dimethyl Aminobenzidine)Amino-4_Phenyl-1__' 2"3,4-tetraindole-P!, ?.,4-Trimethyl The porphyrin was subjected to the method described in Example 11 to give 1~ethylhydrazine- 6-amino- 4-phenyl- 1 , 2 , 3 , 4 - tetrahydro - 2 , 2 , 4 - trimethyl - Q - quinoline (10 Mg) with 3,5-dichloro-2,6-dimethoxybenzoic acid (9 〇mg) and N,N-diisopropylethylamine (22 μL) in tetrahydrofuran (1 ml) for HatU Condensation. Yield: 15.1 mg. Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed MS — ESI : [M+H]+=54l . 1 ; HPLC : Rt = 10 · 92 minutes (method 丄) Example 5 4 1 —B —基一_6_ (2_Ethyloxy_polymethylidene)Amino- 4_Phenyl-1,2_ι 3,4-tetrahydro-2;_2,4-trimethyl porphyrin according to implementation The method described in Example 1 1 makes the i-ethinyl- 6-amine basic paper scale applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) ' -- -77- 1322144 A7 B7 V. Description of invention (7 Today (please read the notes on the back and fill out this page) -4 - Phenyl-1,2,3,4 tetrahydro-2,2,4-trimethylhydrazine (10 mg) and 2_ Ethyloxybenzoic acid (6 · Omg ) and N, N - II Isopropylethylamine (22 μL) was subjected to HATU condensation in tetrahydrofuran (1 mL). Yield: 1.1 mg. MS-ESI: (M+H)+=471. 2; HPLC: Rt = 14 · 35 min (method 1) Example 5 5 1 -ethyl hydrazino-6 - (2-ethylamino--5-bromo Benzyl hydrazino)amino-4-yl-phenyl-1,2,3,4-tetradecane-2,2,4-trimethylquinoline according to the method described in Example 1 1 to give 1-ethylidene _ 6 -Amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl π-quinoline (10 mg) with 2-ethylamino--5-bromo Benzoic acid (6. Omg) and N,N-diisopropylethylamine (22 μL) were subjected to HATU condensation in tetrahydrofuran (1 mL). Yield: 2.3 mg. MS-ESI: [Μ+Η]+=530·2; HPLC: Rt=12. 01 minutes (method 1) Example 5 6 1 One 醯 6 6 6 5-Bromo- 2_N,N-dimethylamine-mercaptobenzylidene)Amino-4-phenyl-1,2,3,4_tetraindole - This paper scale applies to Chinese National Standard (CNS) Eight 4 specifications (210X297 mm) -78- 1322144 A7 B7 V. Description of the invention (2,2,4-trimethyl d-quine (please read the note on the back and fill out this page). According to Example 11 Method, 1-ethylamino-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylsodium morpholine (10 mg) and 5-bromine water Salicylic acid (8. Omg) and N,N-diisopropylethylamine (22 μL) were subjected to HATU condensation in tetrahydrofuran (1 ml). Yield: 3.0 mg. MS-ESI: [M+ H]+=580.2; HPLC: Rt=12 · 53 min (Method 1) Example 5 7 1 Ethyl (2_ 44_tolyloxy) benzhydryl) Amino-4-phenyl-1 , 2,3,4, a tetrahydro-2,2,4-trimethyl ti-quinoline according to the embodiment 1 Method for making 1-ethylindolyl-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (10 mg) with 5-bromo A 2-methylaminobenzoic acid (Printed by the Ministry of Economic Intelligence, Employees' Consumer Cooperative, 8.4 mg) and N,N-diisopropylethylamine (22 μL) in tetrahydrofuran (1 mL) for HATU condensation Yield: 13.2 mg. MS - ESI : [M + H]+ = 522.1; HPLC: Rt = 8.95 min (method l) Example 5 8 The paper scale applies to the Chinese National Standard (CNS) A4 size (210X297 mm) -79- 1322144 Α7 ________Β7 V. Description of the invention (丄2~7, 峥基-6-(2-methyloxybenzyl benzoquinone) Amino-phenyl-" __' 2,3 '_4~~4,-2,2,4-Trimethyl (please read the notes on the back and fill out this page) (a) 1 Ethyl-based 6-(2-methoxy a certain benzamidine, an amine, a benzene, a 1, 2, 3, 4 - 4 gas - 2, 2, 4 - trimethyl hydrazine, according to the method described in Example 11, 1 -amino- 4-phenyl- 1 , 2 , 3 , 4~ tetrahydro-2,2,4_ trimethyl 0 quinolin (0 · 6 g) and 2-methoxybenzhydryl chloride (1. 〇g) and N 'N-diisopropylethylamine (1.7 ml) in four gas 咲 (6 0 HCl) for HATU condensation. Yield: 0.65 grams. MS - ESI : [Μ + Η]+=443.4 (b) 1-Ethyl- 6-(2-hydroxybenzhydrazide)amine-4-phenyl--1,2,3,4-tetra —2 , 2 , 4 -: BBr3 (〇. 69 ml) was added dropwise to 1 Ethyl ketone-6-(2-methoxybenzhydryl) by the Intellectual Property Office of the Ministry of Economic Affairs. Amino-tetraphenyl- 1 , 2 , 3 , 4 -tetrahydro-2,2,4-dimethyl π-quinoline (〇. 64 g) in dichloromethane (40 mL). After stirring for 4 hours, TL C indicated complete conversion. Water was added to the reaction mixture and stirring was continued for 15 minutes. The mixture was washed with a 5% aqueous sodium hydrogencarbonate solution and water. The organic layer was dried (MgSO4) and concentrated in vacuo. The resulting product was used without further purification. This paper scale applies to China National Standard (CNS) A4 specification (21〇Χ: 297 mm) ~ 1322144 A7 B7 V. Description of invention (yield: 0.62 g. MS-ESI: [M+H]+= 429.4 Intellectual Property Office of the Ministry of Economic Affairs, Staff and Consumer Cooperatives, India (C) 1 — Ethyl- 6 — C 2 — Methylsulfonyloxymethylcarbendyl” Amine 4 phenyl—1 2 5 3 j 4 Tetrahydrogen 2 &gt; 2 4 dimethyl Q quinolinate 1 - ethoxymethyl 6 - ( 2 - hydroxybenzimidyl) amino - 4 - phenyl - 1 &gt; 2, 3 9 4 - tetrahydro-2 9 2 3 4 —Dimethyl Q-quinoline (12 mg) and methylsulfonyl chloride (6 • 5 μl) were sulfonated in pyridine. After stirring for 1 6 hours, Τ L C analysis showed conversion to a more fluid product 〇 Concentration of the mixture &gt; The residue was dissolved in the dichlorocarbazone and washed with water. The organic layer was dehydrated (sodium sulfate) and concentrated in vacuo. The crude product was purified by column chromatography on silica gel column chromatography. Gengyuan / ethyl acetate = 8 / 2 (V / / V ) 1 C &gt; Yield 8 • 0 ί mg 〇Μ S — Ε SI : [Μ - Η Η ] + = 5 0 7 * 4 t Η Ρ LCR t = 5 • 0 3 minutes (Method 2) Example 5 9 1 — Ethyl _ 6 — ( 2 _ c 3 5 _ dimethylisoxazole — 4 醯 醯 1 1 氧基 ) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Base; 〇1 according to the method described in Example 58, with 1-ethylidene-6-(2-hydroxybenzhydryl)amino-4-phenyl-1, 2,3, 4-14 (please Read the precautions on the back page and fill in this page. This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) -81 - 1322144 A7 B7 V. Invention description (7 orders (please read the notes on the back first) Fill in this page) Hydrogen-2,2,4-trimethylquinoline (20mg) and 3,5- Methylisoxazole-4-sulfonyl chloride (27 mg) in pyridine (2 ml) sulfonation yield: 14 mg. MS-ESI: [M+H]+=588.4; HPLC: Rt=14 · 46 minutes (method 1) Example 6 0 1 -Ethyl fluorenyl-6-(2-methoxycarbonylethyl oxooxy benzophenone) Amino-4 Tephenyl-1,2,3,4- Tetrahydro-2,2,4-trimethyl [1 quinoline according to the method described in Example 6. 1-Ethyl fluorenyl-6-(2-hydroxybenzylidene)amino-4-phenyl group 1, 2,3,4-tetrahydro-2,2,4-trimethylquinoline (20 mg) with methyl mercaptopropyl chloride (14 mg) and N,N-diisopropylethylamine (40 μL) was subjected to deuteration reaction in tetrahydrofuran (2 ml). Yield: 2 1. 4 mg. MS - ESI: [M+H]+ = 543. 6; Printed by the Intellectual Property Office of the Ministry of Economic Affairs 1^卩1^(::111 = 6.98 minutes (method 1) Example 6 1 1 ethyl hydrazino _6_ (2_ ί5_methylisoxazole-3 carbonyl) oxybenzimidamide _4_Phenyl-1,2,3,4_tetrakis-2,2,4_trimethylhydrazine quinine This paper scale applies to China National Standard (CNS) Α4 Grid (210X 297 mm) -82- 1322144 A7 B7 V. Inventive Note (Please read the back note first and then fill out this page) According to the method described in Example 6 with 1-ethyl ketone-6 - (2 -Hydroxybenzhydryl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (15 mg) and 5-methylisoxazole -3 - Carbonyl chloride (1Omg) and N,N-diisopropylethylamine (30 μL) were subjected to a oximation reaction in tetrahydrofuran (1 mL). Yield: 4.0 mg. MS - ESI : [M+H]+=538.4; HPLC: Rt = 9 · 84 min (method 1) Example 6 2 1 - ethyl hydrazine - 6 - (2_ ί2 - oxazolidinone - [5 - A a gas-based benzoylamino)amino-4-yl-phenyl-1,2,3,4-tetraindole-2,2,4-trimethyl porphyrin according to the method described in Example 39 Mercapto-6-(2-hydroxybenzimidyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylhydrazine (20 mg) 5_Chloromethyl-Ministry of Economics, Intellectual Property Office, Staff Consumer Cooperative, 2 oxazolidinone (7mg), carbonated (63mg) and tetrabutylammonium bromide (3Omg) in acetonitrile (1ml) Alkylation. Yield: 2 5 mg. MS - ESI : [M + H]+ = 542. 4; ^1?匕(::1^ = 8.21 min (method 1) Example 6 3 1 - Ethyl _6_ (2-[morpholine-4 —carbonyl]oxybenzamide This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) -83- 1322144 A7 B7 V. Description of invention (8) Base) Amino-4_phenyl- 1 , 2,3,4_tetrakis-2,2, 4-trimethylporphyrin (please read the note on the back and fill out this page). According to the method described in Example 6, 1-Ethyl-based 6_ (2-hydroxybenzhydryl)amino- 4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (15 mg) and morpholine_4_ The oximation reaction of carbonyl chloride (12 μL) and N,N-diisopropylethylamine (30 μL) in tetrahydrofuran (1 mL). Yield: 5.4 mg. MS - ESI: [Μ+ Η]+=542·4; HPLC: Rt=10 · 02 min (Method 1) Example 6 4 1 -Ethylamino-6-(2-anilinobenzylidene)amino- 4-phenyl- 1 , 2, 3, 4- four gas - 2,2,4-trimethylquinoline Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing according to Example 1 1 Method for 1 - ethyl fluorenyl-6-amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (15 mg) with N-phenyl Anthranilic acid (2 lmg) and N,N-diisopropylethylamine (3 3 μl) were subjected to HATU condensation in tetrahydrofuran (1 ml). Yield: 5.8 mg. MS-ESI: Μ+ Η]+=504·4; HPLC: Rt = 13 42 minutes (method 1) Example 6 5 This paper scale applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) -84- 1322144 A7 _B7_ V. Invention Description: 珣1 - acetyl -6 - (2 - pyrrolidinone - N - ethyl carbonyl) amine - 4 - phenyl - 1 ' 2, 3, 4 - 4 - 2, 2, 4 Dimethyst (please read the note on the back and fill out this page) Porphyrin (3) 1 - B-based 6-propane-burning amine ~ 4 A benzene a 1, 2, : ^}, 4氤, 2, 4, 4, a trimethyl porphyrin according to the method described in Example 6 as 1-ethyl fluorenyl-6-amino-4-phenyl-1,2'3,4-tetrahydro-2 , 2 '4-trimethyl [I-quinoline (0.12 g) with acryloyl chloride (39 μg) and N,N-diisopropylethylamine (0.21 ml) was subjected to a deuteration reaction in tetrahydrofuran (1 ml). Yield: 0.13 g. MS - ESI : [M + H]+=363.2 (b) 1-Ethyl-(2-pyrrolidone-N-?-, a fluorenyl)amine _4-phenylene-1' 2 3, 4_四氤—2,2, 4—Trimethylquinoline Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative printed in 2-pyrrolidone (19mg) and sodium hydride (18mg, 60% in oil) in THF (1 ml) a mixture of 1-ethyl fluorenyl-6-acrylamido-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethyl π-quinoline (8 mg) ) in THF (1 ml). After 18 hours of stirring, TLC analysis showed conversion to a higher fluidity product. The mixture was diluted with ethyl acetate and washed with water, 〇 5 N HCl 1 and water. The organic layer was dried (sodium sulfate) and concentrated in vacuo. Purified by helium gel column chromatography, using heptane / ethyl acetate. This paper scale is applicable to China National Standard (CNS) A4 specification (210X 297 mm) -85- 1322144 A7 B7 V. Description of invention = 8/ 2 = &gt;l/l (v/v) as eluent. Yield: 4.6 mg. (Please read the note on the back and fill out this page) MS — ESI : 〔M + H〕+ HPLC: Rt = 4.51 min (Method 2) Example 6 6 1 Ethyl thiol-6-(ethoxyethoxycarbonyl) amine _4 - Benzene 1 , 2, 3, 4- 4-gas-2,2,4-trimethylquinoline according to the method described in Example 6 5, with 2-ethoxyethanol (1 9 mg) and 1-ethylindolyl-6-acrylamidoamine-4 Monophenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (8 mg) was subjected to Michael addition in THF (1 ml). Yield: 1.0 mg. MS - ESI: [Μ + Η]+=453·4; HPLC: Rt = 5 . 03 min (Method 2) Example 6 7 1 -Ethyl- 6-(2-pyrrolidone-N-methoxycarbonyl) Printed by the Consumers' Cooperative of the Intellectual Property Office of the Ministry of Carbon Economy. Amino- 4-phenyl-1, 2, 3 4-tetrahydro-2,2,4-trimethyl p-quinoline N-hydroxymethyl-2-pyrrolidone (22 mg) and 1-ethylindenyl-6-(6) according to the method described in Example 11. Hydroxycarbonylmethylcarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4

甲基喹啉(15毫克)於HATU (29mg)及N,N 本纸張尺度適用中國國家標準(CNS &gt; A4規格(210X297公釐) ~ -86 - 1322144 A7 ____B7 五、發明説明(的 -二異丙基乙基胺(3 3微升)於四氫呋喃(2毫升)之 媒介下進行縮合作用。 產量:1 1毫克。 (諳先閲讀背面之注意事項再填寫本頁} MS-ESI : 〔 M + H〕+ =538.4 ; HPLC : Rt = 5 · 32 分鐘(方法 2) 實施例6 9 _1_—乙醯基—6 — ( 2 —呋喃甲氧羰某甲羰某)胺某一 ' 二_苹基—1 ’ 2 ,3 ,4 —四氫〜2 ,?. ,4 —二甲芊哼 Φ_ 根據實施例1 1所述方法,使糠醇(1 7微升)及1 —乙醯基—6 —(經鑛基甲羰基)胺基_ 4 —苯基—1 , 2,3 ,4 一四氫一 2 , 2,三甲基喹啉(15毫克 )於HATU (29mg)及N,N —二異丙基乙基胺( 3 3微升)於四氫呋喃(2毫升)之媒介下進行縮合作用 產量:7.1毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI: CM+H]+=475 . 4 ; HPLC : Rt = 5 3〇 分鐘(方法 2) 實施例7 〇 —(環丙某甲基胺甲羰某)胺某—4 —苯 ,4 一四氤-2,2,4 —三甲某哮啉 根據實施例2 9所述之方法,使環丙基甲胺(4 . 0 本纸張尺度適用中國國家標準(CNS )从胁(2丨〇&gt;&lt;297公瘦) -87- 1322144 A7 B7 五、發明説明(的 微升)與1 一乙醯基-6-(溴乙醯基)胺基一 4 —苯基 —1 ,2 , 3,4_四氫_2,2,4_三甲基喹啉( (請先閲讀背面之注意事項再填寫本頁) 1 Omg )及N,N ——異丙基乙胺(ι 3微升)於二氯 甲烷(1毫升)進行烷化作用。 產量:6 . 8毫克。 M S - E S I : [Μ + Η)+=535 . 6 ; HPlC : Rt = 6 · 29 分鐘(方法 2 ) 實施例7 1 丄二乙醯基-4— (2_甲氧苹基_) —6 — (4一苯基苯 甲麟某)胺基_1,2,3,4— I7q氤—2,2 , 4 -三 甲基啐啉 (a ) 1_乙醯基—6— (4 —苯某苯甲驢 丄2 —二氤一 2,2,4一三甲某 將1-乙醯基—6 —(第三丁氧羰基)胺基_ι,2 一二氫一 2,2 ’ 4 一三甲基曈啉(1 · 〇克)溶於三氟 經濟部智慧財產局員工消費合作社印製 醋酸/CH2C 12 (1/1 ’ v/v,25毫升)之混合 物中且攪拌2小時。將反應混合物於真空下濃縮,用醋酸 乙酯稀釋且用5 %碳酸氫鈉水溶液來淸洗。將有機層分離 ’脫水(硫酸鎂)且濃縮。將殘餘物溶於CH2C 12 ( 25毫升),加入N,N —二異丙基乙胺(5 · 2毫升) 及4 -苯基苯甲醯基氯(2 · 〇克)且將混合物攪拌1 6 小時。將混合物濃縮且以庚烷/醋酸乙酯=1 /〇 = &gt;0/1(v/v)爲洗脫劑在矽膠上層析。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -88 - 1322144 A7 _B7___ 五、發明説明(8Φ 產量:0 · 6 3克。 MS — ESI : 〔M+H〕+ =411. 2 (請先閱讀背面之注意事項再填寫本頁) (b ) 1 —乙醯基一 4 — (2 -甲氧苯某)- fi- f/i- 苯基苯甲醯基)胺基—1 ,2,3,4 —四氤一 2,2 , 4 一三甲基喹啉及1—乙醯基-4— (4 —甲氧.苯基)一 6-(4_苯基苯甲醯基)胺基一 1 ,2,3,4 —四氣 —2,2,4 —三甲基哮啾 根據實施例3所述方法,在存在A 1 C 13 (〇 . 5克 )下以茴香醚(25毫升,儲存在3埃分子篩上)與1 — 乙醯基—6— (4 —苯基苯甲醯基)胺基_1 ,2 -二氫 —2 ’ 2 ’ 4 -三甲基D奎啉(〇 · 5克)進行friedel-Crafts烷化作用。藉矽氧凝膠層析純化(洗脫劑:庚烷^/醋 酸乙酯=1/〇 = &gt;〇/1 ,v/v)產生2 —甲氧苯基 取代之衍生物爲其微量產物,及產生4 -甲氧苯基取代之 衍生物爲其主要產物。 產量:4 6毫克。 經濟部智慧財產局員工消費合作社印製 MS-ESI : 〔μ+Η〕+ = 518·0(2-甲氧苯基) 產量0 · 2 〇克。 MS — ES I : 〔μ+Η〕+ = 518. 1(4-甲氧苯基) 實施例7 2 4 — (4 —蹕苯基)_6-(4 一苯基苯甲 酶-棊_」1 ,?,卩,4 一四氫一 2 ,?. ,4 -三甲 本纸張尺度適用中國國家標準(CNS ) M規格(2丨0X297公釐^ -89 - 1322144 經濟部智慧財產局員工消費合作社印製 A7 B7五、發明説明(的 碁」1奎啾 在氮氣氛下於1—乙釀基—4 一(4 一甲氧苯基)-6— (4 —苯基苯甲醯基)胺基—1,2,3,4 —四氫 一2,2,4_三甲基喹啉(0 . 46克)於二氯甲烷之 冷卻(0°C)溶液中加入BB r 3。於室溫下攪拌3小時後 達到完全轉化。將混合物冷卻,加入1 Μ N a Ο Η直到 成爲鹼性Ρ Η値,接著加入醋酸乙酯且混合物用1 M HC 1來酸化。分離有機層,脫水(硫酸鎂且濃縮。 殘餘物在矽凝膠管柱上以庚烷/醋酸乙酯=1 /0 = &gt;0/1(ν/ν)作爲洗脫劑來層析。 產量0 . 1 3克。 MS-ESI : 〔Μ+Η〕+ =504.0 實施例7 3 1 一乙醯基—6- (5 -甲某菸鹼醯基)胺某_4_苯基 -1 ,2,3,4_四氤一2,2,4 —三甲某晻啉 根據實施例1 1所述方法,使1 _乙醯基- 6 -胺基 -4 一苯基一1 ,2 ,3 ,4-四氫一2 ,2 ,4-三甲 基η奎啉(0 . 1克)與5_甲基菸鹼酸(0 . 13克)於 HATU (0 · 18g)及Ν,Ν —二異丙基乙基胺( 0 · 2 8毫升)於二氯甲烷(2毫升)之媒介下進行縮合 作用。 產量:0 . 1 2克。 MS-ESI: 〔M + H〕+ =427.0 本纸張尺度適用中國國家標準(CNS &gt; A4規格(210x297公釐) &quot; (請先閲讀背面之注意事項再填寫本頁) -t _ l·— · -裝. 訂 1322144 A7 B7 五、發明説明(砷 實施例7 4 — F SH於試管內的牛物活件 化合物的F SH活性係在穩定地轉染有人類F SH受 器且共轉染有c AMP反應元件(CRE ) /指示螢火蟲 營光酶受器基因表現之引子之中國倉鼠卵巢細胞(CHO )上進行測試。將配體結合到G s -偶合的F S Η受器上 可以增加CAMP ’其回過頭來會誘使該螢光酶受體建構 物有較高的轉活化作用。該螢光酶訊號係使用螢光計數器 來定量。對於測試化合物,係評估其E C 5 0値(測試化 合物引起最大刺激反應之一半強度反應(5 0%)所需濃 度)。基於該等目的,所以使用軟體程式GraphPad PRISM, 第三版(GraphPad software Inc .,San Diego )。. 所有實施例化合物在低於1 0_5M下都有活性( (請先閲讀背面之注意事項再填寫本頁) E C 2 4 5 3 3 0 5 5 實施例 1,6 — 13,15,16,21- 3 6 5 7 37,45,46,48,50 — 5 8,6 1 ’ 6 3及6 4則顯示有低 値。 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -91 -Methylquinoline (15 mg) in HATU (29 mg) and N, N This paper scale applies to Chinese national standards (CNS &gt; A4 specification (210X297 mm) ~ -86 - 1322144 A7 ____B7 V. Invention description (of - Diisopropylethylamine (33 μL) was condensed under a medium of tetrahydrofuran (2 ml). Yield: 1 1 mg. (Please read the back note and fill out this page again) MS-ESI : 〔 M + H]+ = 538.4 ; HPLC : Rt = 5 · 32 min (Method 2) Example 6 9 _1_-Ethyl- 6-(2-furanmethoxycarbonyl carbonyl) a certain amine基基-1' 2,3,4-tetrahydro~2,?.,4-dimethylhydrazine Φ_ According to the method described in Example 11, sterol (17 μL) and 1-ethylidene group- 6 —(Organyl-carbonyl)amino-4-yl-phenyl-1, 2,3,4-tetrahydro-2, 2,trimethylquinoline (15 mg) in HATU (29 mg) and N,N - Diisopropylethylamine (33 μL) was condensed under a medium of tetrahydrofuran (2 ml). Yield: 7.1 mg. Ministry of Economic Affairs, Intellectual Property Office, Staff Consumer Cooperative, MS-ESI: CM+H]+ =475 . 4 ; HPLC : Rt = 5 3 〇 minutes (method 2) Example 7 〇-(cyclopropylmethylamine carbonyl) amine -4- benzene, 4 氤 4 氤-2, 2, 4 — trimethyl porphyrin According to the method described in Example 29, cyclopropylmethylamine (4.0 paper size is applied to the Chinese National Standard (CNS) from the threat (2丨〇&gt;&lt;297 mm) -87- 1322144 A7 B7 V. Description of the invention (microliter) and 1-ethyl fluorenyl-6-(bromoethenyl)amine- 4-phenyl-1,2,3,4-tetrahydro-2,2,4_ Trimethylquinoline ((Please read the note on the back and fill out this page) 1 Omg) and N,N - isopropylethylamine (iv 3 μl) in methylene chloride (1 ml) for alkylation Yield: 6.8 mg MS - ESI : [Μ + Η) += 535 . 6 ; HPlC : Rt = 6 · 29 minutes (method 2) Example 7 1 丄 醯 -4 4 - (2 _Methoxyethyl _) —6 — (4-phenylphenyl phenyl) Amino-1,2,3,4-I7q氤-2,2,4-trimethylporphyrin (a) 1_ Ethyl yl- 6-(4-phenylene benzoquinone 2 - bismuth 2, 2, 4 1-3, a 1-ethyl fluorenyl-6-(t-butoxycarbonyl)amine _ι,2 Dihydrogen-2,2 '4 Trimethyl porphyrin (1 · 〇克) Dissolved in the Ministry of Finance, Intellectual Property Bureau, Intellectual Property Bureau, Consumer Cooperative, Printing Acetic Acid/CH2C 12 (1/1 'v/v , 25 ml) of the mixture and stirred for 2 hours. The reaction mixture was concentrated in vacuo, diluted with ethyl acetate and rinsed with EtOAc. The organic layer was separated &apos; dehydrated (MgSO4) and concentrated. The residue was dissolved in CH2C12 (25 mL), N,N-diisopropylethylamine (5. 2 mL) and 4-phenylbenzhydryl chloride (2 · gram) were added and the mixture was stirred 1 6 hours. The mixture was concentrated and chromatographed on silica gel eluting with heptane / ethyl acetate = &lt;RTI ID=0.0&gt;&gt; This paper scale applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -88 - 1322144 A7 _B7___ V. Description of invention (8Φ Production: 0 · 6 3 g. MS — ESI : [M+H]+ =411 2 (Please read the note on the back and fill out this page) (b) 1 - Ethyl ketone 4- (2-methoxybenzoyl)-fi-f/i-phenylbenzylidene) Amino —1 , 2,3,4 —tetrakis-2,2,4-trimethylquinoline and 1-ethenyl-4—(4-methoxyphenyl)-6-(4-phenylbenzene Mercapto)amino-1,2,3,4-tetraki-2,2,4-trimethyloxime according to the method described in Example 3, in the presence of A 1 C 13 (〇. 5 g) Anisole (25 ml, stored on a 3 angstrom molecular sieve) and 1-ethylidene-6-(4-phenylbenzhydryl)amino-1,2-dihydro-2' 2' 4 -3 Methyl D-quinoline (〇·5 g) was subjected to friedel-Crafts alkylation. Purification by oxime oxygen gel chromatography (eluent: heptane / ethyl acetate = 1 / 〇 = &gt; 〇 /1, v / v) to give 2-methoxyphenyl substituted derivatives as their trace products And producing a 4-methoxyphenyl substituted derivative as its main product. Yield: 4 6 mg. MS-ESI: [μ+Η]+ = 518·0 (2-methoxyphenyl) Yield 0 · 2 gram. MS - ES I : [μ+Η]+ = 518. 1 (4-methoxyphenyl) Example 7 2 4 — (4-Phenylphenyl)_6-(4-Phenylbenzoylase-棊_" 1 ,?,卩,4,4,4,4,4,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3 Co-operatives printed A7 B7 V. Inventions (碁 碁 1) 1 啾 啾 under nitrogen atmosphere in 1 - ethyl aryl - 4 - (4-methoxyphenyl) - 6 - (4-phenylbenzhydryl) Amino-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline (0.46 g) was added to a cooled (0 ° C) solution of dichloromethane to add BBr3. After complete stirring at room temperature for 3 hours, complete conversion was achieved. The mixture was cooled, 1 Μ N a Ο 加入 was added until it became basic Ρ Η値, then ethyl acetate was added and the mixture was acidified with 1 M HCl 1. The organic layer was separated and dried. (MgSO4 and concentrated. The residue was chromatographed on a hydrazine gel column with heptane / ethyl acetate = 1 /0 = &gt; 0/1 (v/v) as eluent. Yield 0. 1 3克. MS-ESI : [Μ+Η]+ =504.0 Example 7 3 1 —6-(5-methyl nicotine decyl)amine _4_phenyl-1,2,3,4_tetraindole 2,2,4-trimethyl porphyrin according to Example 11. Method of making 1 _ acetyl -6-amino-4-phenyl- 1,2,3,4-tetrahydro-2,2,4-trimethyl η-quinoline (0.1 g) with 5 _Methylnicotinic acid (0.1 g) was carried out in a medium of HATU (0 · 18 g) and hydrazine, hydrazine-diisopropylethylamine (0 · 28 mL) in dichloromethane (2 mL) Condensation. Yield: 0.12 g. MS-ESI: [M + H]+ = 427.0 This paper scale applies to Chinese national standards (CNS &gt; A4 size (210x297 mm) &quot; (Please read the back Precautions Please fill out this page) -t _ l·- · - Packing. Book 1322144 A7 B7 V. INSTRUCTIONS (Arsenic Example 7 4 - F SH The F SH activity of the bovine material in the test tube is stable Tested on Chinese hamster ovary cells (CHO) transfected with human F SH receptors and co-transfected with c AMP response element (CRE) / indicative of firefly enzyme photoreceptor gene expression. G s - coupled FS Η receiver can add CAMP Which will induce back to the luciferase construct was higher in receptor activation turn. The luciferase signal using fluorescent-based quantitative counter. For test compounds, E C 50 値 was evaluated (the concentration required to test the compound for one of the maximum stimulatory reactions (50%)). For these purposes, the software program GraphPad PRISM, Third Edition (GraphPad software Inc., San Diego) was used. All of the example compounds are active below 10_5M ((Please read the back note first and then fill out this page) EC 2 4 5 3 3 0 5 5 Example 1,6 — 13,15,16,21 - 3 6 5 7 37,45,46,48,50 — 5 8,6 1 ' 6 3 and 6 4 show low opinion. The Intellectual Property Office of the Ministry of Economic Affairs, the Consumers' Cooperatives, prints the paper scale for Chinese national standards ( CNS ) Α 4 Specifications (210Χ297 mm) -91 -

Claims (1)

1322144 A8 B8 C8 D8 六、申請專利範圍1 附件3 : 第9 1 1 1 1 887號專利申請案 中文申請專利範圍替換本 ^^年繼正碰产 1 ·—蒱田於坊法丨丨4r杳士々π &amp;护,芦户恬备T 之四氫哇啉衍生物或其藥學可接受之鹽類,1322144 A8 B8 C8 D8 VI. Application for Patent Scope 1 Attachment 3: Patent Application No. 9 1 1 1 1 887 Patent Application Replacement of this patent ^^年继正正产1 ·—蒱田于坊法丨丨4r杳々 々 &; 护, 芦 恬 T 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 式I . 其中 R1爲甲醯基、(1 一 6C)烷羰基或(1 — 6C)烷磺醯 基; R2及R3爲Η或(1 一 4C)烷基; R4爲苯基,其隨意地被一或多個取代基所取代,該取代基 係選自羥基,胺基,鹵素,硝基,三氟甲基,氰基,(1 —4C)烷基,(2 — 4C)烯基,(2 — 4C)炔基, (1 一 4C)烷氧基,(1 — 4C)(二)烷胺基; R5爲(1-4C)烷基; Υ — X 爲 c(o)-〇,s(o)2-o, NHC (〇) - 〇 ' NHC (S) - 0 · 0C (0) - 0 ,鍵 _〇,C (〇)一NH,S ( 0 ) 2 - N Η -NHC (〇) - ΝΗ ’NHC (S) - ΝΗ, i紙張尺度適用中國國家標準(CNS)A4规格(210x297公釐) 為 (請先閲,背面之注意事項再填寫本頁) -'s 4. 經濟部智慧財產局員工消費合作社印製 J 1322144 8 8 8 8 ABCD 七、申請專利範圍2 〇 C ( 〇 ) — N Η ,鍵- -Ν Η,Ν Η -C ( 0 j 〇 — C ( 〇 ) Ν Η — S (0 ); 1 » 或0 一 S ( 〇 )2 5 或 X — Y 表 示 鍵 » R 6爲氫 (但排除掉Y - X 爲鍵) 三氟甲基, :1 — 6 C ) 烷 基 &gt; 1 — 或 2 — 金 剛- 院基( 1 -4 C ) 院 基, ( 2 — 6 C ) 烯 基 f ( 2 — 6 C )炔基 5 (3 - 9 C ) 雜 芳 基 , ( 3 — 6 C ) ΤΞΙ 壞 院 基 j ( 2-6 C )雜環烷基, ( 1 — 4 • C ) 烷 硫 ( 1 — 4 C ) 院 基,.( 6 - -1 0 C ) 芳 基 ( 1 — 4 C ) 院 基 ( 3 — 9 c )雜芳 基 (1 - 4 C ) 院 基 y ( 3 — 6 C ) 環 烷 基 ( 1 — 4 C ), 院基,( 2 — 6 C ) 雜 環 烷 基 ( 1 — 4 C ) 院 基 ,R 8,R 9 -胺羰基( 1 — 4 C ) 烷 基 R 8 ,R 9 — 胺 基 ( 1-4 C )院基 ,R 8 — 氧 琢 基 ( 1 — 4 C ) 烷 基 , R — 氧基( 1 一 4 C )烷基 R 8 — γμ&gt; fSk 基 ( 1 — 4 C ) 院 基 或 (6 - 1 0 C ) 芳 基 y 然 而 若 ( 6 — 1 0 C ) 芳基是苯基 苯基可隨意地 被 羥 基 &gt; 胺 基 » m '鹵 素 硝 基 y 二 氟 甲 基 氰基, ( 1 - 4 C ) 烷 基 , ( 2 — 4 C ) 烯 基 ( 2 — 4 C ) 炔 基, ( 1 — 4 C ) 烷 經 氧 基 ( 1 一 4 C ) ( — )烷胺 基 ,( 6 — 1 0 C ) 芳 濟‘ 部 智 基 &gt; ( 6 — 1 0 C ) 芳 氧 基,( 6 -1 0 C ) 芳 基 ( 1 慧 財 — 4 C ) 烷 氧 基 &gt; ( 3 — 9 C ) 雜 芳基 j ( 3 一 9 C ) 產 局 員 雜 芳 氧 基 ( 3 — 9 C ) 雜 芳基, ( 1 - 4 C ) 院 氧 基 &gt; X 消 費 ( 1 _ 4 C ) 垸 振 基 胺 基 ,(1 _ 4 C ) 烷 羰 氧 基 ( 合 作 3 — 6 C ) 環 烷 m 氧 基 5 (1 - 4 C ) 烷 氧 山 振 基 ( 1 — 社 印 製 4 C ) 烷 氧 报 氧 基 , ( 1 -4 C ) 烷氧 基 ( 1 4 C ) 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先聞臂背面之注意事項再填寫本頁) -2- 以144 A8 B8 C8Wherein R1 is indolyl, (1-6C)alkylcarbonyl or (1-6C)alkylsulfonyl; R2 and R3 are deuterium or (1 -4C)alkyl; R4 is phenyl, optionally Substituted by one or more substituents selected from the group consisting of hydroxyl, amine, halogen, nitro, trifluoromethyl, cyano, (1-4C)alkyl, (2-4C)alkenyl, (2 - 4C) alkynyl, (1 - 4C) alkoxy, (1-4C) (di)alkylamino; R5 is (1-4C)alkyl; Υ - X is c(o)-〇, s(o)2-o, NHC (〇) - 〇' NHC (S) - 0 · 0C (0) - 0 , key _〇, C (〇)-NH,S ( 0 ) 2 - N Η -NHC (〇) - ΝΗ 'NHC (S) - ΝΗ, i The paper size applies to the Chinese National Standard (CNS) A4 specification (210x297 mm). (Please read it first, and then fill in the back of this page) -'s 4. Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed J 1322144 8 8 8 8 ABCD VII. Patent Application 2 〇C ( 〇) — N Η , Key - -Ν Η, Ν Η -C ( 0 j 〇 - C ( 〇 ) Ν Η — S (0 ); 1 » or 0 a S ( 〇) 2 5 or X — Y means the key » R 6 is (but exclude Y-X as a bond) Trifluoromethyl, :1 - 6 C ) Alkyl&gt; 1 — or 2 — King Kong - Dean (1 -4 C ) Institute, ( 2 - 6 C ) Alkene Base f ( 2 - 6 C ) alkynyl 5 (3 - 9 C ) Heteroaryl, ( 3 - 6 C ) ΤΞΙ Bad Institute J ( 2-6 C ) Heterocycloalkyl, ( 1 - 4 • C ) Alkyl sulfide ( 1 - 4 C ), (6 - -1 0 C ) aryl ( 1 - 4 C ) (3 - 9 c ) heteroaryl (1 - 4 C ) — 6 C ) cycloalkyl ( 1 — 4 C ), fen, ( 2 — 6 C ) heterocycloalkyl ( 1 — 4 C ), R 8 , R 9 —amine carbonyl ( 1 — 4 C ) Alkyl R 8 , R 9 —amino( 1-4 C ), R 8 —oxyindolyl ( 1 - 4 C )alkyl, R —oxy( 1 4 C )alkyl R 8 — γμ&gt ; fSk group ( 1 - 4 C ) or (6 - 10 C ) aryl y However, if ( 6 - 1 0 C ) aryl is phenylphenyl optionally hydroxy > amine » m ' Halogen nitro y difluoromethyl cyano, ( 1 - 4 C ) alkyl, ( 2 - 4 C ) alkenyl ( 2 - 4 C ) alkynyl, ( 1 4 C ) alkoxy group (1 - 4 C ) (-) alkylamino group, (6 - 1 0 C) arylji 'trim base> (6 - 1 0 C) aryloxy, (6 -1 0 C) aryl (1 huicai-4 C) alkoxy&gt; (3-9C) heteroaryl j (3-9C) hydroxyaryl (3-9C) heteroaryl, ( 1 - 4 C ) oxime &gt; X consumption ( 1 _ 4 C ) oxime-based, (1 _ 4 C ) alkoxycarbonyl (co- 3-6 C) cycloalkane moxy 5 (1 - 4 C ) alkoxy oxane (1 - 4C printed by ASD) alkoxyoxy, ( 1 -4 C ) alkoxy ( 1 4 C ) This paper scale applies to China National Standard (CNS) A4 specification (210X297 mm) (Please note the back of the arm before filling in this page) -2- to 144 A8 B8 C8 '申請專利範圍3 院幾氧基’ (6 一 10C)芳羰氧基,(3 — 9C)雜 芳绩氧基’ (1— 4C)烷磺醯氧基,(6 — 10C) (請先閲讀背面之注意事項再填寫本頁) ^嘴隨氧基,(3 一 9C)雜芳基磺醯氧基,(1-4 Q \ — (二)烷基氨基甲醯基’ (6 — 10C)(二)芳 @氨&lt; 基甲醯基,(2 — 6C)雜環烷基氨基甲醯基,( g 〜10C)(二)芳基胺基,(3 — 6C)環烷基, (^ 6C)環烷基(1-4C)烷基 ’ (2 — 6C) 雜環院基或(2 一 6C)雜環烷基(1 — 4C)烷基取 代 、 ’及然而R6中之所有芳基及雜芳基可隨意地被一或多 個取代基所取代,該取代基係選自羥基,胺基,鹵素, 硝基’三氟甲基,氰基,(1 — 4C)烷基,(2 — 4 C)靖基’ (2 - 4C)炔基,(1 — 4C)烷氧基或 (1 ~ 4 c )(二)烷胺基; R7爲氫’ (1 — 4C)烷基,(1-4C)烷氧基,鹵素 ’三氟甲基,氰基,硝基,羥基;及 經濟部智慧財產局員工消費合作社印製 R8及/或R9爲氫,(1 — 4C)烷基,(2 — 4C)烯 基’ (2-4C)炔基,(6-10C)芳基,(3-9 C)雜芳基,(6 — i〇c)芳基(1 — 4C)烷基,( 3 — 9C)雜芳基(1 — 4c)烷基,(3 - 6C)環烷 基(1 — 4C)烷基,(2-6C)雜環烷基(1 — 4C )烷基,(1 — 4C)(二)烷胺基(1-4C)烷基, (1 — 4C)烷氧基(1 一 4C)烷基,(1 — 4C)烷 硫基(1 — 4C)烷基,(1-4C)烷羰胺基(1 一 4 C)烷基,(1 — 4C)烷氧羰基(1 — 4C)烷基,( 本纸張尺度逋用中國國家標準(CNS ) A4規格(210X297公釐) -3- 1322144 經濟部智慧財產局員工消費合作社印製 Α8 Β8 C8 D8 六、申請專利範圍4 1— 4C)院氧羰胺基(i-4C)烷基,(3 — 6C) 環烷基’(2 — 6 C)雜環烷基或R8及R9可聯合成—個 (2 — 6C)雜環烷基之環,其中每—(3_9(:)雜芳 基意指咪唑基、噻二唑基、吡啶基、噻吩基、苯並噻吩基 、呋喃基、苯並呋喃基、喹啉基、四氫喹啉基、喹噁啉基 或吲哚基,及 每一(2 — 6 C )雜環烷基意指哌啶基、嗎啉基或吡咯啶 基。 2 · —種如下式I之四氫喹啉衍生物或其藥學可接受 之鹽類, 6'Application for patent range 3 Institute of oxy-(6-10C) arylcarbonyloxy, (3-9C) heteroaryl oxy '(1-4C) alkanesulfonyloxy, (6-10 C) (please first Read the precautions on the back page and fill in this page) ^Acetyloxy, (3-9C) Heteroarylsulfonyloxy, (1-4 Q \ - (di)alkylcarbamoyl' (6 - 10C (2) aryl@amino&lt; mercapto, (2-6C)heterocycloalkylcarbamoyl, (g~10C)(di)arylamino, (3-6C)cycloalkyl, (^ 6C)cycloalkyl(1-4C)alkyl' (2-6C) heterocyclic or (2-6C)heterocycloalkyl(1-4C)alkyl substituted, 'and yet all of R6 The aryl and heteroaryl groups may be optionally substituted by one or more substituents selected from the group consisting of hydroxyl, amine, halogen, nitro 'trifluoromethyl, cyano, (1-4C)alkyl , (2 - 4 C) Jingji' (2 - 4C) alkynyl, (1 - 4C) alkoxy or (1 ~ 4 c ) (di)alkylamino; R7 is hydrogen '(1 - 4C) alkyl , (1-4C) alkoxy, halogen 'trifluoromethyl, cyano, nitro, hydroxy; and Ministry of Economic Affairs Intellectual Property Bureau R&D Co., Ltd. printed R8 and/or R9 as hydrogen, (1-4C)alkyl, (2-4C)alkenyl '(2-4C)alkynyl, (6-10C)aryl, (3-9 C Heteroaryl, (6 - i〇c) aryl (1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl (1-4C) Alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (1-4C)(di)alkylamino(1-4C)alkyl, (1-4C)alkoxy (1) a 4C) alkyl group, (1-4C)alkylthio(1-4C)alkyl, (1-4C)alkylcarbonylamino (1-4C)alkyl, (1-4C)alkoxycarbonyl (1) — 4C) Alkyl, (This paper scale uses Chinese National Standard (CNS) A4 specification (210X297 mm) -3- 1322144 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed Α8 Β8 C8 D8 VI. Patent application scope 4 1—4C) oxycarbonylamino (i-4C) alkyl, (3-6C) cycloalkyl '(2-6 C)heterocycloalkyl or R8 and R9 may be combined into one (2-6C) a ring of a heterocycloalkyl group, wherein each -(3_9(:)heteroaryl means imidazolyl, thiadiazolyl, pyridyl, thienyl, benzothienyl, furanyl, Benzofuranyl, quinolinyl, tetrahydroquinolinyl, quinoxalinyl, or indolyl, and each of the (2 - 6 C) heterocycloalkyl means a piperidinyl, morpholinyl or pyrrolidinyl. 2 - a tetrahydroquinoline derivative of the following formula I or a pharmaceutically acceptable salt thereof, 6 R3 2 式i 其中 R1爲甲醯基、(1 — 6C)烷羰基或(1 — 6C)烷磺酿 基; R2及R3爲Η或(1 — 4C)烷基; R 4爲苯基’其隨意地被一或多個取代基所取代,該取代基 係選自羥基’胺基,鹵素,硝基,三氟甲基,氰基,(1 -4C)烷基,(2-4C)烯基,(2 — 4C)炔基, (1 — 4C)烷氧基,(1 一 4C)(二)烷胺基; 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) — — — — — — — 裝 I I I I 訂 I I I 線 (請先聞·«背面之注意事項再填寫本頁) -4- 1322144 A8 B8 C8 D8 六、申請專利範圍5 R5爲(1— 4C)烷基; Y — X 爲 C(0)-0,S(0)2-0, (請先閲部背面之注意事項再填寫本頁) NHC (〇)一 〇,NHC (S)— 0,〇C (0)_0 ,鍵一〇,C (0)— NH,S (〇)2-NH, NHC (O)-NH &gt; NHC (S) - N H &gt; OC (〇)一NH ,鍵一NH ,NH — C (0), 0 - C ( 0 ) ,1^11-3(0)2,或〇一3(〇)2,或 X _ Y表示鍵; R6爲氫(但排除掉Y-X爲鍵),三氟甲基,(1 — 6C) 烷基,1 一或2 —金剛烷基(1_4C)烷基,(2_6 C)烯基,(2_6C)炔基,(3_9C)雜芳基,( 3 — 6C)環烷基,(2-6C)雜環烷基,(1 — 4C )烷硫(1 — 4C)烷基,(6 — 10C)芳基(1 — 4 C)烷基,(3 — 9C)雜芳基(1 — 4C)烷基,(3 一 6C)環烷基(1 — 4C)烷基,(2-6C)雜環烷 基(1 — 4C)烷基,R8,R9—胺羰基(1 — 4C)烷 基,R8,R9 —胺基(1 一 4C)烷基,‘R8 —氧羰基( 經濟部智慧財產局員工消費合作社印製 1 — 4C)烷基,R8 —氧基(1 — 4C)烷基,R8 -羰 基(1 — 4C)烷基或(6 — 10C)芳基然而若(6_ 1 0 C)芳基是苯基,苯基可隨意地被羥基,胺基,鹵素 ,硝基,三氟甲基,氰基,(1一4C)烷基,(2— 4C)烯基,(2—4C)炔基,(1—4C)烷氧基 ,(1 - 4 C )(二)烷胺基,(6 — 10C)芳基, (6 — 10C)芳氧基,(6 — 10C)芳基,(1 一 本纸張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) -5- 1322144 A8 B8 C8 D8 經濟部智慧財產局員工消費合作社印製 六 、申請專利範圍 6 1 1 4 C ) 院 氧 基, ( 3 - 9 C ) 雜 芳基, ( 3 — 9 C ) 雜 1 1 芳 氧 基 &gt; ( 3 - 9 C ) 雜 芳 基 ( 1 — 4 C ) 烷 氧 基 , ( 1 I 1 — 4 C ) 烷羰基胺基 ( 1 — 4 C ) 烷 W. 氧 基 ( 3 諸 1 先 1 _ 6 C ) 環 院鑛 氧 基, ( 1 _ 4 C )烷氧羰基 ( 1 — 4 聞 讀 1 1 C ) 烷 氧 W. 氧基 (1 — 4 C ) 院氧基 ( 1 _ 4 C ) 烷 背 1 I 之 1 f m. 氧 基 &gt; ( 6 - 1 0 C ) 芳 ·¥,山 Μ 氧 基,( 3 — 9 C ) 雜 芳 注 意 事 1 Μ 氧 基 ( 1 - 4 C ) 烷磺醯氧基,( 6 — 1 0 C ) 芳 項 再 1 % 1 磺 醯 氧 基 , (3 — 9 C ) 雜芳基磺醯氧基 &gt; ( 1 — 4 C 寫 本 裝 頁 1 ) ( 二 ) 烷 基氨 基 甲醯 基 ) ( 6 -10 C ) ( 二 ) 芳 基 1 氨 基 甲 醯 基 ,( 2 —6 C ) 雜環烷基氨基甲醯基 ( 6 1 1 — 1 0 C ) (二 ) 芳基胺基 5 ( 3-6 C ) 環 烷 基 ( 1 1 3 — 6 C ) 環烷基 (1 — 4 C ) 烷基, ( 2 — 6 C ) 雜 訂 I rm 壞 烷 基 或 ( 2 - 6 C ) 雜 環 烷 基 (1 一 4 C ) 烷基取代 1 1 I » 及 然 而 R 6中之所有芳基及雜芳基可隨意地被 一 或多個 I 1 取 代 基 所 取 代, 該取代基係選 白 羥基, 胺 基 鹵 素 5 硝 1 1 基 二 氟 甲 基, 氰 基, ( 1 — 4 C )烷 基 5 ( 2 ^v 4 C 線 | ) 烯 基 ( 2 - 4 C ) 炔 基 ( 1-4 C ) 院 氧 基 或 ( 1 I 1 — 4 C ) (二 )烷胺基 » 1 1 I R 7爲氫, ( 1 - 4 C ) 烷基 5 ( 1 - 4 C ) 院氧基 J 鹵素 1 1 &gt; 二 氟甲基 ,氰基, 硝基, 羥基 r 及 1 1 R 8及/或R 9爲氫 ,( 1 _ 4 C〕 烷基, ( 2 — 4 C ) 烯 1 | 基 ) ( 2 — 4 C )炔基 &gt; (6 - -1 0 C ) 芳基 &gt; ( 3 — 9 1 I C ) 雜芳基 ,( 6 -1 3 C ) 芳基(1 一 4 C ) 烷基 &gt; ( 1 1 3 — 9 C ) 雜芳基 (1 - 一 i 4 C ) 烷基,( 3 — 6 C ) 環烷 1 1 1 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -6- 1322144 A8 B8 C8 D8 申請專利範圍 7 基(1 — 4C)烷基,(2-6C)雜瓌垸基(1 — 4C )烷基,(1 — 4C)(二)烷胺基(1 — 4C)烷基, (1—4C)烷氧基(1-4C)烷基 ’ (1—4C)烷 硫基(1 — 4C)烷基,(1 一 4C)烷羰胺基(1 一 4 C)烷基,(1— 4C)烷氧羰基(1 一 4C)烷基,( 1 一 4C)烷氧羰胺基(1 一 4C)烷基’ (3 - 6 C ) 基,(2 — 6C)雜環烷基或R8及R9可聯合成一個 —6 C)雜環烷基之環, 環烷 (2 其中每一(3 — 9 C)雜芳基意指咪唑基 啶基 基 、噻吩基、苯並噻吩基、呋喃基 '苯並 四氫喹啉基、喹噁啉基或吲哚基,及 噻二唑基、吡 呋喃基、唾啉 每一(2 — 6 C )雜環烷基意指哌啶基、嗎啉基或吡咯啶 基 苯甲醯基胺 但條件爲該衍生物不爲1 _乙醯基一 6 基一4 — (4 —甲基苯基)一1 ,2,3 ’ 4 —四氫一2 ,2,4_三甲基11奎啉,1—乙醯基_4_苯基一1 ’ 2 4-四氫一2 ,2,4,6 —四甲基D奎琳,1-乙 請 先 閲 面 之 注 I 訂 經濟部智慧財產局員工消費合作社印製 ,3 醯基-4—苯基_1,2,3,4 一四氫—2,2 6, 基一 1 - -1 一乙 4 一 4 8 —五甲基D奎啉’ 1 一乙酿基一 甲氧基一4 一苯 1 ,2 ,3 ,4 —四氫一2 ,2,4 -三甲基喹琳, 乙酿基一 6 —三氟乙酿胺基_ 4 — ( 4 —甲基苯基) ,2,3 ,4 一四氫-2,2 ,4 —三甲基喹啉,1 醯基一 6 —三氟乙醯胺基—4_苯基—1,2,3, 四氫一 2 ’ 2 ’ 4 一三甲基11奎啉’ 1—乙酸基一4 — 本纸張尺度適用中國國家標準(CNS)A4规格(210&gt;&lt;297公着) 7- 1322144 A8 B8 C8 D8 六、申請專利範圍8 (4 —氯苯基)—1 ,2 ,3 ,4 —四氫一 2,2,4 6 -四甲基咱啉,1一乙醯基—4 — (4 一溴苯基)一 4 一四氫一2,2 6 -四甲基D奎啉 —乙醯基—6 -胺基一4_ (4 —胺基苯基)一1 ,2, 3 ’ 4 一四氫一2 ,2 ,4 —三甲基喹啉、6 —胺基一1 —乙基羰基一4 —苯基)一1 ,2,3,4 —四氫_2, 2 ’ 4一三甲基喹啉、1-乙醯基一6-胺基_4_苯基 -1 2 4 —四氫一2 ,2,4_三甲基π奎琳 經濟部智慧財產局員工消費合作社印製 3 .如申請專利範圍第2項之四氫喹啉衍生物或其藥 學可接受之鹽類,其中Y — X爲C (0) _NH,0C ( 〇)一N Η或 C ( 0 ) — 〇。 4 ·如申請專利範圍第2或3項之四氫喹啉衍生物或 其藥學可接受之鹽類,其中γ_χ爲C(0)—ΝΗ。 5 .如申請專利範圍第2或3項之四氫喹啉衍生物或 其藥學可接受之鹽類,其中ri爲(1 — 4 C)烷羰基。 6 .如申請專利範圍第2或3項之四氫喹啉衍生物或 其藥學可接受之鹽類,其中R2,R3及R5各自爲(1 _ 4 C )烷基。 7 .如申請專利範圍第2或3項之四氫喹啉衍生物或 其藥學可接受之鹽類,其中R6爲(6 — 1 0C)芳基,( 3 — 9 C )雜芳基 6 — 10C)芳基(1-4C)烷 基或(3 — 9C)雜芳基(1 — 4C)烷基,然而若(6 一 1 0 C )芳基是苯基,苯基可隨意地被羥基,胺基,鹵 本·纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲请背面之注意事項再填寫本頁) -8- 1322144 A8 B8 C8 D8 六、申請專利範圍9 素’硝基,三氟甲基,氰基,(1 — 4C)烷基, — 4C)烯基,(2 — 4C)炔基,(1 — 4c) 基’ (1-4C)(二)烷胺基,(6 — l〇c)芳基 ,(6 — 10C)芳氧基,(6 — 10C)芳基( 4C)烷氧基,(3 — 9C)雜芳基,(3 — 9C 芳氧基’ (3 — 9C)雜芳基(1 — 4C)烷氧基 1 — 4C)烷羰基胺基,(1—4C)烷羰氧基, 一 6C)環烷羰氧基,(i_4C)烷氧羰基(1 C)烷氧羰氧基,(1-4C)烷氧基(1— 4C (2 烷氧 1 - 雜 (3 -4 請 先 閲 讀 背 之 注 意 事 項 再 羰氧基, 羰氧基, 磺醯氧基 6 — 10C)芳羰氧基 1—4C)烷磺醯氧基 3 — 9 C )6 - 1 〇 c 3 — 9 C)雜芳基磺醯氧基 (6 - 1 0 C ) 經濟部智慧財產局員工消費合作社印製 氨基甲醯基,(2-6C)雜環烷基氨基甲醯基, —10C)(二)芳基胺基,(3 — 6C)環烷基 3 — 6C)環烷基(1 — 4C)烷基,(2 — 6c 環烷基或(2 - 6)雜環烷基(1 _4C)烷基取 及然而R6中之所有芳基及雜芳基可隨意地被一或$ 代基所取代,該取代基係選自羥基,胺基,鹵素, 氟甲基,氰基 1 — 4 C )院基 烯基,(2 _ 4 C )炔基 一 4 C )(二)烷胺基。 )烷 雜芳 )芳 4 C 芳基 智 訂 2 4 )雜 代, 個取 硝基 C 、 1 — 4C)烷氧基或 8·如申請專利範圍第2項之四氫喹啉衍生物_ 學可接受鹽類,其係用於生育力控制。 其藥 本纸張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) -9R3 2 Formula i wherein R1 is indolyl, (1-6C)alkylcarbonyl or (1-6C)alkylsulfonyl; R2 and R3 are deuterium or (1-4C)alkyl; R4 is phenyl' Optionally substituted with one or more substituents selected from the group consisting of hydroxy 'amine, halogen, nitro, trifluoromethyl, cyano, (1-4C)alkyl, (2-4C) olefin Base, (2 - 4C) alkynyl, (1 - 4C) alkoxy, (1 - 4C) (di) alkylamine; This paper scale applies to Chinese National Standard (CNS) Α 4 specification (210X297 mm) - — — — — — Install IIII Set III line (please smell the first note on the back page) -4- 1322144 A8 B8 C8 D8 VI. Patent application scope 5 R5 is (1-4C) alkyl; Y — X is C(0)-0, S(0)2-0, (please read the note on the back of the section first.) NHC (〇)〇, NHC (S) — 0, 〇C (0 )_0, key one 〇, C (0) - NH, S (〇) 2-NH, NHC (O)-NH &gt; NHC (S) - NH &gt; OC (〇)-NH, bond-NH, NH — C (0), 0 - C ( 0 ) , 1^11-3(0) 2, or 〇 3 (〇) 2, or X _ Y represents a bond; R6 is hydrogen (but exclude YX as a bond), trifluoromethyl, (1 - 6C) alkyl, 1 or 2 - adamantyl (1_4C) alkyl, (2_6 C)alkenyl, (2_6C) alkynyl, 3_9C)heteroaryl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl, (1-4C)alkylthio(1-4C)alkyl,(6-10C)aryl (1— 4 C) alkyl, (3 - 9C)heteroaryl (1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl (1 - 4C) alkyl, R8, R9-amine carbonyl (1-4C)alkyl, R8, R9-amino (1 - 4C) alkyl, 'R8 - oxycarbonyl (Ministry of Commerce, Intellectual Property Office, Staff Consumer Cooperative, Printed 1 — 4C)alkyl, R 8 —oxy(1-4C)alkyl, R 8 —carbonyl(1-4C)alkyl or (6—10C)aryl, whereas (6—10 C)aryl is phenyl, The phenyl group may be optionally hydroxy, amine, halogen, nitro, trifluoromethyl, cyano, (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (1 — 4C) alkoxy, (1 - 4 C ) (di)alkylamino, (6 - 10C) aryl, (6 - 10C) aryloxy, (6 - 10C) aryl, (1 a paper Zhang scale Applicable to China National Standard (CNS) A4 Specification (210X297 mm) -5- 1322144 A8 B8 C8 D8 Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Printed VI. Application Patent Range 6 1 1 4 C ) College Oxygen, (3 - 9 C ) Heteroaryl, ( 3 — 9 C ) hetero 1 1 aryloxy &gt; ( 3 - 9 C ) Heteroaryl ( 1 - 4 C ) alkoxy, ( 1 I 1 - 4 C ) alkylcarbonyl Amino ( 1 - 4 C ) alkane W. oxy (3 s 1 first 1 _ 6 C ) oxime ore, ( 1 _ 4 C ) alkoxycarbonyl ( 1 - 4 read 1 1 C ) alkoxy W. oxy (1 - 4 C ) alkoxy ( 1 _ 4 C ) alkane back 1 I 1 f m. oxy &gt; ( 6 - 1 0 C ) aryl·¥, hawthorn oxy, (3 — 9 C ) Heterofang Notes 1 Μ oxy ( 1 - 4 C ) alkane sulfonyloxy, ( 6 — 1 0 C ) aryl term again 1 % 1 sulfonyloxy, (3 - 9 C ) heteroaryl Alkyl sulfonyloxy&gt; (1 - 4 C Write a page 1) (b) Alkylaminomethyl hydrazino) (6 -10 C ) (b) aryl 1 Amino Mercapto, ( 2 - 6 C ) heterocycloalkylcarbamoyl ( 6 1 1 - 1 0 C ) (di) arylamine 5 ( 3-6 C ) cycloalkyl ( 1 1 3 - 6 C) cycloalkyl (1 - 4 C ) alkyl, ( 2 - 6 C ) miscellaneous I rm bad alkyl or ( 2 - 6 C ) heterocycloalkyl (1 - 4 C ) alkyl substituted 1 1 I And, however, all of the aryl and heteroaryl groups in R 6 may be optionally substituted with one or more I 1 substituents selected from the group consisting of a white hydroxy group, an amine halogen 5 nitro 1 1 dimethyl difluoromethyl group, Cyano, ( 1-4 C )alkyl 5 ( 2 ^v 4 C 线 | ) alkenyl ( 2 - 4 C ) alkynyl ( 1-4 C ) alkoxy or ( 1 I 1 - 4 C ) ( 2) alkylamino group » 1 1 IR 7 is hydrogen, ( 1 - 4 C ) alkyl 5 ( 1 - 4 C ) alkoxy J halogen 1 1 &gt; difluoromethyl, cyano, nitro, hydroxy And 1 1 R 8 and/or R 9 are hydrogen, ( 1 _ 4 C) alkyl, ( 2 - 4 C ) olefin 1 | group) ( 2 - 4 C ) alkynyl group > (6 - -1 0 C ) aryl &gt; ( 3 — 9 1 IC ) Heteroaryl, ( 6 -1 3 C ) aryl (1 - 4 C ) alkyl &gt; ( 1 1 3 — 9 C ) Heteroaryl (1 - i 4 C ) alkyl, ( 3 — 6 C ) naphthenic 1 1 1 This paper scale applies to Chinese National Standard (CNS) A4 size (210X297 mm) -6 - 1322144 A8 B8 C8 D8 Patent Application No. 7 base (1-4C) alkyl, (2-6C)heteroalkyl (1-4C)alkyl, (1-4C)(di)alkylamine (1 — 4C) alkyl, (1-4C)alkoxy(1-4C)alkyl'(1-4C)alkylthio(1-4C)alkyl, (1-4C)alkylcarbonylamine (1 -4) C) alkyl, (1-4C) alkoxycarbonyl (1-4C)alkyl, (1-4C) alkoxycarbonylamino (1-4-C)alkyl' (3-6C) group, (2 - 6C) Heterocycloalkyl or R8 and R9 may be combined to form a ring of -6 C)heterocycloalkyl, cycloalkane (2 wherein each (3-9 C)heteroaryl means imidazolylridyl, thiophene Benzo, benzothienyl, furyl 'benzotetrahydroquinolyl, quinoxalinyl or fluorenyl, and thiadiazolyl, pyrrolyl, porphyrin (2-6C) heterocycloalkane Base means piperidinyl, morpholinyl or pyrrolidinylbenzimidylamine, provided that the derivative is not 1 _ethyl fluorenyl- 6 4-(4-methylphenyl)-1,2,3'4-tetrahydro-2,2,4-trimethyl-11-quinoline, 1-ethenyl_4_phenyl-1' 2 4-tetrahydro-2,2,4,6-tetramethyl D-quine, 1-B, please read the note first I. Printed by the Intellectual Property Office of the Ministry of Economic Affairs, employee consumption cooperative, 3 thiol-4-phenyl _1,2,3,4-tetrahydro-2,2 6, ki- 1 - -1 - ethane 4 - 4 8 -pentamethyl D-quinoline ' 1 -ethyl keto-methoxy- 4- benzene 1 , 2 , 3 , 4 - tetrahydro - 2 , 2 , 4 - trimethylquinine , ethyl aryl - 6 - trifluoroethylamino _ 4 - ( 4 - methylphenyl ) , 2 , 3 , 4 tetrahydro-2,2,4-trimethylquinoline, 1 fluorenyl-6-trifluoroacetamido- 4-phenyl- 1,2,3, tetrahydro- 2' 2 ' 4 Trimethyl 11 quinolin ' 1 -acetate - 4 - This paper scale applies to China National Standard (CNS) A4 specification (210 &gt;&lt; 297 public) 7 - 1322144 A8 B8 C8 D8 VI. Patent application scope 8 (4-chlorophenyl)-1,2,3,4-tetrahydro-2,2,4 6-tetramethylporphyrin, 1-ethylindolyl-4(4-bromophenyl)- 4 tetrahydrogen-2,2 6-tetramethyl D-quinoline-ethenyl-6-amino- 4-(4-aminophenyl)- 1,2,3 ' 4-tetrahydro- 2,2 , 4-trimethylquinoline, 6-amino-1-ethylcarbonyl-4-ylphenyl-1,2,3,4-tetrahydro-2, 2'4-trimethylquinoline, 1 -Ethylamino-6-amino _4_phenyl-1 2 4 -tetrahydro-2,2,4_trimethyl π quinine Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing 3 . The quinone hydrogen quinolin derivative or a pharmaceutically acceptable salt thereof, wherein Y - X is C (0) _NH, 0C ( 〇) - N Η or C ( 0 ) - 〇. 4. A tetrahydroquinoline derivative or a pharmaceutically acceptable salt thereof according to claim 2 or 3, wherein γ_χ is C(0)-oxime. 5. A tetrahydroquinoline derivative or a pharmaceutically acceptable salt thereof according to claim 2 or 3, wherein ri is (1-4C)alkylcarbonyl. 6. A tetrahydroquinoline derivative or a pharmaceutically acceptable salt thereof according to claim 2 or 3, wherein each of R2, R3 and R5 is (1 _ 4 C )alkyl. 7. A tetrahydroquinoline derivative or a pharmaceutically acceptable salt thereof according to claim 2 or 3, wherein R6 is (6-10C) aryl, (3-9C)heteroaryl 6- 10C) an aryl (1-4C) alkyl group or a (3-9C) heteroaryl (1-4C) alkyl group, whereas if the (6-100C) aryl group is a phenyl group, the phenyl group may be optionally a hydroxy group. , Amine, halogen, paper scale applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the note on the back and fill out this page) -8- 1322144 A8 B8 C8 D8 VI. Apply for a patent Range 9 'nitro", trifluoromethyl, cyano, (1-4C)alkyl, -4C)alkenyl, (2 - 4C)alkynyl, (1 - 4c)yl' (1-4C) ( 2) alkylamino, (6 - l〇c) aryl, (6-10C) aryloxy, (6-10C) aryl (4C) alkoxy, (3-9C) heteroaryl, (3 — 9C aryloxy '(3-9C)heteroaryl(1-4C)alkoxy-1-4C)alkylcarbonylamino, (1-4C)alkylcarbonyloxy, 6C)cycloalkylcarbonyloxy, (i_4C) alkoxycarbonyl (1 C) alkoxycarbonyloxy, (1-4C) alkoxy (1-4C (2 alkoxy 1 - hetero) (3 -4 Please read the notes on the back of the carbonyloxy group, carbonyloxy group, sulfonyloxy 6 - 10C) arylcarbonyloxy 1-4C) alkanesulfonyloxy 3 - 9 C ) 6 - 1 〇 c 3 — 9 C) Heteroarylsulfonyloxy (6 - 1 0 C ) Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperative Printed Carbamoyl, (2-6C) Heterocycloalkylcarbamyl, — 10C) (di)arylamino, (3-6C)cycloalkyl 3-6C)cycloalkyl(1-4C)alkyl, (2-6c cycloalkyl or (2-6)heterocycloalkyl (1 _4C)alkyl group. However, all aryl and heteroaryl groups in R6 may be optionally substituted by one or a substituent which is selected from the group consisting of a hydroxyl group, an amine group, a halogen group, a fluoromethyl group, and a cyano group. 1 - 4 C ) Alkyl, (2 _ 4 C ) alkynyl-4 C) (di)alkylamino. Alkane aryl) aryl 4 C aryl cleavage 2 4 ) heterogeneous, nitro C, 1-4C alkoxy or 8 · tetrahydroquinoline derivative as claimed in claim 2 Salts are acceptable for use in fertility control. The standard of the paper is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -9
TW91111887A 2002-06-03 2002-06-03 Tetrahydroquinoline derivatives TWI322144B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91111887A TWI322144B (en) 2002-06-03 2002-06-03 Tetrahydroquinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91111887A TWI322144B (en) 2002-06-03 2002-06-03 Tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
TWI322144B true TWI322144B (en) 2010-03-21

Family

ID=45073914

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91111887A TWI322144B (en) 2002-06-03 2002-06-03 Tetrahydroquinoline derivatives

Country Status (1)

Country Link
TW (1) TWI322144B (en)

Similar Documents

Publication Publication Date Title
EP1406628B1 (en) Tetrahydroquinoline derivatives
JPH07215863A (en) Non-peptidotachykinin receptor antagonist
AU2002317848A1 (en) Tetrahydroquinoline derivatives
SA516380585B1 (en) Histone Demethylase Inhibitors
JP2002535244A (en) Non-peptide GnRH agent, preparation method thereof and intermediate
JP4545000B2 (en) Tetrahydroquinoline derivatives and their use as FSH receptor modulators
TW200806650A (en) P38 inhibitors and methods of use thereof
JP2002510630A (en) Gonadotropin-releasing hormone antagonist
JP2002510628A (en) Gonadotropin-releasing hormone antagonist
JP2002510685A (en) Gonadotropin-releasing hormone antagonist
RU2328488C2 (en) Tetrahydroquinolin derivatives, based pharmaceutical composition based on them and their application as fertility modulator
JP2002510684A (en) Gonadotropin-releasing hormone antagonist
TWI322144B (en) Tetrahydroquinoline derivatives
TW200918058A (en) TSH receptor antagonizing tetrahydroquinoline compounds
TW483896B (en) Condensed-ring thiophene derivatives, their production and use
KR20050085694A (en) Tetrahydroquinoline derivatives and their use as fsh receptor modulators
MXPA05006767A (en) Tetrahydroquinoline derivatives.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees